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SUMMARY
Patients undergoing surgery must be maintained at a certain anesthetic state
(loss of sensation) in order to prevent the awareness of pain and to attenuate the
body's stress response to injury. In order to provide safe and adequate anesthesia,
the anesthesiologist must guarantee hypnosis and analgesia (pain relief). Hypnosis,
referred to as depth of anesthesia, is a general term indicating unconsciousness and
absence of postoperative recall of events. Generally, anesthesiologists use bispectral
index (BIS) and mean arterial pressure (MAP) as the indirect measurements of
hypnosis and analgesia, respectively. Anesthetics (or hypnotics) and opioids are
administered to regulate hypnosis and analgesia, respectively in the patient during
the surgery.
Automation of anesthesia is very useful as it will provide more time and exibility
to anesthesiologists to focus on critical issues that may arise during the surgery. Un-
til now, much of the research in this area has dealt with the automatic manipulation
of single drug and manual administration of other drugs. Also, there have been only
a few studies on using model predictive control (MPC) for anesthesia regulation.
The objective of this work is to develop the MPC control strategies for regulation of
hypnosis with various drugs and thoroughly evaluate and compare MPC controller's
performance with the performance of other control structures. The second objec-
tive of this study is to develop and evaluate the MPC control structure to nd the
best infusion rates of the anesthetic and analgesic drugs by considering drug inter-
action for simultaneous regulation of hypnosis and analgesia such that the patient's
anesthetic state is well regulated even as the side eects (due to overdosage) are
minimized. This assures cost reduction as a result of minimized drug consumption
and shortened postoperative recovery.
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Specically, MPC was designed for regulation of hypnosis using BIS as the con-
trolled variable by manipulating the inhalational drug isourane. Because of poten-
tial patient-model mismatch, several simulations are conducted to check the robust-
ness of the MPC controller. The performance of the proposed MPC scheme has also
been tested for several set-point changes, various disturbances in the form of surgical
stimuli, noisy measurement signals and loss of measurement signal which can occur
during the surgery. The performance of the proposed MPC scheme for the above
mentioned scenarios is comprehensively compared with that of PI, PID, PID-P,
PID-PI, and RTDA (Robustness, set-point tracking, disturbance rejection, aggres-
siveness) controllers which were also designed for regulation of hypnosis with isou-
rane using BIS as the controlled variable. Next, the performance of the proposed
MPC scheme is compared with that of cascade internal model controller (CIMC) and
cascade controller with modeling error compensation (CMEC) which are available
in the literature.
Next, control strategies such as MPC, IMC, MEC and PID were extended to
regulate hypnosis by infusing intravenous drug propofol with BIS as the controlled
variable. The performance of the advanced, model based controllers (MEC, IMC and
MPC) is comprehensively compared with that of PID controller for the robustness,
set-point changes, disturbances and noise in the measured BIS.
Finally, MPC strategy was extended for the simultaneous regulation of hypnosis
and analgesia by infusing propofol and remifentanil. The infusion rates of both drugs
are determined according to the hypnosis level and the surgical stimulus leading to a
satisfactory regulation of the patient hypnotic and analgesic state. The performance
of the MPC is compared with that of decentralized PID controllers developed for
simultaneous regulation of hypnosis and analgesia. Results show the lesser usage of
hypnotic drug when compared to the controllers designed to regulate hypnosis alone
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1.1 Anesthesia and its Regulation
Clinical anesthesia is a reversible pharmacological state which can be dened as a
balance between the triad combination of hypnosis, analgesia and muscle relaxation
of the patient (see Figure 1.1). In clinical practice, anesthesiologists administer
drugs and adjust several infusion devices to achieve desired anesthetic state in the
patient (Linkens & Hacisalihzade 1990) and also to compensate for the eect of
surgical stimulation while maintaining the important vital functions of the patient.
Hypnosis





Fig. 1.1. Schematic representation of triad combination of anesthesia
Hypnosis describes a state of anesthesia which is not only related to unconscious-
ness of the patient but also to the disability of the patient to recall (amnesia) events
that occurred during surgery. The disability to recall is important because dur-
ing surgery, when the patient is intubated and ventilated articially, he/she might
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feel pain and be aware of the surgical procedures but cannot \communicate". This
awareness can be a traumatic experience, which should be avoided by maintaining
sucient hypnosis level in the patient. Hypnosis is provided by administration of
hypnotic agents, which are either inhalational (e.g., isourane) or intravenous (e.g.,
propofol). An acceptable metric to quantify the depth of hypnosis is the bispectral
indexTM (BIS) (Rampil 1998).
Analgesia describes the disability of the patient to perceive pain (antinocicep-
tion). Surgical procedures are painful and can discomfort the patient. Analgesia
is provided by administration of analgesics (opioids). A stable analgesia state is
partially responsible for a stable hypnosis and vice versa. Therefore, it is important
to have a \balance" between hypnosis and analgesia. At present, there are no spe-
cic measures to quantify pain intraoperatively and mean arterial pressure (MAP)
is often used as an indirect measure.
Muscle relaxation (relaxing skeletal muscles) is a standard practice during induc-
tion of anesthesia to facilitate the access to internal organs and to depress movement
responses to surgical stimulations. Many surgical procedures require skeletal muscle
relaxation to improve surgical conditions or to reduce surgical risks caused by move-
ments of the patients. Relaxation is provided by administration of neuromuscular
blocking agents (NMBs) and can be assessed by measuring the force of thumb ad-
duction induced by stimulation of the ulnar nerve or by single twitch force depression
(STFD).
In addition to maintaining the balanced anesthetic depth, the anesthesiologist is
also responsible to maintain vital functions of the patient throughout the surgery.
The main vital functions are heart rate (HR) and blood pressure (BP) which are
continuously monitored. These are considered as the principal indicators for hemo-
dynamic stability and are maintained by administration of anesthetics and/or re-
placement of blood volume by isotonic solutions or (rarely) by blood transfusions. As
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spontaneous breathing is suppressed by several anesthetics, the patient is ventilated
articially to ensure sucient blood oxygenation and carbon dioxide elimination.
The anesthesiologist's tasks are usually routine in nature. However, critical inci-
dents (e.g., sudden changes in blood pressure, cardiac arrest etc.) occur during the
surgery and the anesthesiologist needs to be prepared for such critical incidents and
minimize subsequent negative eects on the patient. The importance of automation
is therefore in reducing the workload of the anesthesiologist's routine tasks and al-
low him/her to monitor and deal with critical aspects of the surgery. Automated
systems have the advantage of not being subject to distraction or fatigue, thus they
maintain the same vigilance level throughout the surgical procedure. Continuous
regulation of physiological variables by an automatic control system in combination
with supervision by the anesthesiologist should obviously reduce critical incidents
and reduce patient risk. Other patient benets include faster recovery, reduction in
postoperative care, and fewer side eects due to improved stability of the controlled
parameters. Also, because of automatic control, drug consumption will be mini-
mized and lead to the reduction in health care costs. The motivation for designing
automatic control system that infuses drugs based on patient's anesthetic level relies
on the following facts:
 Better anesthetic depth is achieved compared to manual administration be-
cause the controlled variables are sampled more frequently leading to active
adjustment of the delivery rate of suitable drugs (O'Hara et al. 1992, Glass &
Rampil 2001).
 High quality of anesthesia can be obtained by providing drug administra-
tion guidelines, which pursue multiple control objectives such as tracking of
reference signals, disturbance compensation, handling of input and output
constraints and drug minimization.
3
1.2 Drugs and their Eect during Anesthesia
 A well-designed drug administration policy should suppress the inter- and
intra-individual variability thus avoiding both overdosages and underdosages.
It must also compensate for dierences in surgical procedures and anesthetic
regimes (Bailey & Haddad 2005).
 A well-designed automatic control system can tailor the drug dosage based on
the patient's response. This leads to minimal drug consumption, less intra-
operative awareness and shorter recovery times, thereby decreasing the cost
of surgery and also the cost of postoperative care. Overall, this improves the
patient's rehabilitation and safety during and after the surgery (Mortier et al.
1998, Absalom et al. 2002, Bailey et al. 2006).
1.2 Drugs and their Eect during Anesthesia
During the surgical process, anesthesiologists administer a combination of anes-
thetics, opioids, and neuromuscular blocking (NMBs) drugs by adjusting respective
infusion devices to maintain an adequate level of anesthetic depth (a triad combi-
nation of hypnosis, analgesia and muscle relaxation). The development of safer and
more potent agents with faster onset of eect and, in certain cases, shorter duration
of action, has greatly impacted anesthesia practice. Nowadays, small drug quan-
tities used in appropriate combination can produce a balanced state of anesthesia
while minimizing side-eects.
1.2.1 Anesthetics
Inhalation gases like isourane are still the anesthetic agents on which stan-
dard practice is based. However, intravenous agents like propofol are increasingly
employed in the operating room. Currently, administration of intravenous agents
is geared towards facilitating intubation, compensating for undesirable changes in




Commonly used inhaled anesthetics are isourane, desurane, and sevourane in
conjunction with nitrous oxide. All these drugs induce a decrease in MAP (analgesic
eect) when administered to healthy subjects. A major advantage with inhaled anes-
thetics is that the drug uptake in the arterial blood stream can be precisely titrated
by measuring the dierence between the inspired and expired concentrations. Hence,
inhaled gases are extensively used in the maintenance phase of anesthesia process.
Intravenous anesthetics
Intravenous anesthetics are also called as hypnotics as they do not provide anal-
gesic eects like inhaled anesthetics at normal clinical concentrations. However,
they are strongly synergistic when used in conjunction with opioids, both in terms
of hypnosis and analgesia. Propofol is a commonly used intravenous anesthetic drug
for induction and maintenance of anesthesia process. Its higher lipid solubility per-
mits ready penetration of the blood brain barrier resulting in rapid induction, fast
redistribution and metabolism. Hence, it can be easily used in infusion schemes as
it provides very fast emergence compared to most other drugs used for the rapid
intravenous induction of anesthesia. This is one of the most important advantages
of propofol compared to other intravenous anesthetic drugs.
Inhalation versus intravenous anesthetics
Inhaled anesthetics are used by many anesthesiologists for the maintenance of
anesthesia while the intravenous anesthetics are used at the start of the surgical
procedure as they provide rapid induction of anesthesia. Inhaled anesthetics have
both hypnotic and analgesic properties while intravenous anesthetics have hypnotic
property only. Inhalational anesthetic concentrations in the brain can be easily
measured as they are closely related to the exhaled vapor concentration. The lung
5
1.2 Drugs and their Eect during Anesthesia
partial pressures of inhaled anesthetics are closely related to the vapor concentra-
tion in the brain, and the control problem is signicantly simplied since additional
states are measurable. On the other hand, the concentration of intravenous drug
in the brain is not easily measurable. As a result, anesthesiologists face more chal-
lenges in titration of these drugs as they do not have any feedback on plasma drug
concentration (which is directly related to concentration of drug in the brain). How-
ever, since intravenous agents are more specic than inhaled anesthetics, they give
more exibility in separately controlling the functional components of anesthesia.
Also, the short acting characteristic of intravenous drugs result in too strong eects
over too short periods of time when they are administered as boluses. The inabil-
ity to measure the plasma concentration of intravenous drugs makes it dicult for
anesthesiologists to set precise rates of infusion. The result is that they usually rely
on experience as well as on infusion regimens published in medical journals. Such
estimations can lead to error, and the resulting titration might not correspond to
the actual needs of the patient.
1.2.2 Analgesics
Morphine, fentanyl, alfentanil, remifentanil, sufentanil analgesics (opioids) are
unique in the sense that they provoke analgesia without loss of touch, temperature
and consciousness, when administered in small doses. They act as agonist at specic
receptors within the central nervous system (CNS) and to a much lesser extent in
peripheral tissues outside the CNS. Their principal eect may be the inhibition of
neurotransmitter release, resulting in a signicant analgesic eect.
Unlike most anesthetics, opioids do not depress the heart and are thus partic-
ularly suitable for cardiac anesthesia. Opioids can produce unconsciousness when
used in very large doses. This observation has led some authors to believe that opi-
oids should be considered to be anesthetics. However, the state of unconsciousness
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brought by opioids is not reliable. It has been shown, for instance, that they cannot
fully replace inhaled vapors to provoke an adequate state of hypnosis. However,
their use can reduce the requirements of inhaled anesthetics by up to 50%. Also,
the sedative eect of opioids is opposed by the presence of acute pain. Hence, even
though patients in severe pain receive very large amount of opioids, they can remain
aware. In current practice, therefore, opioids are almost always supplemented by
other anesthetics.
Five opioid compounds are used in clinical anesthesia: morphine, hydromorphine,
fentanyl, sufentanil and remifentanil. While they all have similar eects, their char-
acteristics dier tremendously due to large dierences in their lipid-solubility. Of
particular interest is remifentanil, a relatively new agent introduced in the mid
1990s. Remifentanil is used mostly to provide the analgesic component of general
anesthesia. The potency of remifentanil is twice that of fentanyl and its eect-site
equilibration time is slightly smaller than that of alfentanil (1.1 min). The main
characteristics of remifentanil are: brevity of action, rapid onset, noncumulative
eects in inactive tissues and rapid recovery after termination of the infusion. Its
brevity of action allows patients to recover rapidly from undesirable opioid-induced
side-eects such as ventilatory depression.
1.2.3 Neuromuscular blocking agents
Neuromuscular blocking agents (NMBs) block transmission of nerve impulses
at the neuromuscular junction, causing paralysis of the aected skeletal muscles.
Because NMBs may also paralyze muscles required for breathing, mechanical ven-
tilation should be given to maintain adequate respiration. These are used together
with hypnotics and/or analgesics to produce skeletal muscle relaxation to facilitate
intubation of the trachea and to provide optimal surgical conditions. NMBs do not
have any hypnotic or analgesic properties but may sometimes cause transient hy-
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potension. Also, these do not interact in a clinically signicant way with anesthetics
and opioids. NMBs such as Vecuronium, mivacurium and rocuronium are normally
used when a longer eect is desired.
1.3 Measuring and Monitoring of Anesthesia
Measuring the state of anesthesia is still a grey area. Advances have been made
towards the use of the electroencephalogram, usually in its processed forms (e.g.,
bispectral index, wavelet index, auditory evoked potentials), for correlated measures
of consciousness. Some interesting work has also been done in the eld of analgesia
monitoring where surrogate measures have shown some potential. Nevertheless,
the major problem faced by most of these sensors is the established correlation
accuracy between their output and consciousness. While extensive studies have
been conducted to demonstrate such properties, the reality is that only directly
measurable vital signs have a true meaning. Such measurements are already used by
anesthesiologists (BIS, MAP, BP, HR and respiratory rate etc.) in their practice, but
still these are indirect measurements. The argument that favors the use of surrogate
measures is their ability to remove delays and time constants from the normally
used vital signs. This is emphasized by the existence of sensors working better than
others when it comes to the estimation of the anesthetic state. Continuous responses,
reduced delay and time constant in the determination of the consciousness/analgesia
level will favor the use of that particular sensor.
Another limiting factor on current sensors is their sampling frequency. The per-
formance limitations generated by a slow sensor can be overwhelming, e.g., the
inability of the controller to correct for fast transients (Bibian et al. 2003).
More important than the accessibility of the measurement is the reliability of
the sensor to the rough environment of the operating room that is valued highly.
The sensor needs to cope with articially created (e.g., electrocautery, x-ray, move-
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ment) and patient generated (e.g., muscular, neural) artifacts. Surrogate measures
can also be inuenced by other factors such as the administration of other drugs
(e.g., pre-medicants), blood loss, etc., which will result in unreliable measurements.
It is therefore mandatory to establish a therapeutic window and normal working
conditions for each sensor.
All these issues indicate the need to spend signicant eort toward improving
the sensors. The other direction of development is the combined use of surrogate
measures with measurable vital signs for better estimation of the anesthetic state.
1.3.1 Measuring and monitoring of hypnosis
Until recently, no direct measure of hypnosis was available and arterial blood
pressure has been used as an indirect indicator. In 1996, an EEG derived parameter
(Bispectral Index (BIS), Aspect Medical Systems) was introduced, which correlates
with the hypnotic component of anesthetic state. More recently, few promising
monitors (NeuroWave by CleveMed, Ohio, 2003) have been released. These recent
monitors have yet to establish a signicant market share. Description of few mea-
sures for hypnosis are given below. However, this thesis work considers only BIS as
a measure of hypnosis.
Bispectral analysis
A commercial monitor (approved by U.S. Food and Drug Administration (FDA))
from Aspect Medical systems (Newton, MA, USA), is available to measure the depth
of hypnosis in terms of Bispectral IndexTM (BIS). It is an electroencephalogram
(EEG) derived variable that quanties the power and phase couplings of the EEG
at dierent frequencies (Sigl & Chamoun 1994). Multivariate statistics have been
used to combine the dierent features into a single indicator as BIS (Rampil 1998).
Values of BIS lie in the range 0-100. A value in the range 90-100 represents a fully
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awake state, whereas values around 60-70 represents light hypnotic state and 40-50
represents moderate hypnotic state. BIS has been found to be a reliable measure
of sedation irrespective of the kind of anaesthetic drug, and has been successfully
tested for isourane, propofol and midazolam (Glass et al. 1997).
Power spectrum analysis
 Median edge frequency (MEF) is the frequency below which 50% of the signal
power is present i.e., it splits the power spectrum distribution into two parts
of equal power.
 Spectral edge frequency (SEF) is the frequency below which 95% of the signal
power is present (Schwilden et al. 1987, 1989).
Wavelet analysis
The wavelet transform is a computationally eective signal processing method
and the wavelet coecients derived from the EEG can be used to derive a univariate
descriptor of the depth of hypnosis (Bibian et al. 2001). WAVCNS (wavelet based
anesthetic value for central nervous system) is used as a measure to quantify (on a
100-0 scale like BIS) cortical activity. The WAVCNS technology is currently being
used in NeuroSENSETM Monitor (CleveMed NeuroWave Inc., Ohio, 2003).
Entropy analysis
Entropy analysis is used to quantify the complexity of of EEG and (Electromyo-
gram) EMG signals. Datex-Ohmeda EntropyTM Module (Datax-Ohmeda Division,
Instrumentarium Corp., Helsinki, Finland) (Vierti-Oja et al. 2004) is available to




Midlatency auditory evoked potentials (MLAEP) are the specic features of
EEG, which are extracted from transitory oscillatory signals generated by auditory,
visual or tactile stimulation. Distinct shape of this feature enables to distinguish
between dierent unconsciousness levels of the patient. However, poor signal to
noise ratio limit the usage of this feature. Recently, a new method was developed
for extracting auditory evoked potential waves from the EEG signal by employing an
autoregressive model with an exogenous input (ARX) adaptive model (Struys et al.
2002, 2003). Devices based on such features/models have yet to become universally
accepted in surgical environment.
1.3.2 Measuring and monitoring of analgesia
There is no direct measure to quantify analgesia when the patient is in an uncon-
scious state. The widely accepted indirect measures are the hemodynamic variables
like mean arterial pressure (MAP) (Gentilini et al. 2002, Mahfouf et al. 2003) and
heart rate variability (HRV) (Pomfrett 1999).
1.4 Conducting the Anesthesia Process
The general anesthesia process is a combination of three distinct phases which
are induction, maintenance and emergence.
1.4.1 Induction
This phase is the most critical part of the anesthesia process because patient's
state will be changed from alert to an anesthetized state. This can generally be
achieved by bolus intravenous injection of drugs (such as propofol) that work rapidly.
Normally, inhalational agents are not used to induce anesthesia because of their
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slower onset. With the intravenous agents, respiratory and cardiovascular reexes
are depressed with the sudden onset of unconsciousness.
In addition to the anesthetic drug, a bolus dose of opioid must be given to most
of the patients. Hypnotic drugs and opioids work synergistically to induce anesthe-
sia. These opioids help in reducing the undesirable responses like increase of blood
pressure and heart rate which may occur because of endotracheal intubation and
incision of the skin.
It is to be noted that these drugs induce respiratory depression which in turn
reduces the spontaneous breathing. If surgery requires NMBs, the respiratory de-
pression is even more. Thus, securing of the airway is the crucial step in the induction
process and articial ventilation is important for the patient.
This induction process usually lasts for only a few minutes.
1.4.2 Maintenance
This phase is the most stable part of anesthesia process. At this point, the
eect of propofol infused during induction phase begins to wear o, and the patient
must be kept anesthetized with a maintenance agent. This is usually done with
the infusion of inhalational anesthetic agents such as isourane, desurane etc. into
the lungs of the patient. These may be inhaled as the patient breathes himself or
delivered under pressure during each mechanical breath of the ventilator.
However, appropriate levels of anesthesia must be chosen based on the surgical
procedure. Also, before any surgical incision or any other stimulating surgical event,
infusion of a small bolus dose of opioid is required. The inhalational agent also acts
as an analgesic, hence care must be taken when infusing opioid as higher doses can
lead to cardiac arrest. This maximizes patient safety and rehabilitation. In some
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cases, propofol is also infused continuously during the maintenance period along
with inhalational agents. This is because intravenous agents give faster onset and
also has fewer side eects compared to inhalational agents. A major drawback with
the intravenous agents is the unavailability of plasma drug concentration. In recent
years, total intravenous anesthesia (TIVA) is practiced by many anesthesiologists
because of their faster onset and the real time plasma drug concentrations are ob-
tained through pharmacokinetic (PK) models. But, large inter- and intra-patient
variability limits their usage in practice.
Irrespective of whether inhalational or intravenous agents are used, the desired
level of anesthesia should be maintained by giving the minimum amount necessary
for the planned surgical event. This needs a reliable measurement of anesthetic
depth and some of the available measures based on EEG were discussed earlier in
section 1.3.
If muscle relaxants are not required for the surgery, inadequate anesthesia becomes
easily noticeable. The patient will move or cough if the anesthetic is too light for
the stimulus being given. If muscle relaxants are required for the surgery, then the
patient is unable to demonstrate any of these phenomena. Hence, anesthesiologist
must rely on careful observation of measures of EEG, autonomic phenomena such
as MAP, tachycardia, sweating, and capillary dilation to decide on the required
actions to achieve the correct anesthetic depth. This requires experience and sound
judgment { failure to recognize such signs can lead to tragic consequences for the
patient. On the other hand, excessive anesthetic is associated with decreased heart
rate and blood pressure, and can be fatal if carried to extremes. Also, excessive
depth caused by higher usage of the drug results in more side eects and slower
awakening of the patient which leads to more time required for the postoperative




Towards the end of the surgical procedure, anesthesiologists are also responsible
to plan for patient's emergence from anesthesia. This is achieved by decreasing the
infusion of the anesthetic or by entirely switching o the drug infusion and allow
time for them to be exhaled by the lungs. This is usually done during skin closure
so that patient wakes up faster at the end of the surgery. Also, adequate analgesic
may be given to keep the patient comfortable in the recovery room. If articial
ventilation is used, the patient is restored to breathing by self as anesthetic drugs
dissipate and the patient emerges to consciousness.
1.5 Modeling Anesthesia
The design of an automatic controller for regulating anesthesia requires a reliable
mathematical model of the patient to represent anesthesia (hypnosis and analgesia)
dynamics and also appropriate hardware devices to measure and monitor the depth
of anesthesia. The mathematical model should accurately represent the relation-
ship between administered anesthetic dose and its eect on the patient in terms of
hypnosis and analgesia.
Various methods are available for modeling biological systems for the distribution
of drugs and their eect. The pharmacology of anesthetic drugs includes linear
pharmacokinetic (PK) eects as well as nonlinear pharmacodynamic (PD) eects.
Pharmacokinetics (PK) represent the dynamic process of drug distribution in the
body while pharmacodynamics (PD) represents the description of the eect of the
drug on the body. Empirical, compartmental and physiological models are the three
main forms to model the anesthesia process.
Empirical models are black box models, and relate the inputs to outputs by an-
alytical expressions, such as the sums of exponentials. Compartmental models are
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formulated on the basis of the minimal number of compartments that adequately ts
observed data. Physiologically based models are the most realistic representation
of drug kinetics, because the parameters relate directly to physiology, anatomy and
biochemistry.
Compartmental models are subdivided into simple, catenary and mammillary
models. The simple model can be viewed as a special case of the other two model
types. The peripheral compartments of the mammillary model are arranged around
a central compartment. All peripheral compartments are linked via micro rate
constants to the central compartment. The compartments of the catenary model
are on the other hand arranged in the form of a chain (Bibian et al. 2001).
In general, mammillary compartmental models are widely used in the PK-PD
modeling of inhalational and intravenous administered drugs (Parker et al. 1999,
Bibian et al. 2005). A typical structure is shown in Figure 1.2. The pharmacoki-
netics is described by one central compartment (compartment 1 in Figure 1.2) and
one or more peripheral compartments, which are linked to the central compartment
(compartment 2 in Figure 1.2). Drug distribution is described by the micro rate
constants (k12 & k21) and by the elimination rate constant (k10). The pharma-
codynamics are described by an additional dynamic compartment, the eect-site
compartment (E) and a static dose-eect nonlinearity (fractional Emax model). The
identication of PK/PD model is normally a two step approach.
1. The pharmacokinetics are identied on the basis of input-output data se-
quences. A drug bolus, u is administered (either as inhalational or intravenous
dose) and the time course is measured by taking blood samples. The infusion
time of the bolus is generally neglected and therefore the response can be
viewed as an approximation of an impulse response. For inhalational drug,
lungs compartment and for intravenous drug, the \blood" (or more appropri-
ately, \plasma") compartments are used as central compartment (compart-
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ment 1). Depending on the characteristics of the drug, one or more peripheral
compartments (compartments 2, 3, 4, 5 etc.) are added.
Emax model









Fig. 1.2. Schematic representation of combined respiratory, PK and PD models
Typically, the concentration in the central compartment versus the drug
eect shows a time lag. In pharmacology, this is often referred as \hysteresis"
because a plot showing drug concentration after a bolus versus drug eect
looks similar to a hysteresis. Moreover, the peripheral compartments are used
to describe the characteristic time course of drug concentration in the central
compartment. Generally, the time course of drug eect will dier from the
time course in any of the compartments.
2. To describe this time lag, an eect-site compartment (compartment E in Fig-
ure 1.2) is added to the PK model. The eect-site concentration is only used
to account for the time lag between drug concentration and drug eect. A
standard fractional sigmoid Emax model (PD model) relating concentration at
the eect-site to drug eect is added.
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1.6 Automatic Control Strategies to Regulate Anesthesia
Measurement and control of anesthesia during surgery is one of the important
problems in biomedical eld (Morari & Gentilini 2001, Bibian et al. 2003, Dua &
Pistikopoulos 2005). In clinical practice, anesthesiologists administer drugs (either
inhalational or intravenous) by adjusting several infusion devices to achieve desired
anesthetic state in the patient (Linkens & Hacisalihzade 1990). Figure 1.3 depicts
the Input/Output (I/O) representation of the anesthesia process during surgery.
The components of anesthesia (hypnosis, analgesia and muscle relaxation) are un-
measurable and they must be assessed by correlating them to available physiological
























Fig. 1.3. Input/Output (I/O) representation of the anesthesia problem
The above discussion concludes that the anesthesiologist is acting as a manual
feedback controller. It is dicult to tailor the drug administration to the needs of
each patient in time because of the considerable inter-patient variability (based on
patient's weight, age, sex etc.) that exists. Moreover, it will be more challenging
for the anesthesiologist to adjust the infusion rates of several drugs simultaneously
for regulation of several variables (BIS, MAP etc).
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In clinical anesthesia, automatic regulation, i.e., closed-loop control of infusion of
drugs has been shown to provide more benets when compared to manual admin-
istration (O'Hara et al. 1992). Drug delivery using the automatic control system
clinically adjusts the rate of anesthetic uptake according to a patient's status by
monitoring changes in BIS, MAP, blood pressure and heart rate etc. Also, closed-
loop system would precisely titrate infusion agents according to the patients' needs,
resulting in lesser intra and postoperative side-eects. In addition, by judiciously
selecting the set-points, the patient will be quickly driven into an appropriate anes-
thetic depth according to the requirements of the surgery and the anesthesiologist's
judgment. Also, to be on safe side, anesthesiologists administer large amounts of
drugs than required to reduce the chances of intraoperative awareness in the patient.
Even though, this this is not a major health risk, overdosing is one of the main rea-
sons for patients' discomfort (nausea, vomiting) and slow recovery. Closed-loop
systems based on new state-of-the-art monitors of the anesthetic state can signi-
cantly reduce drug consumption and lessen recovery times. Overall, this improves
patient rehabilitation and also reduces the costs associated with drugs and postop-
erative care (Bailey & Haddad 2005). One more important issue that motivates the
design of automatic drug infusion systems is that it can impose bounds on dosages
and infusion rates to avoid underdosing and overdosing while keeping monitored
variables within bounds.
Drugs are often combined for anesthesia during surgery because they interact
synergistically to create the desired anesthetized state. For example, induction of
anesthesia may consist of intravenous administration of a benzodiazepine before
induction, a hypnotic to achieve loss of consciousness, and an opioid to blunt the
response to noxious stimulation. Because of the synergistic interaction between
the drugs, the anesthesiologist faces diculty in adjusting the amount of infused
drugs to get the desired level of hypnosis and analgesia. Closed-loop controllers can
overcome this diculty by titrating suitable doses of the drugs to tightly maintain
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the variables at desired set-point. Also, with automatic controllers, the degree of
drug interaction of dierent drugs can be quantied by assessing the dierences
in drug consumption. Hence, adequate anesthesia can be obtained by maintaining
several variables at their desired levels by infusing several drugs and from the control
engineering point of view, it can be inferred as a multi input-multi output (MIMO)
problem.
All the above mentioned favorable characteristics of automatic drug infusion sys-
tems have motivated researchers to propose several automatic closed-loop control
strategies for regulation of anesthesia. The control strategies applied for regulation
of several variables by infusing various drugs in clinical anesthesia will be discussed
in detail in chapter 2. Most of the closed-loop systems are still under development
and in testing phase only. Wide use of closed-loop systems in clinical anesthesia
will happen only when the developed systems pass all the requirements suggested
by anesthesiologists. These requirements include the achievement of robust and
stable performance in spite of considerable variability existing among the patients
(inter-patient variability).
Despite the advantages mentioned above, there are considerable challenges asso-
ciated in the design of closed-loop systems for anesthesia. Some of the important
challenges addressed in this work are listed in section 1.7.
1.7 Motivation and Scope of the Work
The purpose of current research project is to investigate how modern multivariate
model based control techniques can be eectively applied to clinical anesthesia.
Following are the specic issues that provide motivation for this thesis work.
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Challenges in automatic control of anesthesia
 Patient variability results from dierences in the way the drug distributes and
eliminates by the body's renal and liver function, cardiac output, patient's
age, body mass and also from how drug aects the corresponding state of
the patient. Genetic dierences and enzyme activity might also alter the
mechanism of action of the drug. Also, some patients might be hypo-reactive
(insensitive patients) and some may be hyper-reactive (sensitive patients).
Due to signicant inter- and intra-patient variability, there is considerable
uncertainty in dose-response models obtained from population based studies.
The designed feedback controller must be stable and perform satisfactorily in
spite of considerable variability in the patients.
 When using dierent drugs in combination to regulate several components of
anesthesia, synergistic interactions among the drugs play an important role.
Synergistic eect means that the resulting eect is greater than what could
be expected from simple superposition. Synergism often appears when using
hypnotics in combination with opioids. From a control point of view, such
interactions between drugs tend to generate an important cross-coupling. Only
very few models of such coupling have been discussed in the literature (Vuyk
1997, Vuyk et al. 1997, Minto et al. 2000, Vuyk 2001). These models are
mainly mathematical expressions that describe drug interactions at steady
state. There is a need for developing closed-loop feedback controllers in a
multivariable framework by accounting for the cross coupling introduced by
the PD interactions of the drugs. This would be useful for optimizing the drug
dosages while not compromising on patient's comfort and safety during and
after the surgery.
 Constraints on drug delivery rate and maximum amount of drug infused are
most important for patient safety. Hence, these constraints should be explicitly
included in the designed closed-loop feedback controller algorithm.
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 Better regulation of anesthetic depth is possible by regulating as many number
of variables as possible with the automatic controllers. This mainly depends
on the success of measuring the key variables during the surgery. For ex-
ample, on-line concentration measurement is possible with inhalational drugs
(alveolar concentration) whereas this is not the case with intravenous drugs
(concentration in blood plasma). Hence, predicting the concentrations and
also at the same time updating the assumed nominal PD model parameters
with some of the key predicted parameters would be helpful for better regula-
tion of the anesthetic depth. This would be more helpful in the design of fault
tolerant controllers i.e., if any one of the feedback signals accidentally discon-
nects or gets corrupted by artifacts (highly noisy environment), the feedback
controller can still rely on other reliable measurements for eectively control-
ling the anesthetic depth.
 Set-point changes are often made in the variables during the surgery depend-
ing on the surgical procedure being performed. The controller should perfectly
respond to these changes without any considerable delay in the response. Also,
disturbances of varying magnitudes occur during the surgery depending on the
strength of the surgical stimuli. The designed controller should satisfactorily
guarantee the required anesthetic depth in the patient despite these distur-
bances.
 Success of feedback controllers for anesthesia largely depends on the sensors
that measure the dierent components of anesthesia. Hypnosis and analgesia
are the result of dierent mechanisms and there are no universally accepted
metrics to quantify them. Even though it is not possible to assess them di-
rectly, indirect measures like BIS for hypnosis and MAP for analgesia have
been used by anesthesiologists over the past several years. These signals are
more prone to noise because of electromyographic (EMG) inference caused by
movement of the patient and also electromagnetic inference caused by other
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monitors or sensors. The designed feedback controller should consider these
limitations associated with sensors and should perform satisfactorily.
1.8 Organization of the Thesis
The above mentioned issues and challenges are considered in this thesis. A de-
tailed description of the scope of the present work and organization of the thesis is
given below.
An extensive review about various control strategies applied in clinical anesthesia
has been covered in chapter 2.
Several clinical studies comparing closed-loop to manual anaesthesia control per-
formance have been reported (Schwilden & Schuttler 1995, Kenny & Mantzaridis
1999, Struys et al. 2006). These studies used proportional-integral-derivative (PID)
controllers as well as model based controllers. However, there is a need for com-
prehensive evaluation of closed-loop systems to establish their safety, reliability and
ecacy for anesthesia regulation. This requires a detailed evaluation of promising
and/or recent controllers for a range of patients and conditions via simulation. The
study in chapter 3 investigates the performance of single-loop PI, PID, cascade PID-
P, PID-PI, MPC and RTDA (robustness, set-point tracking, disturbance rejection,
aggressiveness) controllers for closed-loop regulation of hypnosis using isourane
with BIS as the primary controlled variable. MPC is a popular control scheme
used in process industries over the past three decades for complex multivariable
constrained processes (Ogunnaike & Ray 1994, Qin & Badgwell 2003). The MPC
scheme employs an identied model to predict the future behavior of the system
over an extended prediction horizon and computes the optimal manipulated vari-
able moves to achieve the desired process states (Morari & Lee 1999). An important
issue in the design of drug infusion systems is the need to impose bounds on dosages
and infusion rates to avoid underdosing and overdosing (Rao et al. 2001). While
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most control strategies handle such constraints in an ad hoc manner, the primary
advantage of MPC is its ability to handle constraints explicitly. Its optimization-
based framework allows computation of the optimal infusion rates subject to input
and output constraints. For example, constraints on drug infusion rates and out-
put variables (such as maintaining BIS and/or MAP above a minimum value) can
be explicitly specied and the resulting control actions will satisfy them. RTDA
is the most recent control scheme used for single input-single output (SISO) sys-
tems (Ogunnaike & Mukati 2006). This controller design combines the simplicity
of PID controller with the advantages of MPC. Extensive simulations are carried
out using a model that simulates patient responses to the drug, surgical stimuli
and sudden failure of the feedback signals which can happen anytime during the
surgery. Results of this comprehensive evaluation show that model predictive and
RTDA controllers provide better regulation of BIS compared to the other controllers
tested.
In chapter 4, the performance of the designed MPC controller is comprehensively
compared with the performances obtained with other controllers available in lit-
erature such as cascade internal model controller (CIMC) and cascade controller
with modeling error compensation (CMEC). The proposed MPC uses the approxi-
mate linear PK-PD model in the controller design and regulates patient's BIS and
endtidal concentration by manipulating the infusion rate of isourane. Because of
potential patient-model mismatch, several simulations are conducted to check the
robustness of the MPC controller. The proposed MPC scheme has also been tested
for disturbance rejection and noisy measurement signals.
The above studies are limited to closed-loop regulation of hypnosis with the in-
halational drug isourane. The study in chapter 5 investigates the performance of
MPC, IMC, MEC and PID controllers for closed-loop regulation of hypnosis using
intravenous drug propofol with BIS as the primary controlled variable. The main
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objective in chapter 5 is to comprehensively compare the performance of MPC, IMC,
MEC and PID controllers for hypnosis control. Cascade control structure is imprac-
tical for propofol-based hypnosis regulation because of unavailability of continuous
propofol concentration measurement. Hence, MEC and IMC strategies (and not
their cascade versions) are employed here. The performance of the advanced, model
based controllers (MEC, IMC and MPC) is comprehensively compared with that of
PID controller. Extensive simulations are then conducted to test the robustness of
the four controllers, by considering parameter variations in the selected model to
account for patient-model mismatch. The four controllers are tested for set-point
changes, disturbances and noise in measured BIS. Results of these simulations point
to the choice of the best controller(s).
While studies in chapters 3, 4 and 5 are limited to regulation of hypnosis by
infusing either isourane or propofol, the study in chapter 6 investigates the simul-
taneous closed-loop regulation of hypnosis and analgesia by infusing intravenous
drugs propofol and remifentanil. BIS and MAP are indirect measurements for hyp-
nosis and analgesia respectively. The objective in chapter 6 is to determine the best
infusion rates of the hypnotic and analgesic drugs such that the patient's anesthetic
state (i.e., BIS and MAP) is well regulated and the side eects (due to overdosage)
are minimized. A MPC strategy that incorporates a PK model and a PD interaction
model is devised for the simultaneous administration of both the drugs. The infu-
sion rates of the drugs are determined according to the BIS and MAP measurements
which can be disturbed by noise and surgical stimuli. The performance obtained is
compared with the performance of decentralized PID controllers developed for simul-
taneous regulation of hypnosis and analgesia. Results of these simulations indicate
that the MPC performs better. The simulation results are also used to compare the
amount of drugs infused with the controller designed to regulate hypnosis alone.
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Conclusions from the present work and key areas identied for future work are
presented in chapter 7.
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Chapter 2
LITERATURE REVIEW
2.1 Feedback Control in Anesthesia
Biomedical applications of process control have been attracting attention of re-
searchers for several years now (O'Hara et al. 1992, Doyle et al. 2007, Marchetti
et al. 2008). As seen in chapter 1, automatic feedback control of anesthesia is an
important and challenging biomedical problem. During surgery, anesthesiologists in-
fuse several drugs by adjusting respective infusion devices to maintain an adequate
level of anesthetic depth (a triad combination of hypnosis, analgesia and muscle
relaxation) (Linkens & Hacisalihzade 1990). Hypnosis is related to unconsciousness
and also to the inability of the patient to recall events (amnesia). An automatic
controller that infuses drugs based on patient's anesthetic level may provide several
benets. One of the signicant benet is it will reduce the anesthetist's workload
during the surgery and allow him/her to monitor and deal with other critical aspects
of the surgery such as blood loss and sudden blood pressure change etc.
However, to design a feedback controller for controlling anesthesia (hypnosis and
analgesia), a reliable mathematical model of the patient to represent anesthesia
is required. In addition, appropriate hardware devices to measure and monitor
the level of anesthesia are mandatory (Schwilden et al. 1989). In general, mam-
millary compartmental models are widely used to describe the pharmacokinetics
(PK) and pharmacodynamics (PD) of inhalationally and intravenously administered
drugs (Bibian et al. 2005). The mathematical model employed in recent studies on
hypnosis and/or analgesia control is a series combination of a linear PK model and
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a nonlinear PD model. A theoretical eect compartment is also attached to the cen-
tral compartment to represent the time-lag between observed eect and the central
(plasma) concentration. The values for parameters used in the PK and PD models
are the population mean values; consequently, the \patients" would have parameters
that are dierent from the nominal values used in the controller design. The PK
model parameters can be approximately estimated through covariate adjustments
of weight, age and sex, but it is not possible to estimate the PD parameters. The
designed controller should be robust and result in stable responses for all patients
characterized by a range of PD parameters (Grieder et al. 2001). Hence, the con-
troller design should take into consideration inter- and intra-patient variability and
provide robust performance against uncertainties like modeling errors, noisy mea-
surements and signal failure. In the following paragraphs, a literature survey on the
feedback control of hypnosis and analgesia is provided.
2.2 Feedback Control for Hypnosis
The concept and implementation of closed-loop anesthesia have been investigated
via numerous attempts by controlled titration of various anesthetic drugs through
feedback control. As stated earlier, BIS is a measure derived from EEG to measure
the depth of anesthesia. BIS accurately predicts the return of consciousness (Doi
et al. 1997, Glass et al. 1997), and it has been developed and veried based on
the EEG recordings of about 5000 subjects. More than 600 peer-reviewed articles
and abstracts describe the clinical evaluation of BIS as specied in the literature
(www.aspectmedical.com). More than 2.5 million patients (around the globe) have
been monitored with BIS.
Anesthesiologists have a choice of administering dierent combinations of drugs to
maintain the required anesthetic depth in the patient during surgery. Though spe-
cic drugs may belong to the same class of drugs (e.g., opioids), they have dierent
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properties. An extensive review of the anesthetic drugs is available in the litera-
ture (Stoelting & Hillor 2006). Generally, for regulation of hypnosis, inhalational
drug isourane and intravenous drug propofol are most commonly used.
Schwilden et al. (1987) and Schwilden & Schuttler (1995), tested a model-based
adaptive controller by infusing methohexital and isourane, respectively using me-
dian edge frequency (MEF) as a controlled variable. Adaptation was done if the
system output diverged too far from its reference. Results on volunteers have shown
that a constant excitation is necessary to guarantee the reliability of the feedback
quantity (otherwise the volunteers were drifting from a drug-induced unconscious-
ness into a natural sleep). This technique also works for opioids (alfentanil). The
controlled drug was used as the only anesthetic agent during the maintenance phase.
Propofol is a common intravenous anesthetic drug and is widely used for both
induction and maintenance of general anesthesia during surgical operations because
of its favorable pharmacokinetic (PK) proles and inhibition of postoperative nausea
and vomiting (Huang et al. 1999). Many closed-loop feedback systems for propofol
infusion have been proposed in the literature. Schwilden et al. (1989) developed
a model-based adaptive controller using the median frequency of the EEG as the
controlled variable. A linear two-compartmental PK model was used to describe
the relation between infusion rate of propofol and its plasma concentration. A
closed-loop proportional-integral (PI) controller was developed by Kenny & Ray
(1993, 1995) and Kenny & Mantzaridis (1999) to control the depth of anesthesia
using auditory evoked potential index (AEPindex), a parameter derived from EEG,
as the controlled variable. The AEPindex is used to determine the target blood
concentration of propofol required to induce and maintain general anesthesia. They
observed that there was no incidence of intraoperative awareness and only minimal
patient movement during surgery. Cardiovascular stability and overall control of
anesthesia were satisfactory. Nayak & Roy (1998) and Huang et al. (1999) also used
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AEPindex as the controlled variable by infusing halothane and propofol. They used
a fuzzy rule-based control system regulating either the vaporizer or giving reference
to a target-controlled infusion (TCI) device. These works mostly emphasize the
hypnosis index derived from midlatency auditory potentials using wavelet analysis.
Due to the extensive averaging needed, a value quantifying the level of hypnosis was
calculated every 3 min.
After the commercial availability of BIS monitor in 1998, Mortier et al. (1998)
developed a model based adaptive closed-loop feedback system for propofol infusion
based on BIS as a controlled variable for spinal anesthesia. Later, the designed
model-based adaptive control system was tested for general anesthesia (Struys et al.
2001). They used a lookup table of the drug pharmacodynamic model to set the
target plasma concentration of a target controlled infusion device in order to reach
and maintain a given hypnotic reference. The authors concluded that the closed-
loop system worked better than the manual administration of propofol in a clinical
setting. Sakai et al. (2000) proposed a closed-loop PID control system for propo-
fol administration using BIS as the controlled variable. They concluded that their
system provided intraoperative hemodynamic stability and a prompt recovery from
the sedative-hypnotic eects of propofol. Morley et al. (2000) also investigated the
performance of a PID controller for administering propofol using BIS as the tar-
get for control. They claimed that the closed-loop systems oered no performance
advantage over conventional, manual anesthetic administration. They dened per-
formance based on intraoperative conditions and initial recovery characteristics. Ab-
salom et al. (2002) developed a similar closed-loop PID controller using BIS as the
controlled variable, and a propofol targeting central plasma concentration-controlled
infusion system as the control actuator. The authors concluded that further studies
are required to determine if control performance could be improved by changing the
proportional gains of the PID controller or by using an eect-site-targeted propo-
fol controlled infusion system. Later, they modied their control algorithm to a
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target-controlled infusion (TCI) system which regulates eect-site concentration,
and proved it to be more ecient. However, the PID controller still faced some
stability problems (Absalom & Kenny 2003).
Struys et al. (2004) proposed a simulation methodology to test the performance
of the two published controllers (PID and model based controllers). They modeled
a disturbance signal which is caused by stimulation during the surgery. This dis-
turbance signal together with random noise was added to the original BIS signal.
Simulations were then carried out by feeding back this combined BIS signal to the
controller. This study concluded that model-based controller outperformed (lower
median absolute prediction error for BIS targets 30 and 50) the conventional PID
controller. In a recent review, Struys et al. (2006) noted the need for further evalu-
ation of existing closed-loop systems to establish their safety, reliability and ecacy
for anesthesia regulation. This requires a comprehensive evaluation of promising
and/or recent controllers for a range of patients and conditions via simulation.
The closed-loop control system proposed by Gentilini et al. (2001a) emphasize that
the problem is far from being solved due to the challenges posed by the intra- and
inter-patient variability. They used the cascade internal model controller (CIMC)
to regulate the level of hypnosis by infusing isourane. The cascade type control
structure has a master controller which controls BIS and a slave controller that regu-
lates the endtidal concentration (concentration of isourane in the exhaled breathing
gas). The basic approach in IMC framework is to invert the minimum phase com-
ponents of the plant model and multiply it with the lter transfer function to get
the controller proper (Morari & Zariou 1989, Brosilow & Joseph 2002). In the
work of Gentilini et al. (2001a), the PK model is linear and minimum phase, and
hence directly invertible. However, the PD model is nonlinear and the inversion is
not straightforward. Therefore the PD model was linearized and then inverted. The
designed controller thus has the inverted plant model and this compensates for the
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plant dynamics. The tuning of the IMC lter is relatively easy with the lter time
constant as the only tunable parameter. Inter-patient variability can be handled by
selecting the lter time constant appropriate to each patient. The clinical results
provided by Gentilini (2001c) showed that the CIMC strategy worked well when
compared to manual drug administration.
Recently, Puebla & Alvarez-Ramirez (2005) proposed an adaptive feedback con-
troller for regulation of hypnosis based on modeling error compensation (MEC)
approach by infusing isourane. They used the BIS as the measure of level of hyp-
nosis and employed it as the controlled variable. They also used the cascade control
conguration along with the MEC approach. The central idea in the MEC-based
approach is to lump input-output uncertainties into a term whose trajectory is es-
timated and compensated via a suitable algorithm (Alvarez-Ramirez et al. 2002).
This approach automatically takes care of the inter-patient and intra-patient vari-
ability to achieve stable control of BIS. Several tuning parameters characterize the
MEC-based cascade control scheme. Puebla & Alvarez-Ramirez (2005) suggest val-
ues for these tuning parameters. An important feature of the MEC-cascade scheme
is that the linearization of the PD model is not required and that the model need not
be minimum phase. The adaptive nature of this control strategy has the potential
to minimize the eect of disturbances and patient-model mismatch. The cascade
MEC controller (CMEC) performed better than the CIMC controller (Puebla &
Alvarez-Ramirez 2005).
2.3 Feedback Control for Analgesia
Opiates are used for intraoperative and postoperative pain treatment. In the
postoperative setting, the drug infusion rate is adjusted according to the patient's
pain level. With patient-controlled analgesia (PCA), the patient can regulate the
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administration of opiates without supervision of the medical sta (Liu & Northrop
1990, Johnson & Luscombe 1992).
The intraoperative administration of opiates is not directly related to pain treat-
ment, since no specic measures of pain are available when the subject is uncon-
scious (Habibi & Coursin 1996). The International Association for the Study of
Pain denes pain as an \unpleasant sensory and emotional experience associated
with actual or potential tissue damage". Consequently, it may even be improper to
speak about \pain" during general anesthesia when the patient experiences uncon-
sciousness.
Several feedback controllers have been proposed in the literature for analgesia.
For analgesia, where no reliable measure exists, it was noted that the patient's
autonomic responses to painful stimulations are present both in the awake state and
with hypnotic and analgesic agents (Pinskier 1986). An acceptable task would be
to deliver the sucient amount of drugs to reduce the eect of pain. Hemodynamic
variables such as mean arterial pressure (MAP), cardiac output (CO) and heart
rate (HR) have been considered as the measures to represent pain (Isaka & Sebald
1993, Rao et al. 2000). Surgical stimulation causes increase in MAP and HR - these
reactions must be minimized during surgery (Prys-Roberts 1987). Generally, these
reactions can be decreased by infusing opiates which can decrease autonomic stress
reactions to surgical stimulation (Ausems et al. 1988, Kaplan 1993). MAP control is
also crucial during surgery to improve surgical visibility and to guarantee adequate
perfusion to internal organs (Furutani et al. 1995).
Several open- and closed-loop approaches have been investigated to improve the
intraoperative administration of analgesics. Ausems et al. (1986) titrated opiate
infusion to several clinical endpoints such as MAP and HR, somatic responses, and
autonomic signs of inadequate anesthesia, such as sweating and lacrimation. In their
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clinical validation, infusion rate of alfentanil was gradually decreased in the absence
of signs of inadequate analgesia as a remedy to prevent overdosing.
Schwilden & Stoeckel (1993) tested a closed-loop controller which administers
alfentanil to maintain the patient's median frequency (MF) of the electroencephalo-
gram (EEG) at 2-4 Hz. Despite the adequate performance of the control system,
it is questionable to look at the MF of EEG as the clinical end-point for analgesic
drugs. Further, if used in combination with analgesics, hypnotics compromise the
reliability of MF by inducing burst-suppression episodes in the EEG (Rampil 1998).
Moreover, from clinical data, it is not clear whether and how noxious stimuli aect
the EEG (Rampil & Laster 1992, Kochs et al. 1994).
Recently, Gentilini et al. (2002) proposed a model predictive control (MPC) strat-
egy for the regulation of analgesia by infusing alfentanil with MAP as the controlled
variable. They claimed that the proposed control worked well in the clinical setting.
The above studies are encouraging because they conrm the possibility of achieving
good hemodynamic control with opiates. They also suggest that an optimal closed-
loop system aiming at the regulation of MAP with opiates must include a way to
minimize the drug consumption and must oer some degree of freedom to adjust
the infusion rate based on other qualitative signs of inadequate analgesia.
2.4 Feedback Control for Simultaneous Regulation of Hyp-
nosis and Analgesia
Drugs are routinely combined to regulate several states of anesthesia during
surgical process. Some drug combinations interact synergistically to create the de-
sired anesthetic state. The goal of combining these synergistic interacting drugs is
to decrease toxicity by minimizing the overdosage while maintaining or increasing
ecacy of the drugs (Rosow 1997). Generally, anesthesia is maintained with a com-
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bination of a hypnotic (e.g., propofol, isourane) to achieve loss of consciousness
(reduce BIS levels) and an analgesic or opiate (e.g., remifentanil, alfentanil, nitrous
oxide) to blunt the response to noxious stimulation (reduce MAP and HR) (Vuyk
1997). There are several studies conducted by researchers for simultaneous auto-
matic regulation of anesthetic drugs. Linkens (1992, 1994) was probably among
the rst to attempt the control of distinct anesthesia components simultaneously
(analgesia and areexia) using dierent agents (atracurium and isourane) by using
expert systems and fuzzy logic. An in-depth analysis of such cases reveals the need
for strong knowledge of the patient model. The intra- and inter-patient variability
makes the establishment of a priori rules very dicult.
Several studies reported that propofol-remifentanil combination improved the
speed of induction and also lower propofol concentrations are sucient for loss of
consciousness in the presence of high remifentanil concentrations (Bouillon et al.
2004, Schraag et al. 2006). Propofol is a common intravenous hypnotic drug while
remifentanil is a short acting opioid, provides hemodynamic stability and rapid post-
anesthetic emergence and recovery. Although higher remifentanil concentrations
may enhance the control of somatic and autonomic responses, there is a threshold
on it, i.e., further increase in its concentration may not decrease the concentration
of hypnotic needed for the desired unconscious state. Also, as the opioid decreases
the spontaneous ventilation of the patient, it should not increase beyond the thresh-
old associated with adequate spontaneous ventilation, otherwise recovery is delayed.
Hence, hypnotic propofol and analgesic remifentanil dosages should be administered
optimally by taking the synergistic interaction between these two drugs into consid-
eration. This will help to achieve the objectives of a stable intra-operative course
and rapid recovery to consciousness with adequate spontaneous ventilation (Glass
1998). Hence, drug interactions provide additional challenges for optimal drug dos-
ing strategies during anesthesia and also play an important role in the regulation of
the anesthetic states.
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In general, propofol-remifentanil anesthesia is associated with the most rapid re-
turn of consciousness after any infusion duration compared with fentanyl, sufentanil
or alfentanil (Egan 2000, Epple et al. 2001). Another benet of remifentanil is that,
even at suboptimally high remifentanil concentrations, return of consciousness is
postponed marginally only. Remifentanil reduces the propofol dose requirement be-
cause of its synergistic interaction with propofol and this may lead to hemodynamic
stability during the surgical process (Mertens et al. 2003). In elderly patients, or
patients with cardiovascular instability, high remifentanil/low-propofol anesthesia
may be associated with increased hemodynamic stability during induction of anes-
thesia (Kern et al. 2004, Johnson et al. 2008). Also, the level of postoperative pain
experienced by the patient is not only inuenced by the type of surgery but also
by the propofol-remifentanil concentrations used intraoperatively. When propofol
is given in high concentrations, the need for intraoperative opioids are low. At the
end of the surgery, when propofol infusion is discontinued, the opioid concentration
may then appear to be insucient for adequate postoperative analgesia. To prevent
this from happening, in anticipation of severe nociception, intraoperative low opi-
oid concentrations may be avoided (Lichtenbelt et al. 2004). These aspects should
be taken care when designing an automatic control protocol for Total Intravenous
Anesthesia (TIVA), i.e., to optimize intravenous delivery of these two synergistically
interacting drugs.
Several studies in the literature have considered the simultaneous administra-
tion of propofol and remifentanil to regulate hypnosis and analgesia, and supported
their favorable synergistic interactions (Bouillon et al. 2004, Mertens et al. 2003).
Generally, these works consider a closed-loop feedback approach for administration
of propofol and open-loop administration of remifentanil or both drugs by open-
loop administration (Struys et al. 2006). Schraag et al. (2006) clinically supported
their synergistic interaction by considering automatic administration of propofol and
manual administration of remifentanil in 45 subjects. Milne et al. (2003) considered
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the closed-loop PID (proportional-integral-derivative) control of propofol by using
auditory evoked potential index (AEPindex) as the controlled variable and manual
administration of remifentanil. This work concluded that there is a synergistic inter-
action between propofol and remifentanil because propofol requirement considerably
decreased with the use of remifentanil to get the same level of unconsciousness. Men-
donca et al. (2006) considered adaptive predictive control strategy for the regulation
of BIS by automatic control of propofol and manual administration of remifentanil.
This single input-single output (SISO) controller design takes care of interaction
between the drugs which is modeled using a response surface.
Very few works in the literature have reported the closed-loop control of both
hypnosis and analgesia by simultaneous administration of hypnotic and analgesic
intravenous drugs. Zhang et al. (1998) reported a closed-loop system for TIVA by
simultaneously administering propofol and fentanyl. They studied the interaction
between propofol and fentanyl for loss of response to surgical stimuli using an un-
weighted least squares nonlinear regression analysis of human data. A look-up table
of optimal and awakening combinations of concentrations was built and used to de-
termine the fentanyl set-point according to propofol set-point. This approach was
limited to the control of the plasma concentration of propofol and fentanyl in dogs,
where the set-points were chosen to minimize the wake up time. Mahfouf et al.
(2005) considered the multivariable fuzzy control strategy for simultaneous regula-
tion of hypnosis and analgesia with propofol and remifentanil. The hybrid patient
model with the use of fuzzy concept they developed in another work (Nunes et al.
2005) was used for this closed-loop control. This model relates the HR, the systolic
arterial pressure and the AEP features to the eect concentrations of propofol and
remifentanil. Later, Nunes et al. (2006) improved the developed model by including
the eect of surgical stimulus. They demonstrated that the developed control algo-
rithm optimally administers these two drugs simultaneously in the operating theater
during surgery. Further, Cardoso & Lemos (2008) considered MPC strategy for the
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regulation of BIS by automatic control of propofol, taking the remifentanil dose
(used to regulate analgesia) as a disturbance to BIS because of synergistic eect of
remifentanil and propofol on hypnosis. This SISO controller design also takes care
of interaction between the drugs which is modeled using a response surface.
As an overall remark, it seems that, while the previous attempts were promising,
the researchers did not design controllers that completely account for inter-patient
variability and drug interactions. The results reported in the literature involve
healthy population and very few \patients". As a consequence, these closed-loop
achievements did not manage to convince practicing anesthesiologists about the
viability of the proposed methods. The work presented in the following chapters
answers some of the above mentioned issues by designing controllers which are able
to handle inter-patient variability as well as drug interactions.
2.5 Summary
Anesthesiologists have succeeded in making anesthesia a safe procedure. How-
ever, despite many studies and potential benets, closed-loop control of anesthesia
is not yet accepted for routine use. It is therefore natural to ask if automation in
clinical anesthesia is a valuable research endeavor. The reality is that, eorts in
fast acting drug development, sensor design and robust control complemented by
changes in the current anesthesia practice, are paving the way to closed-loop anes-
thesia control. Based on the literature (Kissin 2000, Glass & Rampil 2001, Mahfouf
2006), the control of anesthesia cannot be done based on a single feedback quantity.
It is necessary to consider all functional components of anesthesia when setting the
controller specications and requirements. To respect the current balanced anesthe-
sia practice, a rst step would be the regulation of both a hypnotic agent (e.g., such
as an inhalational anesthetic or intravenous anesthetic) and an opioid, in order to
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reach an adequate anesthetic state. Such a system would be directly usable in most
elective surgeries, where the use of neuromuscular blocking agent is not required.
From a control point of view, the challenges are many. First, such a controller
will need to account for inter- and intra-patient variability. Also, models linking
the infusion of drugs and their eects will need to be developed in a multivariable
framework so as to account for the interactions introduced by their PK and PD
dynamics. Finally, the nonlinear nature of the models developed and of the sensors
used to provide the feedback measurements will have to be included in the design.
On the way to such high level goals, the purpose of current research project is to
investigate how modern advanced control techniques like model predictive control
(MPC) strategy, can be eectively applied to clinical anesthesia. The resulting
closed-loop system would precisely titrate the infusion rate according to the patients'
needs, resulting in lesser intra- and postoperative side eects. Hence, MPC for
anesthesia control is studied and presented in the next 4 chapters.
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Chapter 3
EVALUATION OF PID, CASCADE, MODEL
PREDICTIVE AND RTDA CONTROLLERS FOR
REGULATION OF HYPNOSIS WITH ISOFLURANE
3.1 Introduction
Several clinical trials on closed-loop hypnosis regulation with isourane using BIS
as the controlled variable have already been conducted and reported in the litera-
ture (Morley et al. 2000, Gentilini et al. 2001a, Locher et al. 2004). These studies
used the ubiquitous proportional-integral-derivative (PID) controllers, as well as ad-
vanced model-based controllers. Because of the potential risks of such clinical trials,
they are often conducted on young, healthy patients undergoing noncritical surgical
procedures. As such, the ecacy of controllers in the presence of extreme patient
sensitivities (e.g., that of a young child or an elderly person) and unexpected surgi-
cal events (e.g., sudden loss of feedback signal) cannot be fully evaluated. Without
extensively validating the performance of controllers under these scenarios, the ap-
plication of such closed-loop systems remains limited. Recently reported simulation
studies for regulation of hypnosis with isourane are limited to the nominal pa-
tient (Dua & Pistikopoulos 2005, Puebla & Alvarez-Ramirez 2005). Therefore, it is
important to conduct a comprehensive evaluation of promising and/or recent con-
trollers for a range of patients and conditions via simulation (Struys et al. 2006,
Beck et al. 2007).
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The present chapter has two main objectives. One objective is to apply and evalu-
ate the promising model predictive control (MPC) and the recent RTDA (Robustness,
set-point Tracking, Disturbance rejection, Aggressiveness) approaches for hypnosis
regulation using BIS as the controlled variable by manipulating isourane infu-
sion. MPC is a popular control scheme that has been used by process industries
since many years, for the optimal, constrained control of complex multivariable pro-
cesses (Ogunnaike & Ray 1994, Qin & Badgwell 2003). Recently, this controller
has been used for the regulation of hypnosis with propofol (Furutani et al. 2005).
RTDA is the most recent control scheme used for single input-single output (SISO)
systems (Ogunnaike & Mukati 2006). Another objective is to extensively assess and
compare the performance of single-loop PID, cascade, MPC and RTDA controllers
for hypnosis control. The performance comparison of six controllers is conducted
by testing the robustness (considering parameter variations in the patient model to
account for patient-model mismatch), set-point changes, and disturbances during
the surgery. For realistic assessment, measurement noise is added to the BIS sig-
nal in the simulations. The study and ndings described in this chapter have been
reported in Sreenivas et al. (2009b).
3.2 The Mathematical Model
The model developed for hypnosis consists of three interacting parts: a respi-
ratory system model to describe the inhalation and exhalation of isourane, a PK
model for the distribution of isourane in the internal organs, and a PD model to
describe the eect of drug on the physiological variable, i.e., BIS (Gentilini et al.
2001a, Yasuda et al. 1991). Figure 3.1 presents a schematic of the respiratory system
- comprising of the isourane delivery circuit, and the PK and PD models.
A fresh ow of anesthetic-breathing mixture delivered by the pump combined with
the cleaned exhaled gas is sent to the patient's lungs. The pump stays at rest during
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Fig. 3.1. Schematic representation of combined respiratory, PK and PD models
patient from rebreathing the exhaled gases is guaranteed by unidirectional and pres-
sure relief valves. The breathing bag maintains positive pressure ventilation during
manual ventilation and compensates for excessive pressure during articial venti-
lation. The CO2 absorber uses soda-lime to remove CO2 from the exhaled breath
and this cleaned exhaled gas is added to the fresh gas ow, Q0. The combined gas
compensates for the uptake of anesthetic gases, O2, and the gas exhausted from the
pressure relief valve. The inhaled gas has the drug isourane which is taken into
the lungs from where it diuses into the blood and carried to all parts of the body
before nally distributing into various tissues (compartments). The mammillary
compartment model, i.e., PK model for the distribution of isourane is adopted
from Yasuda et al. (1991). The compartments are also depicted in Figure 3.1. Here,
the rst compartment is the central compartment which represents lungs, second
compartment indicates the vessel-rich group (VRG), third compartment indicates
the muscle group (MG), and fourth and fth compartments indicate the fat group
(FG). Also, the metabolism of the drug is assumed to occur in the second compart-
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ment, i.e., in VRG (liver). The PD part assumes some delay between the inhalation
of isourane by lungs and the dissolving of isourane in brain tissue thereby aect-
ing the hypnosis level. This eect on hypnosis level is represented by a nonlinear
equation relating the state variables and other system variables to BIS.
3.2.1 Model for the breathing system
The breathing system is approximated as a well-stirred tank (Gentilini et al.
2001a). The relation between inspired anesthetic drug concentration Cinsp (vol:%)
to the fresh anesthetic gas concentration C0 (vol:%) and parameters of the breathing




= Q0C0   (Q0  4Q)Cinsp   fR(VT  4)(Cinsp   C1) (3.1)
where V (`) is the volume of the breathing system, C1 (vol:%) is the alveolar con-
centration or endtidal concentration, measured as volume percent of the breathing
mixture, fR (min
 1) is the frequency of respiration, VT (`) is the tidal volume (vol-
ume of each breath), 4 (`) is the physiological dead space, 4Q (`=min) represents
losses of the breathing circuit through the pressure relief valves, and Q0 (`=min) is
the ow rate of fresh gas entering the breathing system. C0 (vol:%) is the manipu-
lated variable.
Typical ranges for the parameters of the respiratory system are (Gentilini 2001c):
Q0 = 1 - 10 `=min, fR = 4 - 25 min
 1, VT = 0.3 - 1.2 `, V = 4 - 6 `, 4 = 0.1
- 0.2 `, and 4Q = 0.1 - 0.5 `=min. The nominal values for the above parameters
are (Yasuda et al. 1991, Gentilini et al. 2001a): Q0 = 1 `=min, fR = 10 min
 1, VT
= 0.6 `, V = 5 `, 4 = 0.15 `, and 4Q = 0.2 `=min.
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3.2.2 Pharmacokinetic model
The PK model for distribution of drug is described by a mass balance between
the ve compartments which are attached to the central compartment. The main
assumption here is that the distribution of isourane is not aected by the presence
of other drugs. Hence, the resulting mass balance for isourane in the central















(Cinsp   C1) (3.2)
For all the remaining compartments (except second compartment), the correspond-








Rate constants and volumes of the dierent compartments of the
PK model (Yasuda et al. 1991)
Parameter Value Parameter Value
k12 1.26  0.024 min 1 k41 0.00304  0.00169 min 1
k13 0.402  0.055 min 1 k51 0.0005  0.000119 min 1
k14 0.243  0.072 min 1 V1 2.31  0.71 `
k15 0.0646  0.0414 min 1 V2 7.1  2.5 `
k20 0.0093  0.0137 min 1 V3 11.3  5.6 `
k21 0.210  0.082 min 1 V4 3.0  0.7 `
k31 0.023  0.0156 min 1 V5 5.1  4.1 `







  k21C2   k20C2 (3.4)
where k20 is the hepatic metabolism rate constant. Values of the parameters in
equations (3.2) { (3.4) are summarized in Table 3.1.
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3.2.3 Pharmacodynamic model
The above PK model is limited to the representation of distribution kinetics of
isourane into dierent compartments. A PD model is required to relate the eect
of drug and the hypnotic level (BIS). The PK model is attached to an eect-site
compartment model which represents the time lag between the distribution of drug
and its eect on BIS which is given by the nonlinear Hill equation (Beck et al. 2007).
The eect-site compartment accounts for the equilibration time between endtidal
concentration and concentration of drug in the central nervous system (brain). The




= ke0(C1   Ce) (3.5)
where ke0 is used to describe the time course of equilibration between the endtidal
and the eect-site. The eect-site concentration is related to BIS as (Hill equa-
tion) (Bibian et al. 2005):








4BIS = BIS  BIS0 (3.7)
and
4BISMAX = BISMAX   BIS0 (3.8)
where EC50 is the concentration of drug at half-maximal eect and represents the
patient's sensitivity to the drug, and  is a dimensionless parameter that determines
the degree of nonlinearity. BIS has the range between 0 and 100, where BIS0 = 100
denotes a fully conscious state and BISMAX = 0 denotes nil cerebral electrical activ-
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ity, i.e., deep coma. By substituting equations (3.7) and (3.8) into equation (3.6),
it can be written as:







The nominal values of the parameters ke0 = 0.3853min
 1, EC50 = 0.7478 vol:% and
 = 1.534 are obtained from the pooled analysis (Gentilini et al. 2001a).
3.3 Patient Model Variability Analysis
Patient variability in drug responses was simulated by varying important param-
eters in the PK and PD models. Open-loop simulations (by varying each parameter
independently) showed that the dominant PK parameters are breathing frequency
(fR), tidal volume (VT ) and lung volume (V1). In the PD model, all three PD param-
eters (EC50, ke0, and ) were determined to be important. Hence, these three PK
and three PD parameters were varied in three levels (except VT , which was varied
over four levels) within their ranges reported in Yasuda et al. (1991) and Gentilini
et al. (2001a), and then combined to give many PK and PD models with dierent
drug sensitivities. From these, 16 patient proles (PPs) with dierent combinations
of the PK and PD models were chosen, based on decreasing sensitivity to the drug.
Figure 3.2 shows the open-loop responses of all 972 (4  35) patients, along with
those of the 16 selected PPs. These data are for a step change of 0.7068 vol.% in
the input C0, which takes the nominal patient model to a BIS value of 50. This
step change is small compared to the C0 value that is used to induce hypnosis in
a patient, and, hence, a long time is required to attain steady state. Larger step
changes in C0 results in the nal BIS value being well below 50.
Figure 3.2 clearly shows that the 16 selected PPs cover the open-loop dynamics of
the 972 patients. The values of the PK and PD parameters for these 16 selected PPs
are given in Table 3.2, which also includes the steady-state gain of each PP to the
step change of 0.7068 vol.% in the input C0 value used for Figure 3.2. These gains are
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calculated based on the ratio of the dierence between the initial value and the nal
steady-state value of the output (BIS) to the given step input (C0, in units of vol.% ).
A high gain value in Table 3.2 indicates a sensitive patient and a low gain indicates
an insensitive patient. In the set of 16 proles constructed, more emphasis is placed
on insensitive patients, because controller performance is expected to degrade with
decreased sensitivity. Notably, PP 15 and PP 16 represent extremely insensitive
patients who are atypical, and controller performance is expected to be poor when
tested on these PPs.
Fig. 3.2. Comparison of open-loop responses of all 972 patients (rep-
resented by black lines) with the 16 selected patients (represented
by thick red lines)
Because of the uncertainty in the model parameters, it is useful to perform control-
lability, observability, and robustness analysis. These analyses were performed on
the linearized patient model (linearized at the operating point, BIS = 50). For all 16
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patient proles, all seven states were determined to be controllable and observable.
Furthermore, controllability analysis shows that the output (BIS) is controllable for
all the patient proles. Robustness analysis of the closed-loop system of the patient
model with the proportional-integral (PI) controller shows that the system is ro-
bustly stable for the deviations in the parameters considered. It furthermore shows
that the system is more sensitive to the parameters fR and EC50, which is consistent
with the open-loop sensitivity analysis.
Table 3.2
Sixteen PPs and their associated PK and PD parameters
Patient
Prole No.
PK Parameters PD Parameters Steady State
GainfR (min
 1) VT (`) V1 (`) ke0 (min 1) EC50 (vol:%) 
1 25 1.2 1.60 3.4890 0.5146 0.7915 82.8
2 25 1.2 1.60 0.3853 0.7478 1.5340 81.1
3 10 0.6 2.31 3.4890 0.5146 0.7915 74.1
4 (nominal) 10 0.6 2.31 0.3853 0.7478 1.5340 70.7
5 4 0.8 3.02 0.3853 0.7478 1.5340 67.0
6 4 0.8 3.02 3.4890 0.5146 0.7915 66.5
7 4 0.3 3.02 0.3853 0.7478 1.5340 62.2
8 4 0.3 3.02 3.4890 0.5146 0.7915 61.9
9 10 0.6 2.31 0.0804 1.0940 2.9130 60.2
10 25 1.2 1.60 0.0804 1.0940 0.7915 58.8
11 25 1.2 1.60 0.0804 1.0940 2.9130 58.3
12 10 0.6 2.31 0.0804 1.0940 0.7915 54.2
13 4 0.8 3.02 0.0804 1.0940 2.9130 40.1
14 4 0.8 3.02 0.0804 1.0940 0.7915 35.1
15 4 0.3 3.02 0.0804 1.0940 0.7915 30.1




The controller has to maintain BIS between 40 and 60 during the surgery. Ini-
tially it is assumed that the patient is in a fully conscious state (BIS u 100) and then
the controller is turned on to bring the patient to the surgical operating range (i.e.,
BIS u 50) and maintained there for the duration of the surgery. Also, C1 (vol:%)
is the endtidal concentration which can be measured online. C0 is the manipulated
variable which is restricted between 0 and 5 vol:% (Gentilini et al. 2001b, Puebla &
Alvarez-Ramirez 2005). The upper bound for C0 is 5 vol:% because high isourane
concentration may lead to hypnotic crisis, cardiac arrhythmia, or even cardiac ar-
rest. The minimum bound on C0 = 0 vol:% reects the impossibility to administer
negative concentrations of isourane.
Six controllers - identied as PI, PID, cascaded PID-P, cascaded PID-PI, MPC,
and RTDA - were designed for closed-loop administration of isourane to regulate
hypnosis. All these controllers were tuned for minimal integral of absolute error
(IAE) and smaller undershoot in BIS response in the induction period t = 0 { 100
min for the nominal patient. The performance of all the controllers was then checked
for the maintenance period (i.e., for t = 100 { 350 min) and was determined to be
satisfactory, before further testing and evaluation. Thus, controllers were designed
not just for the induction period but also for the maintenance period. PI(D) and
cascade controllers were designed with specic tuning rules and later were ne-tuned,
whereas MPC and RTDA controllers were tuned via a direct search optimization
algorithm.
3.4.1 PI controller design
For the PI controller, the nonlinear patient system was approximated by a linear
rst-order (FO) model. Time delay was neglected due to the large time constant
of the open-loop response. Linear approximation was performed near the operating
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point of the system (i.e., when BIS is near its intraoperative range of 40 { 60),
to facilitate the design of a controller that can respond quickly to changes in BIS
set-point and reject disturbances during the surgical period. Model parameters (K
= -53.3 vol:% 1,  = 317.5 min) were determined by minimizing the sum of squared
error (SSE) between the actual BIS response and the FO model response.
For FO systems with negligible time delay, three tuning rules are applicable:
internal model control (IMC) tuning, which was proposed by Chien & Fruehauf
(1990); the tuning method of Chen & Seborg (2002); and that of Haeri (2005). Of
these, the PI controller settings obtained by the method of Chen & Seborg (2002)
were determined to be better. These controller settings gave oscillatory response
for safe application (because of the nonlinear nature of the patient system), and
therefore the proportional gain was rst lowered, to reduce both proportional and
integral actions. The integral action was then independently increased, to hasten
the response that had become too sluggish. The initial and nal settings of the
PI controller are compared in Table 3.3. Similar ne-tuning was applied to design
other controllers that are studied in this chapter.
Table 3.3
Tuning rules and the PI controller settings
Kc I
Tuning rules (Chen & Seborg
2002)
(2c    2c )=(K 2c ) (2c    2c )=
Original settings -0.46 48.0
Final settings (with ne-tuning) -0.09 12.0
3.4.2 PID controller design
For the PID controller, the tuning methods of Wojsznis et al. (1999) and Friman
& Waller (1997), which are based on the ultimate gain and frequency of the system,
were used. Using P-only control, the ultimate gain and period of the nominal PP
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were determined to be -0.55 vol:% 1 and 12.7 min, respectively. The PID controller
was such that the derivative (D) action acted solely on the ltered BIS measurement,
while proportional (P) and integral (I) actions acted on the error in BIS. This is
to avoid sudden spikes in the controller output that are due to step changes in
set-point. Of the two methods attempted, the settings obtained by Wojsznis et al.
(1999) were determined to be better. The tuning rules of Wojsznis et al. (1999) and
the PID controller settings obtained are reported in Table 3.4.
Table 3.4
Tuning rules and their associated PID controller settings
Kc I D
Tuning rules (Wojsznis et al.
1999)
0:38Kcu 1:2Pcu 0:18Pcu
Original settings -0.21 15.2 2.29
Final settings (with ne-tuning) -0.08 11.5 0.30
3.4.3 Cascade controllers design
For the cascade controllers, the inner and outer controllers were tuned sequen-
tially. The inner process that related the endtidal concentration (C1) to the isou-
rane input was approximated by a FO model, and the model parameters (K =
1.06 vol:% 1,  = 432.5 min) were determined by minimizing the SSE value. The
controller settings were determined using the tuning method of Chen & Seborg
(2002), and their values are as reported in Table 3.5. With the inner loop closed,
the open-loop response of BIS to set-point changes in C1 was approximated by a
FO-plus-time-delay (FOPTD) model.
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Table 3.5
Cascade controller settings using the method of Chen & Seborg
(2002) for the slave controller and the IMC method (Chien & Frue-
hauf 1990) for the master controller
Setting
Slave Controller Master Controller
Kc I Kc I D
PID-PI
Original 5.5 14 -0.020 5.4 0.4
Final (Set 1) 5.5 14 -0.018 6.0 0.1
Final (Set 2) 5.5 14 -0.018 12.0 0.1
PID-P
Original 5.5 - -0.018 6.0 0.1
Final 4 - -0.025 6.0 0.05
Note: IMC tuning for a PID controller is given as follows: Kc =
( + =2)=[K(c + =2)], I = ( + =2) and D = =(2 + ).
Here, the action of the inner loop resulted in faster dynamics of the outer loop, and
the time delay became signicant when compared to the small time constant. Using
the model parameters that have been determined (K = -53.0 vol:% 1,  = 5.0 min
and  = 0.77 min), the controller settings were calculated using the IMC tuning
method (Chien & Fruehauf 1990) (see Table 3.5). Simulations showed that two sets
of settings (set 1, for PPs 1{14, and set 2, for PPs 15 and 16) are required for PID-PI
to guarantee satisfactory performance; only one parameter of the master controller
(I) was adjusted for easier implementation. Two sets need to chosen because the
patient models 15 & 16 are very insensitive and the set 1 which is designed based on
the nominal model is not giving the satisfactory performance for these two patients.
Further, PID-P controller settings were obtained by ne-tuning the PID-PI settings
with the integral action removed.
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3.4.4 Model predictive controller (MPC) design
This section describes the design of a MPC for the regulation of BIS. This control
scheme oers more advantages than the other control schemes; of these, the most
important one is that the constraints on inputs, input rates and outputs can be
considered in a systematic manner (Camacho & Bordons 2004). The MPC scheme
can prevent violations of input and output constraints, drive some output variables
to their optimal set-points while maintaining other outputs within specied ranges,
and prevent excessive movement of the input variables (Bequette 2003, Seborg et al.
2004). These properties make the MPC, the most attractive out of all the advanced
control schemes available presently.
In MPC scheme shown in Figure 3.3, the patient model is used to predict the
current value of the output variable (BIS). The dierence between the measured
BIS from the patient and the model output (residual), serves as the feedback signal
to the prediction block. With this residual and input variable, the prediction block
predicts the future values of output BIS. On the basis of these predicted BIS values,
the controller calculates the future input moves of which only rst input move is
implemented by the controller at current sampling instant. The linear MPC uses a



















Fig. 3.3. Schematic representation of the MPC scheme for regulation of BIS
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The basic objective of MPC as shown in Figure 3.4 is to determine the sequence
of M future control moves (i.e., manipulated input variable changes) such that the
sequence of P predicted responses (output variables) are close to the set-point. Even
though M control moves are calculated at each sampling instant, of which only the
rst input move will be implemented, and the optimization procedure repeats for the
next sampling instant based on the updated measurements of the output variables.










subject to absolute and rate constraints on the manipulated variable
umin  ui  umax (for i = k; k + 1; . . . , k +M   1)
ui 1  4umax  ui  ui 1 +4umax (for i = k; k + 1; . . . , k +M   1)
where, at each sampling instant i, 4ui = ui+1   ui is the vector of manipulated
variable deviations, ei = ri   yi is the vector of predicted errors, ri is the desired
set-point for BIS and yi is the vector of future BIS values those are predicted using
the linear model. The length of these vectors depends on the prediction (output)
horizon P and control (input) horizon M . Also, S and R are the weighting matrices
for BIS and input rate, respectively. These weighting matrices can be used to tune
the MPC controller to achieve the desired tradeo between output performance and
manipulated variable movement. The prediction horizon P is chosen on the basis
of open-loop settling time, whereas control horizon M is chosen on the basis of
tradeo between faster response (large value of M) and robustness (small value of
M). Generally, the chosen value for M is very small, compared to P . To reject
constant disturbances that are due to patient-model mismatch, the patient model is
augmented by the output disturbance model, which is an integrator that is driven
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by white noise. The measurement noise is modeled as Gaussian noise, having zero













k − 1 k k + 1 k + 2 k + M − 1
Fig. 3.4. Schematic representation of basic concept of MPC
A linear MPC requires an internal linear time-invariant model (e.g., a linear step
response model) to estimate the future output values using past and future values of
the inputs. Here, the overall dynamic system for the patient model is a combination
of respiratory system, PK and PD models, which are physically represented as a
series connection from vaporizer setting to concentration at the eect-compartment
in series with the BIS measurement as shown in Figure 3.1. Since, a mathemati-
cal representation of the system is necessary to implement the MPC scheme, the
above physical system can be represented mathematically as a series cascade of two
linear time-invariant systems followed by a static nonlinear system (which provides
the BIS values). The two linear time-invariant systems lead to two SISO models,
where the anesthetic gas (isourane) concentration C0 & the endtidal concentration
C1 are the input & output of the rst model, and the endtidal concentration C1 &
eect-compartment concentration Ce are the input & output of the second model.
The above two SISO models are in series with the nonlinear model which has eect-
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compartment concentration Ce as input and BIS as output. These combined linear
time-invariant systems and the linearized form of the nonlinear subsystem can be
represented in state-space form. The combined state-space model is given in equa-
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k1 = k10 + k12 + k13 + k14 + k15.264BIS
C1
375 =
2640 0 0 0 0 0 km
0 1 0 0 0 0 0
375Cinsp C1 C2 C3 C4 C5 CeT (3.13)
where, km is the linearization constant (equation (3.14)) obtained via linearization
of equation (3.9) around the reference concentration Ce = EC50. Using the values
of ke0 = 0.3853 min
 1, EC50 = 0.7478 vol:%and  = 1.534, km is calculated to be
-51.28.





As discussed above, in equation (3.13), BIS is a controlled variable and C1 is a
measured variable. In the present chapter, a step response model obtained from the
above state-space model is used in the MPC design. However, the state-space model
itself can be used directly in the MPC design (Wang 2004, Wang & Young 2006).
The MPC parameters that have been determined using direct search optimization
for hypnosis regulation are output (BIS) weight, S = 10; input rate (isourane)
weight, R = 1; prediction (output) horizon, P = 25; control (input) horizon, M =
2; and sampling interval of 5 sec.
3.4.5 Robustness, set-point tracking, disturbance rejection, aggressive-
ness (RTDA) controller design
RTDA controller involves a novel control scheme that is suciently simple to im-
plement and can achieve better control (Mukati & Ogunnaike 2004, Ch'ng & Laksh-
minarayanan 2006, Ogunnaike & Mukati 2006). Each of its four tuning parameters
(R, T , D and A) is normalized between 0 and 1 (with 0 being aggressive and 1
denoting conservative settings) and is related directly to one performance attribute
(namely, robustness, set-point tracking, disturbance rejection, and aggressiveness).
Hence, it is possible to tune each parameter independently to obtain the optimum
for the corresponding performance attribute. Thus, the RTDA controller avoids the
tuning problems that are associated with PID and MPC controllers. Furthermore,
RTDA controller uses simple linear MPC strategy based on the model approximated
as FOPTD as like in the design and tuning of PID controllers. The main features
of the RTDA controller for the control of hypnosis are described as follows.
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where y, u, K,  and  represents process output, input, time delay, time constant,
and gain, respectively.
Since, RTDA controller is designed in digital form, the discretised form of equa-
tion (3.15) is given by:
y^ (k + 1) = ay^ (k) + bu (k  m) ; k = 0; 1; 2; : : : (3.16)
where a = e
 t









and t is the sampling time.
Control strategy is implemented as at each time instant k, the computation of
current control move u(k) required to bring the predicted process output as close as
possible to the reference trajectory to be held over the prediction horizon, N beyond
the delay period, m. Based on this strategy, predicted process output is given by:
y^ (k +m+ i) = am+iy^ (k) + ai 1b (k;m) + biu (k) (3.17)
1  i  N , with  (k;m) =
mP
i=1
aiu (k   i), and ni = 1 ai1 a . Because of the use of a
FOPTD model in the place of original model, results in modeling error between the
actual process output and the model predicted output, e (k) = y (k)   y^ (k). The
modeling error, e(k) can be grouped into two types of estimates em(k) and eD(k) as
given by:
e (k) = em (k) + eD (k) (3.18)
where em(k) represents the inherent modeling uncertainties and eD(k) represents
the eects of unmeasured disturbances. By using Bayesian estimation procedure,
eD(k) can be estimated as:
e^D (k) = Re^D (k   1) + (1  R) e (k) (3.19)
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where R, (0 < R < 1), serves as the tuning parameter for robustness of the con-
troller. With the current error estimate, the future error is then estimated to update
the model prediction. This can be written as:






for m+ 1  j  m+N , where,
reD (k) = eD (k)  eD (k   1) (3.21)
and D, (0 < D < 1), serves as the tuning parameter for disturbance rejection.
Using the above outlined error estimation, the future prediction of y (k +m+ i)
over the N -step prediction horizon is given by updating the model prediction in
equation (3.17) with equation (3.20) is represented as:
~y (k +m+ i) = y^ (k +m+ i) + e^D (k +m+ i jk ) (3.22)
For the purpose of set-point (yd) tracking, a desired set-point trajectory (y
) needs
to be dened. The control action is computed based on at each instant k, the single
control move, u(k), is determined to minimize the error between predicted output
from the desired set-point trajectory, y, over the next N discrete steps in the future.
The desired set-point trajectory for the set-point, yd, is given by:





yd (k) ; 1  j  1 (3.23)
with T , (0 < T < 1), serves as the tuning parameter for set-point tracking. The
tuning parameter for overall controller aggressiveness, A, depends on the value of
N and which is given by:




Chapter 3 PID, Cascade, MPC and RTDA Controllers for Regulation of Hypnosis
Having dened a reference trajectory and derived the model prediction with error
correction, the current control action u(k) may now be solved for to obtain the least
deviation from the trajectory. Thus, the analytical solution for the optimization











 i (k) = y
 (k + i)  am+iy^ (k)  ai 1b (k;m)  e^D (k +m+ i jk )
For the present application, the values for RTDA parameters are found to be
R = 0.7675, T = 0.9884, D = 0.5033 and A = 0.6130 by using direct search
optimization algorithm.
3.5 Evaluation of Controllers
For realistic evaluation of controllers, white noise with zero mean and standard
deviation (SD) of 3 and 0.045 vol:% was added to the BIS and C1, respectively,
in all simulations. The SD value of 3 in BIS was used in the study of Struys et al.
(2004) and is also employed here. This value is consistent with our observations in
the local hospital. The SD value of C1 is not known, and so we used 0.045%, which
is 6% of the nominal value (similar to the SD value of BIS). For PI, PID, MPC, and
RTDA controllers, the BIS measurement was passed through a lter with a time
constant of 5 min, whereas, for cascade controllers, the BIS and C1 measurements
were passed through a lter with time constant of 1 and 5 min, respectively. For
cascade control, the inner slave controller led to faster dynamics of the outer BIS
loop, requiring a smaller lter time constant to avoid introducing too much lag into
the closed-loop response. Lower and upper limits of 0 and 5 vol:% (Gentilini et al.
2001a) were also placed on the controller outputs for all six controllers.
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Figure 3.5 shows the schematic representation of the closed-loop setup for regu-
lating hypnosis that uses BIS as the controlled variable. Figure 3.6 shows the BIS
response for all the patient sets reported in Table 3.2 with the PI controller (with
settings in Table 3.3) for a set-point change from 100 to 50. From this gure, one
can clearly observe that the second half of the PPs (PP 9{16) are more insensitive
(mainly because of lower fR, ke0 and higher EC50) compared to the rst half (PP
1{8). Furthermore, responses in case of PP 9, 11, 13 and 16 are oscillatory, because
of the higher  value that is associated with these patient proles. The settling
time, for the case of the most sensitive patient (PP 1), is 30 min, compared to 250
















Fig. 3.5. Setup of a feedback controller for hypnosis regulation
The IAE was used as the main performance criterion, and this value was calculated






Large IAE values indicate responses that are more sluggish and less desirable. How-
ever, they do not indicate the amount of oscillatory behavior. The performance
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criterion based on the performance error (PE), which was used by Struys et al.
(2004), was also employed.
PE =


























Insensitive patient (PP 16)
Nominal patient (PP 4)
Sensitive patient (PP 1)
Fig. 3.6. BIS response with PI controller for all 16 patients for a
set-point change from 100 to 50
The median performance error (MDPE) is a measure of bias and indicates if
the measured value is systematically above or below the set-point. MDPE can be
calculated from the expression
MDPE = MedianfPEi; i = 1; 2; : : : ; Ng (3.28)
where N is the number of PE values obtained for that particular subject. MDPE
is a signed value and therefore represents the direction of PE. It does not reveal
either the oscillatory behavior or the amplitude of possible oscillations in the out-
put (Struys et al. 2004). On the other hand, the median absolute performance error
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(MDAPE), gives the magnitude of control inaccuracy, with larger MDAPE values
being indicative of poorer closed-loop performance.
MDAPE = MedianfjPEij; i = 1; 2; : : : ; Ng (3.29)
Wobble is an index of time-related changes in performance; it measures the de-
gree of intra-patient variability in PEs. It also gives an indication of the degree of
oscillatory behavior.
Wobble = MedianfjPEi  MDPEj; i = 1; 2; : : : ; Ng (3.30)
Large wobble values indicate large variability in PE values and, thus, signify a more
oscillatory response.
In summary, conventional measures (such as IAE) indicates the controller perfor-
mance, in terms of sluggishness in response. These measures do not indicate the os-
cillatory behavior in the response. On the other hand, MDPE indicates whether the
measured values are systematically above or below the specied set-point. MDAPE
reects the magnitude of the control inaccuracy, similar to IAE. Finally, wobble is
an index of oscillatory behavior of the output response.
All the above criteria characterize only the output performance of the controller.
Because controller design invariably involves tradeo between input and output
performance, another measure of controller performance - an input performance
criterion (total variation, TV) - is also used. The required control eort is computed




jui+1   uij (3.31)
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The TV value of u(t) is the sum of all the up and down control moves. Thus, it is
a good measure of the smoothness of the manipulated input. The TV value should
be as small as possible.
Controller performance was evaluated mainly for the surgical stimuli and the
maintenance phase of the surgery. Less emphasis was placed on the induction pe-
riod during which a patient is brought into a hypnotic state. Induction is typically
conducted using open-loop intravenous injection of hypnotics to avoid the undesir-
able slow-acting characteristic of volatile hypnotics such as isourane. In fact, in
clinical trials to evaluate controller performance, such as those conducted by Morley
et al. (2000) and Struys et al. (2001), the induction of anaesthesia was done in open-
loop and the controller was switched on only after induction. The surgical stimuli
period in the present chapter spans time range of t = 100 { 160 min, during which
period the disturbance prole (Figure 3.7) adopted from Struys et al. (2004) was
introduced into the patient system by adding a pulse input of dierent strengths
to the BIS output from the PD model (see Figure 3.5). In Figure 3.7, stimulus
A mimics the response to intubation; B represents surgical incision, followed by a
period of no surgical stimulation (e.g., waiting for pathology result); C represents an
abrupt stimulus after a period of low level stimulation; D shows onset of a continuous
normal surgical stimulation; E, F, and G simulate short-lasting, larger stimulation
within the surgical period; and H simulates the withdrawal of stimulation during
the closing period (Struys et al. 2004).
The maintenance period refers to the entire intraoperative period during which the
surgery proceeds and a desired level of hypnosis must be guaranteed and maintained.
In the simulations, the maintenance period spanned a time period of t = 100 { 350
min and, hence, included disturbances that were due to both surgical stimuli (i.e.,
t = 100 { 160 min) and intraoperative set-point changes (i.e., t = 200 { 350 min).
The set-point changes and their time of introduction are given in Table 3.6. These
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do not include the BIS set-point change from 100 to 50 at t = 10 min, for the
induction.



















Fig. 3.7. Disturbance prole (adopted from Struys et al. (2004))
Table 3.6
Series of intraoperative set-point changes
Time, t (min) BIS set-point change
200 50 to 60
250 60 to 40
300 40 to 50
3.6 Performance of Controllers
Figure 3.8 shows IAE values obtained during the maintenance period for all six
controllers when implemented on the 16 PPs. Advanced controllers were determined
to give better closed-loop control, with reductions of up to 13%, 27%, and 33% in the
mean IAE value for cascade, MPC, and RTDA controllers, respectively, compared to
PI/PID controllers (see Table 3.7). The additional integral action in the inner loop
of the PID-PI controller seems to have made the closed-loop system perform poorly,
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with the IAE value for PP 16 and PP 15 deviating up to 400% and 125% from that
of the nominal patient, even when dierent controller settings were used. PID-P
gave better control for PP 16, with an IAE value of 3375, compared to a value of
5087 for PID-PI. The performance of PID-PI is inferior to that of PID-P for PP 13
to PP 16 (see Figure 3.8). This could be due to the slow dynamics of the inner loop,
which result from the small value of fR (see Table 3.2) and because disturbances
are in the outer loop in hypnosis regulation. Both these are uncommon in chemical
process applications of cascade control. Finally, MPC and RTDA gave the best
robust performance with coecient of variance (SD/mean) values of 0.174 and 0.180,
compared to 0.385 and 0.349 for PID-P and PI (best performing cascade and single
loop controller), respectively. This indicates that MPC and RTDA controllers have
the least dependence on the patient's sensitivity to the drug.























Fig. 3.8. IAE values for the maintenance period for six controllers on 16 patients
Tables 3.7 and 3.8 summarize the performance, in terms of the mean and standard
deviation of each performance criterion, of all six controllers during the maintenance
and surgical stimuli period, respectively. The MDPE values for all controllers were
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negative, which indicated a consistent tendency for the measured BIS to be less than
the set-point. This means that the controllers had a tendency to slightly overdose,
and this observation can be explained by the asymmetric control operation that is
performed by the controllers. They govern only the infusion, but not the elimination,
of drugs from the body, which is a slower process (Struys et al. 2004).
Table 3.7
Controller performance of various controllers for the maintenance
period (t = 100 { 350 min)
Performance
Criterion
Value for the Controllera
PI PID PID-P PID-PI MPC RTDA
IAE 1767 (617) 1801 (624) 1542 (593) 1719 (1017) 1314 (229) 1215 (219)
MDPE -3.29 (4.38) -3.54 (4.46) -2.95 (3.43) -4.11 (10.8) -0.87 (0.61) -0.79 (0.60)
MDAPE 11.5 (5.79) 11.8 (5.98) 9.41 (4.95) 10.8 (9.67) 7.40 (1.80) 6.59 (1.71)
Wobble 10.2 (4.11) 10.3 (4.01) 8.62 (4.30) 8.51 (3.59) 7.24 (1.71) 6.95 (1.64)
% time outside
10 BIS
24.6 (12.2) 25.4 (12.5) 19.4 (12.2) 22.2 (18.1) 15.3 (4.20) 13.5 (3.85)
% time outside
5 BIS
51.4 (16.3) 52.4 (16.0) 43.6 (16.2) 43.8 (18.5) 37.2 (9.71) 34.6 (8.56)
TV 45.42 (9.35) 44.66 (8.99) 53.56 (9.67) 47.58 (9.48) 60.16 (11.49) 63.25 (12.11)
aNote: The mean and standard deviation (shown in brackets) of the criterion are given for each
controller.
Results in Tables 3.7 and 3.8 further conrm that cascade, MPC, and RTDA con-
trollers outperform PI and PID controllers for hypnosis regulation, with reference
to other performance criteria besides IAE. In particular, for the maintenance period
(see Table 3.7), the use of MPC and RTDA resulted in reductions of37% and44%
in MDAPE and 30% and 33% in wobble, respectively, compared to PI/PID con-
trollers, indicating better control and less oscillation. A signicant improvement
in the percentage of time for which measured BIS value was within 5 and 10
from the set-point is also observed for the MPC and RTDA controllers, which indi-
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cates tighter control over the BIS output (see Figure 3.9). However, improvement
in surgical stimuli rejection alone is less with PID-P, MPC, and RTDA controllers,
giving a reduction of 9% { 19% in MDAPE and 14% { 23% in wobble, respec-
tively, compared to PI/PID controllers (see Table 3.8). The performance of PID-PI
controller is disappointing, despite the cascaded setup, giving <10% improvement
in the performance, compared to PI/PID controller (see Tables 3.7 and 3.8).
Table 3.8
Controller performance of various controllers for the surgical stimuli
period (t = 100 { 160 min)
Performance
Criterion
Value for the controllera
PI PID PID-P PID-PI MPC RTDA
IAE 618 (55) 622 (62) 569 (49) 618 (200) 571 (45) 545 (41)
MDPE -1.77 (5.38) -1.86 (5.31) -2.90 (5.00) -0.21 (9.76) -3.16 (5.10) -2.85 (4.56)
MDAPE 18.5 (2.35) 18.7 (3.09) 16.0 (2.35) 17.4 (5.42) 16.8 (2.41) 15.2 (2.25)
Wobble 17.9 (2.13) 18.3 (2.88) 15.3 (2.55) 16.7 (6.52) 15.5 (2.57) 14.1 (2.41)
% time outside
10 BIS
45.2 (6.64) 45.6 (7.52) 39.4 (6.13) 41.3 (8.97) 41.7 (5.77) 37.2 (5.42)
% time outside
5 BIS
72.1 (3.58) 71.8 (4.64) 68.7 (5.53) 69.1 (6.06) 69.2 (6.2) 64.8 (5.6)
TV 22.96 (6.64) 21.89 (6.72) 30.41 (7.61) 23.1 (9.49) 30.75 (7.96) 33.29 (11.85)
aNote: The mean and standard deviation (shown in brackets) of the criterion are given for each
controller.
The last row in Tables 3.7 and 3.8 compare the input performance (i.e., control
eort (TV)) for all the six controllers. These results show that the better control
performance of MPC and RTDA, compared to other controllers, is accompanied by
greater control eort, which may still be acceptable. This clearly shows the aggres-
sive nature of these two controllers, compared to the remaining four controllers.
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Fig. 3.9. Percentage of the time that BIS is 5 units outside its
set-point during the maintenance period
It is worth mentioning that the performance of all six controllers was determined
to have a greater dependence on PD parameters than PK parameters. Although not
presented here, all of them had been determined to give consistent and acceptable
performance in the presence of PK variation only (i.e., with PD parameters kept
at nominal values). PK parameters aect the uptake and distribution of drugs,
whereas PD parameters describe the drug eect and degree of nonlinearity in the
patient system. Hence, variations in PD parameters are expected to have greater
inuence on the closed-loop performance, especially because linear controllers were
employed.
The closed-loop performance of the PID controller for a few patient models is
compared to that of MPC and RTDA controllers in Figures 3.10 and 3.11. Gener-
ally, regardless of the controller, the closed-loop performance became more sluggish
with decreasing drug sensitivity (which can be observed for PP 15 and PP 16 in Fig-
ure 3.11). However, MPC and RTDA gave tighter control of BIS for dierent PPs
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Fig. 3.10. Performance of (a,b) PID, (c,d) MPC and (e,f) RTDA
controllers for PP 1, PP 4 (nominal) and PP 13
(i.e., from PP 1 to PP 16), as can be seen from Figures 3.8 and 3.9, which indicates a
weaker dependence of their performance on the drug sensitivity of patients. Despite
the sluggishness, these controllers tracked the intraoperative set-point changes and
also rejected the disturbances, for PP 13 (a considerably insensitive patient), PP 15
and PP 16 (highly insensitive patients).
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Fig. 3.11. Performance of (a,b) PID, (c,d) MPC and (e,f) RTDA
controllers for the nominal (PP 4) and highly insensitive (PP 15
and PP 16) patients
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3.7 Controller Performance in the Absence of BIS Signal
The measured BIS and C1 are sometimes corrupted with artifacts; BIS artifacts
may come from the high impedance of the electrodes, corruption of the EEG with
the electromyography (EMG) signal and accidental disconnection of electrodes from
the patient's head (Gentilini et al. 2001a), whereas C1 artifacts result from device
calibration errors and disconnection of sample lines. The present section focuses on
evaluating controller performance during the loss of BIS feedback signal, because of
its higher likelihood of occurrence and the higher risks involved.
When BIS signal is lost, the controllers are designed to use an estimated BIS
value as subsequent feedback until the disconnection of electrodes is rectied. BIS
may be estimated using the last BIS measurement or using the measured C1 and
the nominal PD model. We propose a modication of the latter method using a
patient-specic EC50 value, together with nominal ke0 and  values in the PD model
for BIS estimation. The problem with estimating BIS value based on a nominal PD
model (which uses a nominal EC50 value of 0.7478 vol:%) arises when the patient
has a dierent EC50 value. Simulations by varying each PD parameter indepen-
dently were conducted, and the results (with noise removed for clarity) are shown
in Figure 3.12. In these simulations, each patient PD parameter was varied indi-
vidually, and the PID controller performance using the nominal PD model for BIS
estimation during the loss of BIS signal was observed. The results reect that only
EC50 has a drastic eect (as proven by robustness analysis) on the accuracy of BIS
prediction (Figure 3.12); therefore, only this parameter must be known accurately
and the remaining PD parameters can be taken as their nominal values for BIS
estimation.
The patient-specic EC50 value can be estimated by averaging all C1 concentra-
tions (during the induction, t = 0 { 100min) that correspond to BIS within 6 units
(i.e., within 2SD of BIS measurements) from BIS = 50. Table 3.9 summarizes the
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estimated EC50 for all six controllers when implemented on PP 1, PP 7, and PP 13.
All the EC50 estimates are very close to the true values (within a deviation of 3%
from the actual EC50 value) because, C1 measurements are used for the estimation
and these measurements directly reect the patient's sensitivity to the drug.































































Fig. 3.12. Eect of PD parameters on closed-loop performance dur-
ing the loss of BIS signal (t = 120 { 200 min): (a) eect of EC50,
(b) eect of  and (c) eect of ke0
The loss of BIS signal was simulated by breaking the BIS loop at t = 120 min
during the occurrence of extreme surgical stimuli to test the controllers in the most
dicult scenario. When the electrodes attached to the patient's head get discon-
nected, BIS falls sharply to 0, and an estimated BIS value is automatically used as
feedback. Furthermore, prolonged loss of BIS signal (such as when the disconnec-
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tion of electrodes goes unnoticed) was assumed. For PP 3, using MPC and RTDA
controllers, Figures 3.13(a) and 3.13(c) show that BIS cannot be maintained at its
set-point of 50 by simply using the last BIS measurement recorded or BIS estimated
from the nominal PD model as feedback. On the other hand, using the patient-
specic EC50 value that was estimated from the measurements in the induction
period resulted in signicantly improved closed-loop performance.
Table 3.9







Estimated EC50 Estimated EC50 Estimated EC50
PI 0.4986 0.7285 1.1105
PID 0.4975 0.7196 1.1226
PID-P 0.4752 0.7289 1.1195
PID-PI 0.4786 0.7205 1.1235
MPC 0.5055 0.7401 1.0885
RTDA 0.5085 0.7425 1.0902
The calculation of EC50 is patient-specic; therefore, this method of BIS estima-
tion during the loss of feedback signal is expected to be robust for a wide range of
patient sensitivities. The results in Figure 3.14 conrm this for MPC and RTDA.
Similar trends were observed for all other controllers studied in this chapter. Fig-
ure 3.14(e) shows the comparison of performance, in terms of IAE for the 16 pa-
tients for MPC and RTDA controllers; RTDA shows slightly better performance
than MPC.
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Fig. 3.13. BIS response and controller output in the absence of BIS
signal from t = 120 { 200 min for PP 3, using (a,b) MPC and (c,d)
RTDA
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Fig. 3.14. Performance of MPC and RTDA controllers in the absence
of BIS signal in the period of t = 120 { 200 min: (a,b) transient
proles for PP 1, PP 7, and PP 13 using MPC, (c,d) transient proles





The ecacy of PI, PID, PID-PI, PID-P, MPC and RTDA controllers was eval-
uated and compared for a range of patient drug sensitivities and extreme surgical
scenarios. For this purpose, after analyzing the eect of PK and PD model parame-
ters, a set of 16 patient proles was constructed to represent patients with dierent
drug sensitivities. MPC and RTDA controllers are capable of improving hypnosis
regulation by up to 40%, compared to PI/PID controllers, and also display bet-
ter robustness when implemented on dierent patient proles. Cascade controllers
provide an improvement of up to 20% in performance, compared to PI/PID, but
they exhibit less robustness than MPC and RTDA. To cope with the possible loss
of BIS signal during surgery, estimation of a patient-specic EC50 value (based on
BIS and endtidal concentration measurements in the induction period) and its use
for estimating BIS for subsequent feedback was proposed, and its eectiveness was
shown via simulation.
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Chapter 4
A COMPARATIVE STUDY OF THREE ADVANCED
CONTROLLERS FOR THE REGULATION OF
HYPNOSIS WITH ISOFLURANE
4.1 Introduction
The contribution of this chapter is to demonstrate the control of hypnosis us-
ing model predictive controller (MPC), and to comprehensively compare its perfor-
mance with CIMC and CMEC approaches (Gentilini et al. 2001a, Puebla & Alvarez-
Ramirez 2005). The proposed MPC uses the approximate linear PK-PD model in
the controller design, which will regulate patient's BIS by manipulating the infusion
rate of isourane. Because of potential patient-model mismatch, several simula-
tions are conducted to check the robustness of the MPC controller. The proposed
MPC scheme has also been tested for disturbance rejection and noisy measurement
signals. The performance obtained with the MPC controller is compared with the
performances of the CIMC and CMEC. Extensive numerical simulations showed
that the proposed MPC algorithm performed considerably better when compared
to these two control strategies previously reported in the literature (Gentilini et al.
2001a, Puebla & Alvarez-Ramirez 2005). The study and the ndings described in
this chapter have been reported in Sreenivas et al. (2009a).
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4.2 Patient Model - Modeling Hypnosis
The response of a patient to the hypnotic drug, isourane is modeled with a
pharmacokinetic (PK) { pharmacodynamic (PD) model and is detailed in section
3.2.
4.3 Controller Design
The three control strategies mentioned above for the regulation of hypnosis are
described briey in this section.
4.3.1 Cascade internal model controller (CIMC) Design
The CIMC structure to regulate BIS is depicted in Figure 4.1. In this gure, the
blocks P2 (obtained form equations (3.2) { (3.4)) and P1 (obtained from equation
(3.5)) together with the nonlinear equation block (equation (3.9)) represents the pa-
tient's pharmacokinetics and pharmacodynamics, respectively. The corresponding
parallel models are ~P2 and ~P1 together with the linearization constant km. Here,
~P2 is a sixth order transfer function, ~P1 is a rst order transfer function and km is
a linearization constant as given by equation (3.14) and its value calculated to be


















Fig. 4.1. Schematic representation of the CIMC structure
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of the nominal patient models ~P2 and ~P1 with km, respectively. The master controller
Q1 regulates the BIS and the slave controller Q2 regulates C1 (endtidal concentra-
tion). Because controllers Q2 and Q1 are the ltered inverses of the nominal patient
models, the tuning of the IMC controller depends on the lter time constants (2
& 1, respectively) and order of the lters (n2 & n1, respectively). Because IMC
structure cannot handle the manipulated variable constraints, the constraints on
the maximum and minimum infusion rates are eected by placing saturation blocks
(see Figure 4.1).
4.3.2 Cascade modeling error compensation (CMEC) controller design
As in CIMC, here also, the master controller regulates BIS and slave controller
regulates C1 as depicted in Figure 4.2. The master closed-loop observer estimates
the modeling error which is a function of estimated time constant for the master
loop, eM and the error, eM which is the dierence between measured BIS and the
set-point for BIS. With these ndings, the master controller generates the reference
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−
Fig. 4.2. Schematic representation of the CMEC scheme
time constant, cM , and modeling error. Then the slave closed-loop observer esti-
mates the modeling error which is a function of estimated time constant for slave
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loop, eS and the error, eS which is the dierence between measured C1 and C1;ref .
With these observations, the slave controller manipulates the isourane concentra-
tion in inhaled gas, C0, which is a function of slave loop closed-loop time constant,
cS. Maintaining constraints within limits has been taken care within the controller
algorithm. One of the drawbacks with the CMEC approach is the need to tune sev-
eral controller parameters (time constants of the controllers) to obtain the desired
response (Alvarez-Ramirez et al. 2002).
4.3.3 Model predictive controller (MPC) design
The detailed description of the MPC scheme for the regulation of hypnosis with
isourane is provided in section 3.4.4.
4.4 Results and Discussion
This section provides the simulation results of the MPC controller for the con-
trol of BIS by manipulating isourane. The performance of MPC scheme for BIS
regulation has not been reported in the literature. Hence, the MPC performance is
considered in this chapter and compared with the recently reported results based
on CIMC and CMEC controllers. This section rst considers the tuning of the
MPC controller. Then the performance of the MPC scheme will be compared with
the performances of CIMC (Gentilini et al. 2001a), and CMEC (Puebla & Alvarez-
Ramirez 2005) schemes for the control of hypnosis. The comparison will be in terms
of set-point tracking, disturbance rejection, uncertainty in the parameters of the
model, and rejection of unmeasured noise.
The controller has to maintain BIS between 40 and 60 during the surgery. Also, it
is very important to maintain the drug concentration within the acceptable limits in
the patient's body. The endtidal concentration, C1 must be between 0.4 vol:% and
2.2 vol:% (Gentilini et al. 2001a). This is the physiologically acceptable range for
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C1. The lower limit guarantees a minimum delivery of anesthetic, whereas the upper
limit prevents overdosing in the patient's body. C0 is the manipulated variable which
is restricted between 0 and 5 vol:% (Gentilini et al. 2001b).
4.4.1 Tuning of MPC
The control execution interval is set as 5 sec which is same as the sampling
interval for BIS. The same sampling frequency is assumed for the endtidal concen-
tration, C1 also. Next, the tuning of the proposed MPC controller has been done
as follows. The parameters are: M, the input horizon; P, the prediction horizon;
S, the weighting matrix for BIS; and R, the input weighting matrix (for the ma-
nipulated variable C0). The prediction horizon P is chosen as 25 sample intervals
(approximately equal to the settling time of open-loop response of the system) and
the control horizon M is chosen as 2 sample intervals. Here, very low value of M is
chosen (relative to P) because the closed-loop system should be robust and we also
expect fast closed-loop response. Because the safe regulation of hypnosis level is
very crucial during the surgery, the constraints imposed on the inputs and outputs
will be hard constraints, i.e., at any time, the controller should not violate the limits
imposed on the variables. Hence, to avoid problems associated with the constraints
on the output variables, the controller tuning weights should be chosen carefully.
The performance of the proposed MPC is calculated based on ITAE values and are
calculated for time, t = 0 { 50 min based on equation (4.1).




By considering the performance (ITAE) and % undershoot in BIS, the weights
chosen for BIS and input (isourane infusion) are 10 and 1, respectively.
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4.4.2 Comparison of the performances of MPC, CIMC and CMEC con-
trollers
This section gives the results for the comparison of tracking performance of the
proposed MPC controller with CIMC and CMEC. The best performances obtained
with the three controllers are provided here. Figure 4.3 shows the variation of
endtidal concentration together with the input isourane prole for the BIS set-
point change from 100 to 50. The values set for the lter time constants 2 and
1 for the CIMC controller are 0.3 and 1.6, respectively. Also, order of the lters
n2 and n1 set at 3 and 2, respectively (minimum values which make controllers
proper). The values set for the time constants cM , cS, eM and eS for the CMEC
controller are 4, 0.4, 4 and 0.5, respectively. With all controllers, the reference BIS
was tracked within about 12 min. From Figure 4.3, we can observe that the settling
time with the three controllers is comparable. However, faster initial response is
obtained with MPC (= 6 min) when compared to the other two controllers; the
smaller undershoot in case of MPC is acceptable in medical practice. The endtidal
concentration with all the controllers is maintained within the constraint 0.4 vol:% to
2.2 vol:% except for the initial phase of induction period (t = 0 { 5 min). One
can further observe from Figure 4.3 that BIS is tracked by increasing the endtidal
concentration through isourane infusion. The bottom plot in Figure 4.3 shows
the variation of input isourane concentration with time. All the three controllers
maintained the isourane concentration within the specied constraints. Here, MPC
is aggressive compared to the other two controllers, with more drug infused to the
patient to bring BIS quickly to the desired set-point. The CIMC controller is sluggish
when compared to the other two controllers. With CMEC controller, the oscillations
in the manipulated variable are appreciable and this is not good for the sensitive
vaporizer valves.
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Fig. 4.3. Comparison of the best performances of the MPC, CIMC
and CMEC controllers
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4.4.3 Robustness comparison
This section discusses the robustness of the three controllers. We would like
to test if the three controllers can meet the performance specications despite sig-
nicant and reasonable variation in the model parameters (inter- and intra-patient
variability). Here, we assume that variability is in both PK and PD model param-
eters. Open-loop step responses showed that four variables namely frequency of
inhalation (fR), tidal volume (VT ), and volume of the lungs (V1) from the PK model
and concentration of drug at half maximal eect (EC50), from the PD model are
the dominant parameters aecting the patient's response. With the range specied
for the three PK parameters in Table 3.1, each parameter was varied in three levels
(minimum, average, maximum). The single PD parameter was also varied in three
levels (0.5146, 0.7478 and 1.0940), thus 34 = 81 patients were obtained. From these
patient sets, 27 patients were selected based on covering the entire span of insensi-
tive (higher EC50, V1 and lower fR, VT ) to sensitive responses (lower EC50, V1 and
higher fR, VT ) to the drug. Closed-loop simulations are carried out for these 27
patients with each of the three controllers. The results from these simulations are
summarized in Table 4.1.
Table 4.1 shows the best performance obtained for all the 27 patients (rows 2 -
28) with the MPC, CIMC and CMEC controllers which were tuned for the nominal
patient (row 1). Figure 4.4 shows the performance of the MPC controller for several
sets of parameters shown in Table 4.1. From the top portion of this gure, we can
observe that slower response was obtained in all patients (except for the sensitive
patients characterized by lower EC50 value) when compared to nominal patient
(responses also shown in Figure 4.3 and from t = 0 { 50 min in Figure 4.5). Also, if
fR and VT are low and EC50 is high compared to their nominal value, the response is
too sluggish and this sluggishness decreases with the decrease in V1. This is because,
if the volume of lungs is very high, the patient needs more drug (higher EC50) and
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also the frequency of inhalation and tidal volume are low, the controller should
maintain the high isourane concentration for a long time to bring the patient to
targeted hypnotic level.
Table 4.1




fR VT V1 EC50 MPC CIMC CMEC
1 10 0.6 2.31 0.7478 506 684 566
2 4 0.3 3.02 1.0940 5901 7936 6241
3 4 0.3 2.31 1.0940 3465 4560 3658
4 4 0.3 1.60 1.0940 1986 3050 2145
5 4 0.8 3.02 1.0940 1527 2956 2055
6 4 0.8 2.31 1.0940 1329 2106 1764
7 4 0.8 1.60 0.5146 767 991 884
8 4 1.2 3.02 1.0940 1503 2698 1995
9 4 1.2 2.31 0.7478 544 679 565
10 4 1.2 1.60 1.0940 745 1197 803
11 4 1.2 1.60 0.5146 528 647 554
12 16 0.3 3.02 1.0940 1689 2753 2006
13 16 0.3 1.60 0.5146 638 831 715
14 16 0.8 3.02 0.5146 504 505 506
15 16 0.8 2.31 0.7478 502 720 496
16 16 0.8 1.60 1.0940 997 1214 998
17 16 1.2 3.02 1.0940 1426 2108 1674
18 16 1.2 2.31 0.7478 445 655 415
19 16 1.2 1.60 0.5146 555 607 555
20 25 0.3 3.02 1.0940 1524 2378 1787
21 25 0.3 2.31 0.7478 575 700 585
22 25 0.3 1.60 0.5146 615 724 642
23 25 0.8 3.02 0.5146 492 503 498
24 25 0.8 2.31 0.7478 505 709 476
25 25 0.8 1.60 0.5146 540 610 547
26 25 1.2 3.02 1.0940 1406 2070 1595
27 25 1.2 2.31 0.7478 485 637 469
28 25 1.2 1.60 0.5146 434 494 435
Avg. 1148 1632 1272
From the results shown in the bottom portion of Table 4.1 and responses shown in
bottom portion of the Figure 4.4, we can observe that, if fR is high and EC50 is low,
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the remaining two variables have less eect on the performance of the controllers.
Also, from the results summarized in the top portion of Table 4.1, we can observe
that, when fR is low and both V1 and EC50 are high, the performance of the con-
troller increases with increase in VT . This is because, even though the frequency of
inhalation is less, the high tidal volume compensates for the large volume of lungs.
The average ITAE values for all these 28 patients (last row in Table 4.1) shows
that the MPC outperforms the other two controllers, and CMEC is better than
CIMC. Also, variation of manipulated variable movement is less with MPC com-
pared to CMEC. The manipulated variable responses (not shown) reect the BIS
responses shown in Figure 4.4, as insensitive patient needs more isourane infusion
and sensitive patient needs less isourane infusion.
Out of all 28 patients shown in Table 4.1, the second patient (insensitive patient)
shows the worst performance (high ITAE value) regardless of the controller employed
(from t = 0 { 50 min in Figure 4.6). From this gure, we can observe that all the
controllers required more time to bring this patient to the desired hypnotic level
(BIS equal to 50). Also, more isourane is injected to this patient when compared
to the nominal patient (compare Figure 4.6 with Figure 4.3 or Figure 4.5 from t = 0
{ 50 min). This patient is very resistant (insensitive) to isourane. This is because,
for this patient, the frequency of the inhalation, fR and the tidal volume, VT are
low and volume of the lung, V1 and concentration of drug at half maximal eect,
EC50 are at high value. Because of this reason, the controller designed based on the
nominal values give poor performance for this patient when compared to all other
patient models. Even on this patient, the MPC controller performed well (quick
response with very small undershoot) when compared to the other two controllers.
The manipulated variable movement is also minimal with MPC while it is jerky
with CMEC.
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Fig. 4.4. Comparison of the performance of the proposed MPC con-
troller for several patient parameters
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The result in Figure 4.7 (from t = 0 { 50 min) represents patient 28 (sensitive
patient) in Table 4.1. Even in this case, CIMC is sluggish and CMEC has more ag-
gressive manipulated variable movement when compared to MPC. From this gure,
we can observe that all the controllers took less time to bring the patient to the de-
sired hypnotic level (BIS equal to 50). Also, less isourane is injected to this patient
when compared to the nominal patient (compare with Figure 4.3 or Figure 4.5 from
t = 0 { 50 min). This patient is very sensitive to isourane administration. This is
because, for this patient, the frequency of the inhalation, fR and the tidal volume,
VT are high and the lung volume, V1 and concentration of drug at half maximal
eect, EC50 are at low value.
4.4.4 Performance comparison for a step change in BIS and sudden
disturbance in Q0 during the surgery
The three controllers are now tested for a step change in BIS value which may
be required at any time during the surgery. This is because, if surgical stimulation
is severe at any time during the surgical process, the patient needs to be more
unconscious and hence the BIS value should be decreased to some lower value (e.g.,
40). Figure 4.5 depicts the performance of the three controllers for a step change in
BIS from 50 to 40 at t = 50 min for the nominal patient. Here also, performance
(with respect to both BIS response and manipulated variable movement) obtained
with the MPC is better as compared to CMEC and CIMC. This can be attributed
to the inherent online optimization feature embedded in the MPC scheme.
Faults can occur with any of the equipments or variables during surgery. Here,
the simulations are carried out for a sudden increase in the ow rate of inspired gas,
Q0, which is delivered by the pump. Mathematically, this is represented as a step
change in Q0 from 1 to 5 `=min. Figure 4.5 also depicts the performance of all the
controllers for the step change in Q0 at t = 100 min for the nominal patient. From
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Fig. 4.5. Comparison of the performance of the MPC, CIMC and
CMEC controllers to a sudden step change in BIS and to disturbance
in Q0 for the nominal patient
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Fig. 4.6. Comparison of the performance of the MPC, CIMC and
CMEC controllers to a sudden step change in BIS and to disturbance
in Q0 for insensitive patient
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Fig. 4.7. Comparison of the performance of the MPC, CIMC and
CMEC controllers to a sudden step change in BIS and to disturbance
in Q0 for sensitive patient
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the top part of this gure, we can observe that a small drop in BIS occurs because
of sudden increase of ow of gas which carries isourane into the lungs. The feed-
back controllers recovered within 10 min with small undershoot in the BIS. Both
MPC and CMEC performed better when compared to CIMC with respect to BIS
response, but here MPC is more aggressive compared to CMEC in manipulated
variable movement (bottom plot of Figure 4.5).
Figures 4.6 and 4.7 show the comparison of performance of three controllers to
a step change in BIS at t = 50 min and to disturbance in Q0 at t = 100 min for
the insensitive and sensitive patients, respectively. Here also, MPC and CMEC
performed well compared to the CIMC which showed a sluggish response. Also,
when manipulated variable movement is considered, MPC performed better for BIS
set-point change and CMEC performed better for disturbance rejection.
4.4.5 Performance comparison for measurement noise in BIS signal dur-
ing the surgery
The measured signal used for feedback control (BIS) may be corrupted by arti-
facts such as measurement noise. BIS artifacts might come from the high impedance
of the electrodes, corruption of the EEG with the electromyography (EMG) signal
etc. For better control performance, the noise in the feedback signal must be han-
dled appropriately (e.g., ltering). If not, it will be harmful to the patient because
unreliable values of the measured signals will result in wrong drug dosage delivered
to the patient. If controllers are very aggressive, manipulated variable movement is
very rapid because of noise, so care must be taken when tuning the controllers if
proper lters are not available to reduce the noise. Figure 4.8 illustrates the behavior
of the three controllers (MPC, CIMC and CMEC, respectively) when 2% Gaussian
noise is added to the measured BIS signal. Even though the BIS feedback signal has
noise, all the three controllers gave very good performance (BIS < 55) without any
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Fig. 4.8. Performance of the MPC, CIMC and CMEC controllers for




further tuning and BIS did not exceed the surgical operating range (from 40 to 60).
Also, the remaining two variables (C1 and C0) are maintained within constraints.
The endtidal concentration proles (not shown) reect the trend of BIS proles
shown in Figure 4.8. Out of three input isourane concentration proles (C0) for
all the controllers (not shown), the one with CMEC is more aggressive, hence the
response is oscillatory compared to MPC and CIMC out of which MPC is more
aggressive. Due to the non-aggressive nature of CIMC, the isourane prole is
smooth.
4.5 Conclusions
Good hypnosis regulation, using BIS as the controlled variable, has been achieved
through the use of a model predictive control scheme. In comparison with other re-
cently suggested control strategies, namely cascade IMC and cascade modeling error
compensation scheme, the MPC provided better performance while respecting the
imposed constraints on the manipulated and output variables. The MPC strategy
was also found to be more robust to inter-patient variability; it performed well in the
presence of disturbances and measurement noise. The MPC is thus recommended
as a promising strategy for controlling hypnosis.
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Chapter 5
ADVANCED CONTROL STRATEGIES FOR THE
REGULATION OF HYPNOSIS WITH PROPOFOL
5.1 Introduction
The present chapter has two main objectives. One objective is to apply and eval-
uate the promising MEC and IMC approaches for hypnosis regulation using BIS as
the controlled variable and manipulating propofol infusion. Another objective is to
comprehensively compare the performance of MEC, IMC, MPC, and PID controllers
for hypnosis control. Cascade control structure is impractical for propofol-based
hypnosis regulation because of unavailability of continuous propofol concentration
measurement. Hence, MEC and IMC strategies (and not their cascade versions)
are employed here. The four control strategies are applied to the best available PK
model (which accurately predicts the experimental plasma propofol concentration)
and PD models (which accurately relates the eect-site propofol concentration to
BIS) in the literature. Then, extensive simulations are conducted to test the ro-
bustness of the four controllers, by considering parameter variations in the selected
model to account for patient-model mismatch. The four controllers are tested for
set-point changes, disturbances and noise in measured BIS. Then the performance
of the MPC and PID controllers is compared with that of RTDA controller for all
the scenarios mentioned above. Results of these simulations is used to determine
the best controller(s). The study and the ndings presented in this chapter have
been reported in Sreenivas et al. (2008) and Sreenivas et al. (2009c).
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5.2 Mathematical Model for BIS Response to Propofol
The model used for BIS response to propofol consists of two interacting parts: a
PK model for estimating the distribution of propofol in the internal organs, and a
PD model to describe the eect of propofol on the measured physiological variable,
BIS. Figure 5.1 depicts the schematic of the system comprising the propofol delivery
























Fig. 5.1. Schematic representation of propofol delivery circuit with
PK and PD models
For the distribution of propofol, a linear mammillary three-compartmental PK
model is adopted from the literature (Schwilden et al. 1989). The central compart-
ment, V1, which is characterized as a plasma compartment in which drug dissolves
and is carried to the other compartments. Also, because of metabolization of the
drug in the body, elimination of the drug from this compartment is assumed. The
second compartment is a shallow peripheral compartment, V2, which is character-
ized by a very rapid movement of the drug from the plasma to this compartment.
This is the characteristic of certain tissues which are highly perfused (vessel-rich
tissues). The third compartment is a deep peripheral compartment, V3, which is
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characterized by a slow distribution of the drug from the central compartment to
this compartment. This is because of the equilibration of the blood with tissues
which are less perfused.
Initially, the PK part assumes that all compartments (Figure 5.1) have a zero
initial concentration of the drug (propofol). To achieve rapid target plasma drug
concentration (i.e., concentration in V1), sucient drug must be given as a bolus
dose. If the plasma drug concentration is to be kept constant, the amount of drug
entering and leaving the central compartment must be equal. Drug leaves the blood
to pass into V2 and V3 at a gradually decreasing rate as the concentrations in these
compartments increase. Drug (propofol) also leaves the blood because it is metab-
olized (mainly in the liver) (Tackley et al. 1989, Marsh et al. 1991, Dyck & Shafer
1992). The PD part assumes some lag between the infusion of propofol in the blood-
stream and propofol distribution in brain tissue thereby aecting the hypnosis level.
This eect on hypnosis level is represented by a nonlinear equation relating the state
variables and other system variables to BIS.
5.2.1 Pharmacokinetic model
The PK model for distribution of drug consists of mass balances between the
central compartment and the two compartments which are attached to it (Fig-
ure 5.1) (Tackley et al. 1989, Marsh et al. 1991, Dyck & Shafer 1992). The main
assumptions here are that the central compartment is a well mixed-tank with the
plasma propofol concentration being uniform everywhere, and the distribution of
propofol is not aected by the presence of other drugs. Hence, the resulting mass
















5.2 Mathematical Model for BIS Response to Propofol
Here C1, C2 and C3 are concentrations of propofol (g=ml) in the rst (central),
second and third compartments, respectively; V1, V2 and V3 are the respective vol-
umes (`); k12, k13, k21 and k31 are the mammillary rate constants (min
 1) of the
respective compartments, k10 is the hepatic metabolism rate constant to represent
the elimination rate of propofol from the patient (min 1);  = 10 (mg=ml) is the
available propofol concentration;  = 60 (min=hr) is a normalization constant;
and U is the infusion rate of propofol (ml=hr). To convert U in ml=hr to u in
mg=kg=hr (normalized propofol infusion rate with respect to patient weight), it is
multiplied by =w, where w is the weight of the patient in kg. Similarly, for the







With the availability of dierent sets of PK parameters reported by various re-
search groups (Tackley et al. 1989, Marsh et al. 1991, Dyck & Shafer 1992), it is
dicult to select a specic PK parameter set from all the available sets (Coetzee
et al. 1995). Usually, with the dierent PK sets, there is a mismatch between
predicted and actual concentrations. This mismatch is not so critical as long as
Table 5.1
Rate constants and volumes of the dierent compartments of the















the actual concentrations are within the desired therapeutic window. The useful-
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ness of target-controlled infusion (TCI) lies in the ability to dose more accurately,
to maintain stable drug concentrations (and therefore stable eects), and to make
proportional changes to the concentrations. The PK model parameters provided
by Marsh et al. (1991) (referred as Marsh model) accurately predict the plasma
propofol concentration (Coetzee et al. 1995), and this model is used to check the
closed-loop performance of the controllers. Table 5.1 shows the PK parameters men-
tioned in equations (5.1) and (5.2) for a 34 year old person weighing 66 kg for Marsh
model.
5.2.2 Pharmacodynamic model
The above PK model is limited to the representation of distribution kinetics of
propofol into dierent compartments. A PD model is required to relate the eect of
drug and the hypnotic level (BIS). The PK model is attached to an eect-site com-
partment model which represents the time lag between the distribution of drug and
its eect on BIS which is given by the nonlinear Hill equation (Bibian et al. 2005).
The eect-site compartment accounts for the equilibration time between targeted
plasma drug concentration and concentration of drug in the central nervous system
(brain). The eect-site concentration and targeted plasma drug concentration are
related by a rst-order lag given by (Kazama et al. 1999):
dCe
dt
= ke0(C1   Ce) (5.3)
where ke0 is used to describe the time course of equilibration between the plasma
and the eect-site. The eect-site concentration is related to BIS as (Hill equa-
tion) (Bibian et al. 2005):









The detailed description of the parameters in equation (5.4) is provided in section
3.2.3. The nominal values of parameters ke0 = 0.349min
 1, EC50 = 2.65 g=ml and
 = 2.561 are obtained from the pooled analysis (Schnider et al. 1999, Sartori et al.
2005).













γ = 3γ = 2.5
γ = 2γ = 1.5
Slope = −24.16
γ = 1
Fig. 5.2. BIS vs eect-site concentration Ce for dierent values of 
Nonlinearity exists in equation (5.4) and all the remaining equations (from equa-
tions (5.1) { (5.3)) are linear. It comes mainly through the parameter, . Figure 5.2
shows the variation of BIS with eect-site concentration, Ce for dierent  values ac-
cording to equation (5.4). From this plot, we can observe that nonlinearity increases
with the value of  and that the linear approximation is acceptable.
5.3 Controller Design
The four control strategies mentioned earlier for the regulation of hypnosis are
briey described in this section.
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5.3.1 Proportional-integral-derivative (PID) controller
The PID control structure employed in this study is represented by equation (5.5).
The control algorithm is based on standard parameters { proportional gain (Kc),










The proportional term determines the required action to the current error, the
integral term determines the required action to the sum of current & past errors
and the derivative term determines the required action to the rate at which the
controlled variable (CV), i.e., BIS is changing. For this controller, the derivative
(D) action acts solely on BIS signal while proportional (P) and integral (I) actions
act on the error in BIS. This avoids sudden spikes in the controller output due to
step changes in set-points of BIS. Tuning of the three parameters (Kc, I and D)
is required to get faster response of BIS without any oset or oscillations. Here,
the PID parameters are obtained via optimization so as to get the best performance
with this control structure.
5.3.2 Internal model controller (IMC)
The IMC structure to regulate BIS is depicted in Figure 5.3. The blocks P2 and
P1 together with the nonlinear equation represents the patient's pharmacokinetics
and pharmacodynamics, respectively. Here, both P2 and P1 are single input-single
output (SISO) linear time invariant systems. The corresponding parallel models for
the pharmacokinetics and pharmacodynamics are respectively ~P2 and ~P1 together
with the linearization constant km. Here, ~P2 is a third-order transfer function ob-
tained by combining equations (5.1) and (5.2), ~P1 is a rst-order transfer function
obtained from equation (5.3) and km is a constant obtained via linearization of equa-
tion (5.4) around the reference concentration Ce = EC50 and is given by equation
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(3.14). Q is the IMC controller which is obtained by multiplying the low pass lter





















Fig. 5.3. Schematic representation of the IMC structure
In Figure 5.3, the controller Q regulates the BIS by adjusting infusion rate (u) of
propofol based on the error between set-point and the dierence between actual and
predicted BIS. A saturation block is added after the controller Q to keep u within
the constraints specied. Because controller Q is the ltered inverse of the nominal
patient model, the tuning of the IMC controller depends on the lter time constant,
 and order of the lter, n. Inter-patient variability can be handled by adjusting
this lter time constant appropriately to each patient (for robustness) and also for
the speed of response. One of the main drawbacks of the linear IMC controller is
that it cannot handle open-loop unstable systems and nonlinear models should be
linearized for designing the controller (Brosilow & Joseph 2002).
5.3.3 Modeling error compensation (MEC) controller
The central idea in MEC (Alvarez-Ramirez et al. 2002) is to compensate the error
due to uncertainty in the parameters of the model by determining the modeling error
via patient input and output signals, and using this information for controller design.
In addition to normal feedback, an observer is introduced for the modeling error
estimation and this feedback action is explicitly proportional to the error resulting
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due to parametric uncertainties. As like IMC, this controller also regulates BIS by









Fig. 5.4. Schematic representation of the MEC scheme
observer in the controller estimates the modeling error which is a function of esti-
mated time constant for the closed-loop, e, and the error, e, which is the dierence
between measured BIS and the set-point for BIS. With these observations, the con-
troller regulates the infusion rate of propofol, u, which is a function of closed-loop
time constant c. Maintaining infusion rate of propofol within constraints has been
taken care within the control algorithm via a saturation function added explicitly
to the controller. Unlike adaptive control where model parameters are continuously
updated based on patient responses, in this approach adaptation is based on the
estimation of the trajectory of the modeling error function. Hence, this controller
scheme can potentially take care of inter- and intra-patient variability. One of the
drawbacks with the MEC approach is the diculty in tuning the controller parame-
ters (two time constants for each controlled variable) to obtain the desired response.
5.3.4 Model predictive controller (MPC)
The detailed description of the MPC scheme is provided in section 3.4.4. Here,
the overall dynamic system for the patient model is a combination of the propofol
infusion system, PK and PD models as depicted in Figure 5.1. The propofol infusion
system and the PK model are modeled as linear time invariant systems arranged in
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series. The linearized form of the PD model is then cascaded to this system to get the
overall linear representation in state-space form. The combined state-space model
is given in equations (5.6) and (5.7). Here also, km is the linearization constant












































0 0 0 km
 
C1 C2 C3 Ce
T
(5.7)
The above continuous state-space model is converted to discrete time nite step
response (FSR) model to design the MPC controller.
5.4 Results and Discussion
This section provides the application and evaluation of the MPC, IMC and MEC
control strategies, and compares their relative performances among themselves as
well as with the PID controller. This section rst shows the comparison of closed-
loop performance of all the control schemes for the nominal patient model. Later,
the remaining performance comparisons will be provided. The performance com-
parison of controllers will be in terms of ability to handle uncertainty in the model
parameters, set-point tracking, and rejection of disturbances and noise. The set-
point changes made by anesthetist and disturbances that occur during the surgery
cause the relevant physiological changes in the patient. Hence, these events were
considered to assess the performance of all the controllers. The performance of all
the controllers will be evaluated using integral of the absolute error (IAE) as the
metric (equation (3.26)). Also, the performance of all the controllers for dierent
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set-point changes and disturbances during the surgery is evaluated in terms of es-
timating the percentage of the time the output BIS signal is more than 10 units
above or below the specied set-point. Too high or too low BIS values increase the
percentage of the time BIS is outside the 10 units, which indicates poor control.
5.4.1 Closed-loop performance
The closed-loop performance of all the four controllers will be presented here.
Because plasma propofol concentration (C1) measurement is unavailable, it is es-
timated through the nominal PK model. BIS is measured online. The controller
has to maintain BIS between 40 and 60 during the surgery (Ekman et al. 2004).
Initially, it is assumed that the patient is in a fully conscious state (BIS u 100)
and then the controller is turned on and the set-point is changed from 100 to 50.
This brings the patient to the surgical operating range (40  BIS  60) which
must be maintained for the duration of the surgery. The predicted C1 must be
between 0.5 g=ml and 5 g=ml (the clinically acceptable range for C1) (Morley
et al. 2000, Absalom et al. 2002). The lower bound guarantees a minimum deliv-
ery of anesthetic, whereas the upper bound prevents overdosing of the drug for an
average subject. The manipulated variable (propofol infusion rate) u is restricted
between 0 and 40 mg=kg=hr (Krassioukov et al. 1993, Furutani et al. 2005). The
upper bound is needed because higher propofol infusion leads to faster increase of
propofol concentration in the subject's body and this may lead to hypnotic crisis,
cardiac arrhythmia, or even cardiac arrest. The minimum bound on u reects the
impossibility of administering negative concentrations of propofol. For all the four
controllers, the control execution interval is set as 5 sec which is also the sampling
interval for BIS.
We begin by discussing the design of MPC. First, the MPC controller is designed
and tuned on the basis of the Marsh model because this model is the most reliable
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one (lower prediction error between predicted and actual plasma propofol concen-
tration) (Coetzee et al. 1995). The tuning parameters are M, the input horizon; P,
the prediction horizon; S, the weighting coecient for BIS; and R, the weighting
coecient for input rate (to penalize the large changes in u). The prediction hori-
zon P is chosen as 12 sampling intervals and the control horizon M is chosen as 2
sampling intervals. Here, very low value of M is chosen (relative to P) because the
closed-loop system should be robust and we also expect fast closed-loop response.
Because the safe regulation of hypnosis level is very crucial during the surgery, the
constraints imposed on the inputs will be hard constraints, i.e., at any time the
controller should not violate these limits. By considering performance, the weights
S and R for BIS and 4u are chosen as 1 and 0.1, respectively. A higher weight on
BIS is chosen because the BIS signal is the only reliable measured signal and the
control of BIS has been given higher priority. Also, the plasma propofol concentra-
tion is predicted through PK model. From equation (3.14), the value of km obtained
is -24.16.
Next, we examine the design of the IMC controller. The constraints which were
imposed on the MPC controller were also imposed here. But unlike MPC, this
controller cannot handle the constraints on variables. Hence, additional saturation
block (Figure 5.3) is added to the controller to implement the constraint on the
manipulated variable, u. The tuning parameters for the IMC controller are the
lter time constant  which is set at 1.7 and order of the lter n which is set at 2
(minimum value which makes controller proper). Here also, the value of km used is
-24.16. As in MPC, this controller is also designed and tuned on the basis of the
Marsh model. The value chosen for the lter constant is based on the maximum
performance (minimum IAE) with no undershoot.
The MEC controller is considered next. Same constraints are imposed. The
values set for the tuning parameters, i.e., the time constants c and e for the MEC
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controller, are 2.7 and 0.42, respectively (tuned based on Marsh model). The values
chosen for the time constants are based on the maximum performance with no
undershoot. Because the constraint handling algorithm added explicitly to MEC
controller, this algorithm can also handle the constraints imposed on the variables.
With the PID controller (and similar constraints), the settings were Kc = -0.0598,
I = 28.476, and D = 2.368. As with other controllers, the tuning of this controller
is also based on the Marsh model and tuned for maximum performance with no un-
dershoot. As with IMC and MEC, this controller also cannot handle the constraints
imposed on the variables. Hence, a saturation block is added to the controller to
keep u within the bounds imposed. In summary, three parameters (P, S and R) for
MPC (with M kept at a constant value 2), two parameters ( and n) for IMC, two
parameters (c and e) for MEC and three parameters (Kc, I and D) for PID are
used for the tuning of the respective controllers.
The comparison of closed-loop performance of all the four controllers is discussed
next. Figure 5.5(a) shows that all the four controllers provide a similar performance
(IAE value = 217) with respect to BIS. The IAE values are calculated for time, t
= 0 { 50 min based on equation (3.26). Even though response is faster with PID
controller than with the other controllers, a small oset persists throughout the
simulation time. Figure 5.5(b) shows the predicted plasma propofol concentration,
where it is seen that all the controllers result in overshoot (higher with PID con-
troller) but are still maintained within the constraints. From Figure 5.5(c), one can
observe that the controllers follow dierent infusion prole patterns. Because all the
four controllers show similar performance (IAE values are almost identical), further
studies are needed to check the robustness of these controllers.
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Fig. 5.5. Performance of MPC, IMC, MEC and PID controllers for
the Marsh model
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5.4.2 Robustness comparison
This section discusses the robustness of all the four controllers for many param-
eter variations based on Marsh's pharmacokinetic model. We would like to test if
the four controllers are able to meet performance specications despite signicant
and reasonable variation in the model parameters (inter-patient variability). Here,
we assume that variability is in both the PK (based on age and weight) and PD
(based on patient's sensitivity to the drug) model parameters. There is a variation
of 25% in PK model parameters (Schnider et al. 1998, Schttler & Ihmsen 2000)
and a possible range of PD parameters (Schnider et al. 1999, Wakeling et al. 1999).
Our open-loop simulations showed that the variability in PD parameters have more
impact on BIS than the variability in PK parameters. First, each PK parameter
(k10; k12; k21; k13; k31; V1; V2 and V3) is assumed to vary over three levels (minimum,
average, maximum). This gave, 38 = 6561 combinations of patients, and closed-loop
simulations for a step change of 100 to 50 are carried out for these patients with
MPC. Simulations showed that changes in volumes of the compartments (V1; V2 and
V3) has very less eect on the performance (IAE values). Hence, these three param-
eters were kept constant and the simulations are carried out by changing only the
remaining ve parameters and this gave 35 = 243 combinations of patients. Closed-
loop simulations with MPC controller showed that IAE values varied only in the
small range of 201 { 243. Hence, from these 243 combinations, six parameter sets
which span the entire IAE range were selected. With these six parameter sets, three
PD parameters were varied in three levels and this gave 633 = 162 combinations
of patients. Closed-loop simulations with MPC controller showed that IAE values
varied in the range of 168 { 372. From the 162 parameter combinations, 17 sets
were selected to cover the entire span of IAE. The values of the parameters for the
selected 17 patient sets are given in Table 5.2. These 17 patient sets are arranged in
the decreasing order of their BIS sensitivity to propofol infusion. For the insensitive
patient, depletion rate constants of the central compartment (k10; k12 and k13) are
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high (0.149, 0.14 and 0.052, respectively) and absorption rate constants (k21 and k31)
are low (0.041 and 0.002, respectively). In the PD parameters, higher EC50 (3.7)
indicates the need for more drug to get the same hypnosis level, higher  (3.12) rep-
resents higher nonlinearity and lower ke0 (0.239) indicates sluggishness in response.
For the sensitive patient k10; k12 and k13 are low (0.089, 0.084 and 0.031, respec-
tively) and k21; k31 are high (0.069 and 0.004, respectively). In the PD parameters,
lower EC50 (1.6) indicates the need of less drug to get the same hypnosis level, lower
 (2) represents lower nonlinearity, and higher ke0 (0.459) indicates faster response.
Also, since ke0 represents the process gain, higher ke0 (higher gain) represents faster
response and lower ke0 (lower gain) represents slower response of the process. With
these 17 \patients", robustness of all the remaining controllers were tested.
Table 5.2
Values of the parameters for the 17 patient sets arranged in the




k10 k12 k21 k13 k31 ke0 EC50 
1 (Sensitive) 0.08925 0.084 0.06875 0.031425 0.004125 0.459 1.6 2
2 0.14875 0.14 0.04125 0.052375 0.004125 0.239 1.6 2
3 0.14875 0.112 0.04125 0.0419 0.004125 0.239 1.6 3.122
4 0.14875 0.14 0.04125 0.052375 0.004125 0.239 1.6 3.122
5 0.08925 0.084 0.04125 0.052375 0.002475 0.459 2.65 2.561
6 0.08925 0.084 0.06875 0.031425 0.002475 0.349 2.65 2.561
7 0.14875 0.112 0.06875 0.031425 0.002475 0.459 2.65 2.561
8 (Nominal) 0.119 0.112 0.055 0.0419 0.0033 0.349 2.65 2.561
9 0.119 0.112 0.055 0.0419 0.0033 0.239 2.65 2
10 0.119 0.112 0.055 0.0419 0.0033 0.239 2.65 2.561
11 0.08925 0.084 0.06875 0.031425 0.002475 0.459 3.7 2
12 0.14875 0.112 0.06875 0.031425 0.002475 0.349 3.7 2.561
13 0.08925 0.084 0.06875 0.031425 0.002475 0.239 3.7 2.561
14 0.08925 0.084 0.06875 0.031425 0.002475 0.239 3.7 3.122
15 0.08925 0.084 0.04125 0.052375 0.002475 0.239 3.7 3.122
16 0.14875 0.14 0.04125 0.052375 0.004125 0.349 3.7 2.561
17 (Insensitive) 0.14875 0.14 0.04125 0.052375 0.002475 0.239 3.7 3.122
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Figure 5.6 depicts the closed-loop performance of the MPC controller for the 17
dierent patient parameter sets. Figure 5.6(a) shows the tracking performance with
respect to BIS set-point equal to 50. For all these sets, BIS reached the set-point with
a small undershoot (for sensitive patients) and with some time delay (for insensitive
patients). Insensitive patient (IAE = 372) has sluggish response, whereas sensitive
patient (IAE = 168) has faster response when compared to the response of the
nominal patient (IAE = 217). Figure 5.6(b) represents the predicted plasma propofol
concentration, C1 using the nominal (and not the actual) patient model. For the
sensitive patient, nominal patient model predicts lesser concentration than the actual
concentration because it infuses less drug based on the larger gain BIS response
to propofol infusion. Similarly, for the insensitive patient, higher C1 is predicted
with the nominal patient model than the actual concentration because more drug is
infused based on the smaller gain BIS response to propofol infusion. However, the
predicted C1 remained within the constraints and with a small overshoot for all the
17 patient sets. Figure 5.6(c) represents the propofol infusion rate, u. As discussed
above, more drug is infused to the insensitive patient and less drug is infused to the
sensitive patient when compared to the nominal patient.
Figure 5.7 depicts the closed-loop performance of the IMC controller with 17
dierent patient parameter sets. Figure 5.7(a) shows the performance in tracking
the set-point change of -50 units in BIS. For all these \patients", the set-point
was reached but with undershoot that was higher than with MPC controller and
with time delay that depended on the patient's sensitivity to the drug. Despite the
undershoot noticed with some of the patient sets, the BIS set-point was tracked
with this controller without violating the constraints. Figure 5.7(a) also shows the
sluggish response of the insensitive patient (IAE = 396) and faster response of the
sensitive patient (IAE = 122) when compared to the nominal patient (IAE = 218).
The IMC shows some overshoot in C1 for some of the patient sets (not shown), but
all variables were maintained within constraints. Even here, more drug is injected
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to the insensitive patient and less drug is injected to the sensitive patient when
compared to the nominal patient (Figure 5.7(b)).
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Fig. 5.6. Performance of MPC controller for 17 patients
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Fig. 5.7. Performance of IMC controller for 17 patients
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When the simulations were done with MEC controller (Figure 5.8), IAEs of 438,
97 and 217 were obtained for the insensitive, sensitive and nominal patients, respec-
tively. When compared to MPC and IMC, MEC gave a higher IAE value for the
insensitive patient and lower IAE value for the sensitive patient. Also, with MEC
controller, output BIS has no undershoot when compared with MPC and IMC.
With the PID controller (Figure 5.9), IAEs for insensitive, sensitive and nominal
patients are 384, 166 and 217, respectively. With the PID controller, output BIS
has higher undershoot for a few patient models and also has oset when compared
to the remaining three controllers.
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Fig. 5.8. Performance of MEC controller for 17 patients
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Fig. 5.9. Performance of PID controller for 17 patients
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Figure 5.10 shows the comparison of IAE values of all the four controllers for BIS
set-point change from 100 to 50 for these 17 patient sets. The average IAE values
for MPC, IMC, MEC and PID are 237, 267, 249 and 267, respectively. The standard
deviation in IAE values are 57, 83, 81 and 65, respectively. From these we can see
that, by considering both average IAE and standard deviation in IAE, the MPC
controller provides better robust performance when compared to the other three
controllers. Even though the PID controller performs similar to MEC and IMC, the
undershoot and oset in output BIS signal are of some practical concern.



















Fig. 5.10. IAE for all the 17 patients for set-point change from 100 to 50
5.4.3 Performance comparison for disturbances and measurement noise
in the BIS signal
BIS signal may be corrupted by artifacts such as measurement noise and stim-
ulus of dierent strengths. The artifacts in BIS signal might come from the high
impedance of the electrodes, corruption of the EEG with the electromyography sig-
nal (EMG), etc. Disturbances in BIS signal may come from changes in strengths of
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surgical stimuli based on dierent surgical circumstances which cause arousal reex.
For better control performance, the noise and disturbances in the BIS signal must
be handled appropriately (for example, ltering noise). If not, it will be harmful to
the patient because unreliable values of the measured signals will result in wrong
drug dosage delivered to the patient. Here, the simulations are carried out by adding
2% Gaussian noise to the BIS signal and for disturbances, a standard stimulus pro-
le (Struys et al. 2004) is applied from t = 70 { 130 min to all the \patients". The
total stimulation time of 60 min includes virtual inductions of dierent strengths
and dierent periods up to the time of skin closure. Figure 5.11 depicts the cor-
responding stimulus prole (dotted line). The detailed description of the stimulus
prole is provided in section 3.5 (also shown in Figure 3.7).
Figure 5.11 depicts the performance of the MPC controller with noise and distur-
bance in the BIS signal for the nominal patient. Figure 5.11(a) shows the measured
BIS prole with the BIS set-point set at 50. The dashed line includes the disturbance
signal added to output BIS. Even though the BIS signal has noise, the controller
regulates the BIS signal well. But, a strong disturbance for a longer duration of
time causes the BIS signal to cross the limits imposed during the period of distur-
bance. Figure 5.11(b) shows the predicted plasma propofol concentration prole.
Whenever BIS increases, controller increases C1 by increasing propofol infusion rate
to bring back BIS to its original set-point. Unlike BIS, the controller maintains
predicted C1 within the constraints imposed and this is very important for patient
safety. Figure 5.11(c) shows the propofol infusion rate prole and this correlates
very well with the C1 prole. Even though the BIS signal is corrupted with noise,
the MPC controller maintained a smooth infusion prole for propofol.
Figure 5.12 depicts the performance of the IMC controller with noise and distur-
bance in the BIS signal for the nominal patient. This controller also maintained
the predicted C1 within constraints. Unlike MPC, the noise in BIS signal leads to
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Fig. 5.11. Performance of the MPC controller for measurement noise
and disturbances during the surgery
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small uctuations in the propofol infusion rate with IMC (Figure 5.12(b)). This is
perhaps not good for the actuator element (control valve). Figure 5.13(a) depicts
the performance of the MEC controller for the same scenario in the BIS signal for
the nominal patient. Predicted C1 maintained by this controller is within the con-
straints imposed. The prole of the propofol infusion rate (Figure 5.13(b)) is very
noisy compared to MPC and IMC. This indicates the sensitivity of the MEC con-
troller to noise, which can cause frequent movement of the control valve. This can
be a problem in practical applications. Figure 5.14 depicts the performance of the
PID controller. The regulatory performance is sluggish (Figure 5.14(a)), and hence
the PID performance is lower than the other controllers. The propofol infusion pro-
le (Figure 5.14(b)) is less noisy when compared to MEC controller but more noisy
when compared to MPC and IMC controllers.
The performance (IAE values) of all four controllers is tested on the 17 dierent
patient sets for the noise and disturbance in output BIS, and the results obtained are
summarized in Figure 5.15. The average performance is high for the MPC controller
(IAE = 461) and less for the PID controller (IAE = 528). Average IAE values with
MEC and IMC are 489 and 470, respectively. The standard deviation in IAE values
for MPC, IMC, MEC and PID are 21, 22, 19 and 29, respectively.
Figure 5.16 shows the performance of the four controllers for the percentage of
the time, the output BIS value is outside  10 units of the set-point for all 17
patient models for disturbances in output BIS (Struys et al. 2004). The perfor-
mance is evaluated for the disturbance period from 70 to 150 min. The comparison
shows the poor average performance with the PID controller (28%) and high average
performance with the MPC controller (21%). MEC and IMC gave similar average
performance of 23% and 23%, respectively. These percentages are somewhat higher
because of the large magnitudes of disturbance pulses introduced within a short
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period of time. The standard deviation in the above percent times is small (2 { 3%)
for all the four controllers tested.



















































    
    




Fig. 5.12. Performance of the IMC controller for measurement noise
and disturbances during the surgery
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(b)
Fig. 5.13. Performance of the MEC controller for measurement noise
and disturbances during the surgery
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Fig. 5.14. Performance of the PID controller for measurement noise
and disturbances during the surgery
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Fig. 5.15. IAE for all the 17 patient models for noise and distur-
bances in BIS signal





















Fig. 5.16. Percentage of the time output BIS value is outside  10
units of the set-point for all 17 patient models for disturbances in
the BIS signal
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5.4.4 Performance comparison for set-point changes in BIS during surgery
Anesthesiologists can anticipate periods that require more stimulation and also
periods during which light sedation is required during the surgery and accordingly
adjust the BIS set-point. Hence, the four controllers are now tested for dierent
set-point changes in BIS value which may be required at any time based on the
extent of surgery. For example, if surgical stimulation is severe at any time during
the surgical process, the patient needs to be more unconscious and hence the BIS
value should be decreased to some lower value (e.g., 40). Afterward, toward the end
of the surgery, the patient needs to be less unconscious and the BIS set-point may
be increased from 40 to say, 70. Figures 5.17 { 5.20 depict the performance of the
four controllers (MPC, IMC, MEC and PID, respectively) for a step change in BIS
from 50 to 40 at t = 30 min, from 40 to 70 at t = 60 min, and from 70 to 50 at t =
90 min for the nominal patient. In these simulations, 2% Gaussian noise is added
to the output BIS signal.
Plot (a) of Figures 5.17 { 5.20 depicts the performance of four controllers for
dierent set-point changes during the surgery. Despite the noise in the output
BIS signal, all controllers perfectly regulate the BIS near to the specied set-point.
The PID controller gives oset in output BIS signal (Figure 5.20(a)) { this is not
observed with the remaining three controllers. Figure 5.17(b) shows the smooth
predicted C1 prole with the MPC controller. The similar smooth predicted C1
proles are observed with the remaining three controllers. The propofol infusion
prole obtained with the MPC controller is shown in Figure 5.17(c) and is smoother
than the proles obtained with the remaining three controllers which are shown in
Figures 5.18(b), 5.19(b) and 5.20(b). Out of all these, infusion prole obtained with
MEC controller is very aggressive and is deemed not good in a surgical setting.
The performance of all the four controllers is tested with the 17 dierent patients
for the set-point changes mentioned above and the IAE values obtained are depicted
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(c)
Fig. 5.17. Performance of the MPC controller for dierent set-point
changes in BIS during the surgery
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in Figure 5.21. The average performance is high for the MPC controller (IAE =
324) and poor for the PID controller (IAE = 405). MEC and IMC gave average
IAE values of 337 and 340, respectively. The standard deviation in IAE values for
MPC, IMC, MEC and PID are 27, 36, 29 and 42, respectively.




















































    
    
    
  
(b)
Fig. 5.18. Performance of the IMC controller for dierent set-point
changes in BIS during the surgery
Figure 5.22 shows the performance of the four controllers for the percentage of
the time output BIS value is outside  10 units from the set-point for all 17 patient
models for dierent set-point changes in BIS (Struys et al. 2004). The performance
is evaluated for the time period from 30 to 120 min. This comparison also shows
the poor average performance with the PID controller (13%) and high average per-
formance with the MPC controller (10%). MEC and IMC gave similar average
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performance of 11%. The standard deviation in these percent times is 1% for all the
four controllers tested.



















































    
    
    
 
(b)
Fig. 5.19. Performance of the MEC controller for dierent set-point
changes in BIS during the surgery
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Fig. 5.20. Performance of the PID controller for dierent set-point
changes in BIS during the surgery
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Fig. 5.21. IAE for all the 17 patient models for set-point changes




















Fig. 5.22. Percentage of the time output BIS value is outside 
10 units from the set-point for all 17 patient models for dierent
set-point changes
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5.5 Comparison of the performance with the RTDA Con-
troller
This section provides a comparison between the performances of RTDA, MPC
and PID controllers. Because, FOPTD model is used to design and tune RTDA con-
troller, the four state, nonlinear patient model is approximated to FOPTD model
through process reaction curve method. Figure 5.23 depicts the degree of approxi-
mation obtained. The four parameters of this controller are tuned using the direct















τ = 87 min
α = 0.84 min
True patient model
FOPTD model fit
Fig. 5.23. FOPTD model t to true patient model response
search optimization algorithm for the best performance i.e., minimum IAE value
(equation (3.26)) based on set-point changes to BIS from 100 to 50 (the BIS value
recommended during surgery). The BIS response obtained through these settings
gave a small undershoot, hence further ne tuning was carried out using dierent
values of T (tuning parameter which track the set-point changes) while keeping the
remaining tuning parameters constant. Figure 5.24 depicts the performance of the
RTDA controller for dierent values of T and based on the performance, a value
of 0.044 is selected. These settings (R = 0.037, D = 0.937, A = 0.812 and T =
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Fig. 5.24. Performance of the RTDA controller for dierent values of T
0.044) will be used for further performance comparisons. The sampling time of all
the controllers is set to 0.0833 min which is equal to the sampling time of BIS.
5.5.1 Performance comparison for a step change in BIS during surgery
The three controllers are tested for dierent step changes in BIS value on the
nominal patient. Figure 5.25 depicts the performance of the three controllers for
a step change in BIS from 50 to 40 at t = 50 min and from 40 to 60 at t = 100
min. Better transition of the BIS is obtained with RTDA and MPC controllers when
compared to PID controller. Also, the PID controller has a relatively longer settling
time.
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Fig. 5.25. Performance of the RTDA, MPC and PID controllers for
dierent set-point changes during the surgery
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5.5.2 Robustness comparison
This section discusses the robustness of the RTDA, MPC and PID controllers
based on the IAE values. After a sensitivity test of the parameters, 17 patients
(representing the population of patients) are selected (Table 5.2) and used for com-
paring the robustness of the three controllers. Figure 5.26 depicts the closed-loop
performance of the RTDA controller with 17 patient sets. Figure 5.26(a) shows the
tracking performance with respect to BIS set-point 50. With all these sets, the BIS




































   
   










    
    






Fig. 5.26. Robust performance of the RTDA controller for dierent
sets of patient model parameters
value reached the set-point with some undershoot and time delay based on the pa-
tient's sensitivity to the drug. Insensitive patient (IAE = 324) has sluggish response
whereas sensitive patient (IAE = 141) has faster response when compared to the
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Fig. 5.27. IAE for all the 17 patient models for BIS set-point 50
response of the nominal patient (IAE = 217). Figure 5.26(b) represents the propofol
infusion rate, u. In line with the above observations, more drug is injected to the
insensitive patient and less drug is infused into the sensitive patient as compared
to the nominal patient. Figure 5.27 shows the comparison of the performance (IAE
values) of all the three controllers for BIS set-point 50 for these 17 patient models.
In this plot, the average IAE value is lower for the RTDA controller (IAE = 226) and
highest for the PID controller (IAE = 250). The IAE value for the MPC controller
is 237 - this is slightly higher than that obtained for the RTDA controller.
5.5.3 Performance comparison for a sudden disturbance in BIS signal
The three controllers are tested for sudden disturbances which can occur at any-
time during the surgery. Here, simulations are carried out by adding a disturbance
pulse of strength 20 in the BIS signal from t = 50 { 80 min. Figure 5.28 depicts
the performance of all the three controllers with disturbance in the BIS signal for
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Fig. 5.28. Performance of the RTDA, MPC and PID controllers for
disturbance during the surgery
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the nominal patient. Figure 5.28(a) shows the BIS signal (BIS set-point = 50) and
Figure 5.28(b) shows the propofol infusion rate prole. Here also, the performance
of RTDA controller (IAE = 403) is slightly better than MPC (IAE = 407) perfor-
mance. The PID controller performs poorly (IAE = 450) compared to RTDA and
MPC.
5.6 Conclusions
In this chapter, three advanced control strategies (model predictive control, in-
ternal model control, controller with modeling error compensation) for regulation of
hypnosis using BIS as the controlled variable have been evaluated thoroughly. The
performance of these controllers are considered along with the performance of the
conventional PID controller. In comparison with the PID controller, the advanced,
model-based controllers are found to be robust to inter-patient variability, better at
handling disturbances and measurement noise. Even though the performance of the
MEC controller is approximately equal to the MPC controller's performance, the
noise in the BIS signal causes excessive uctuations in the valve movement with the
MEC controller and is not acceptable for surgical applications. The performance
of the IMC controller is less than that of MPC and MEC controllers, but there is
very small movement of the control valve with this controller. Among the four con-
trollers, the MPC is found to perform the best. Finally, the performance of MPC
and PID controllers is compared with the novel RTDA controller. The RTDA con-
troller performs signicantly better than the PID controller and does slightly better
than the MPC controller in regulating hypnosis when tested on patient models. It
also appears to be robust to variation in patient parameters.
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Chapter 6
SIMULTANEOUS REGULATION OF HYPNOSIS AND
ANALGESIA USING MODEL PREDICTIVE CONTROL
6.1 Introduction
The objective of this chapter is to design and thoroughly evaluate, through simula-
tion, a model predictive controller (MPC) for optimal infusion rates of both hypnotic
and analgesic drugs such that the patient's hypnotic and analgesic states (measured
by BIS and MAP, respectively) are well regulated and the side eects (due to over-
dosage) are minimized. The present study is the rst one on two-input two-output
MPC of BIS and MAP using propofol and remifentanil. Manual administration of
neuromuscular blocking drug is assumed for the skeletal muscle relaxation. Exten-
sive simulations are conducted to test the robustness of the proposed controller, by
considering parameter variations in the PK and PD models (to account for patient-
model mismatch) and typical set-point changes and disturbances during surgical
operations. Results show that the MPC provides better performance in comparison
with two (decentralized) PID controllers.
The chapter is organized as follows. Section 6.2 includes the description of the
modeling of BIS response to infusion of propofol & remifentanil and MAP response
to infusion of remifentanil. Section 6.3 includes the detailed description of MPC
and PID control structures used in this chapter. Section 6.4 includes the tuning of
controllers, and the evaluation of performances for MPC and PID controllers for the
set-point changes and disturbances that may occur during the surgery. Individual
137
6.2 Modeling Hypnosis and Analgesia
dierences in model parameters are also considered to evaluate the performance of
controllers in handling inter-patient variability.
6.2 Modeling Hypnosis and Analgesia
The model used for BIS and MAP responses to propofol/remifentanil consists
of two interacting parts: a PK model for estimating the distribution of propo-
fol/remifentanil in the internal organs, and a PD model to describe the eect of
propofol/remifentanil on the measured physiological variables, i.e., BIS and MAP. Fig-
ure 6.1 is a schematic of the system comprising of propofol/remifentanil delivery
circuit, and the PK & PD models. Note that, propofol aects BIS only, whereas
remifentanil aects both BIS and MAP. In this gure, subscripts 'p' and 'r' refer to
the respective variables for propofol and remifentanil.
For the distribution of the drug (propofol or remifentanil), a linear mammillary
three-compartmental PK model is adopted from the literature (Schwilden et al.
1989). The central compartment, V1, represents blood plasma in which drug dis-
solves and is carried to the other compartments. Also, because of the drug metabolism
in the body, elimination of the drug from the central compartment is assumed. The
second compartment is a shallow peripheral compartment, V2, which is character-
ized by a very rapid movement of the drug from the plasma to this compartment.
This is the characteristic of certain tissues which are highly perfused (i.e., vessel-
rich tissues). The third compartment is a deep peripheral compartment, V3, which
is characterized by a slow distribution of the drug from the central compartment
to this compartment. This is because of the equilibration of the blood with tissues
which are less perfused.
The PK part assumes that all compartments (Figure 6.1) have a zero initial
concentration of the drug (propofol or remifentanil). To achieve rapid target plasma
drug concentration (i.e., concentration in V1), sucient drug must be given as a
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bolus dose. If the plasma drug concentration is to be kept constant, the amount of
drug entering and leaving the central compartment must be equal. Drug leaves the
blood (V1) to pass into V2 and V3 at a gradually decreasing rate as the concentrations
in these compartments increase. Drug also leaves the blood because it is metabolized
(mainly in the liver) (Marsh et al. 1991). The PD part assumes some lag between
the infusion of drug in the bloodstream and its distribution to corresponding tissues
(brain or nerve) before aecting the hypnosis and analgesia levels. This eect on
hypnosis level is represented by a nonlinear equation, and on analgesia level by a






























Fig. 6.1. Schematic representation of propofol and remifentanil de-
livery circuit with PK and PD models
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6.2.1 Pharmacokinetic model
Figure 6.1 shows the PK model for distribution of drug (propofol/remifentanil)
which is described by mass balances around each of the three compartments. The
main assumptions here are that the central compartment is a well mixed tank with
the plasma propofol/remifentanil concentration uniform everywhere, and the distri-
bution of these drugs are not aected by the presence of other drugs. Hence, the













  k10C1 + 
V1
U (6.1)
Here, C1, C2 and C3 are concentrations of the drug (propofol, g=ml, or remifentanil,
ng=ml) in the rst (central), second and third compartments, respectively; V1, V2
and V3 are the respective volumes (`); k12, k13, k21 and k31 are the mammillary rate
constants (min 1) of the respective compartments, k10 is the hepatic metabolism
rate constant representing the elimination rate of drugs from the patient (min 1); 
= 10 (mg=ml) and 5  102 (g=ml) are the available propofol and remifentanil con-
centrations, respectively; normalization constant,  = 60 (min=hr) for propofol and
1 (min=min) for remifentanil; and U is the infusion rate of propofol in ml=hr and
remifentanil in ml=min. Clinically, infusion rates of propofol, up and remifentanil,
ur are expressed in mg=kg=hr and g=kg=min (normalized drug infusion rates with
respect to patient's body weight), respectively. To convert U to up in mg=kg=hr
and ur in g=kg=min, it is multiplied by respective

w
, where w is the weight of the
patient in kg. Similarly, for the second and third compartments, the corresponding






  kj1Cj; j = 2; 3 (6.2)
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The PK model parameters provided by Marsh et al. (1991) are used for propofol
and those by Minto et al. (1997) are used for remifentanil. As equations (6.1) and (6.2)
refers to both propofol and remifentanil, indexes 'p' and 'r' are omitted to avoid or
minimize notation overload. Table 6.1 shows the PK parameters for propofol and
remifentanil mentioned in equations (6.1) and (6.2) for a 34 year old person weighing
66 kg.
Table 6.1
Rate constants and volumes of the dierent compartments (Marsh














V1 (`) 15.050 4.409
V2 (`) 30.600 8.184
V3 (`) 191.10 4.323
6.2.2 Pharmacodynamic interaction model for BIS response to propofol
and remifentanil
The above PK model is limited to the representation of distribution kinetics of
propofol and remifentanil into dierent compartments. A PD model is required to
calculate the eect of each drug on the anesthetic level. The detailed description of
the PD model is provided in sections 3.2.3 and 5.2.2.
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The nominal values of the parameters, ke0p = 0.349min
 1, EC50p = 2.65 g=ml and
p = 2.561 for propofol (Sartori et al. 2005) and ke0r = 0.516 min
 1, EC50r = 11.2
ng=ml and r = 2.51 for remifentanil (Minto et al. 1997) are obtained from the
pooled analysis.
The model represented in equation (5.4) is limited to denote the individual eect
of each drug on BIS response. To represent the eect of combination of syner-
gistically interacting drugs on BIS response, an interaction model is needed. Minto
et al. (2000) described an approach based on response surface methodology for char-
acterizing drug-drug interactions between several intravenous anesthetic drugs. This
model can characterize the entire dose-response relation between combinations of
anesthetic drugs and is mathematically consistent with models of the concentration-
response relation of single drugs. Nieuwenhuijs et al. (2003) also used this methodol-
ogy to investigate propofol-remifentanil interaction on cardiorespiratory control and
BIS and concluded that the model can capture the synergistic interaction between
these two drugs. The interaction model developed by Minto et al. (2000), which is
also supported by Bruhn et al. (2003), considered in this study is described below.
Initially, the concentrations were normalized to their respective potencies, i.e.,








where Cep and Cer are the respective eect-site concentrations of propofol and
remifentanil. The additive interaction is represented with the \eective" concentra-
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Deviation from a purely additive interaction is modeled by changing the potency of





By denition,  ranges from 0 (remifentanil only) to 1 (propofol only). Thus, the














where () is the steepness of the concentration-response relation, and U50() is the
number of units (U) associated with 50% of maximum eect at ratio . According
to Minto et al. (2000), the equation for potency as a function of  can be simplied
to a quadratic polynomial:
U50 () = 1  2;U50 + 2;U502 (6.7)
The value of 2;U50 obtained according to Bruhn et al. (2003) is 1.44. The model for
the steepness term, () can be described as
 () = r + (p   r) (6.8)
Figure 6.2(a) is the response surface plot, where the left and rightmost edges of the
surface are the individual sigmoid concentration-response relation for remifentanil
and propofol, respectively. Figure 6.2(b) shows the sigmoid concentration-response
relation for dierent ratios of propofol and remifentanil. From Figure 6.2, it is
evident that the PD interaction between propofol and remifentanil is very nonlin-
ear (Glass 1998).
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(a) Response Surface Plot







































Fig. 6.2. Nonlinear PD interaction between propofol and remifentanil
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6.2.3 Pharmacodynamic model for MAP response to remifentanil
Skin incision and intubation during the surgery may increase MAP. These MAP
changes must be minimized during surgery by infusing sucient amount of opiate.
The success of closed-loop control of MAP lies in the use of reliable models in con-
troller design (Furutani et al. 1995). The PK model for distribution of remifentanil
is described earlier. A PD model that relates eect-site concentration of remifen-
tanil to MAP is not available in the literature. Hence, based on the MAP responses
obtained with remifentanil infusion (Warner et al. 1996, Doyle et al. 2001) and
also from the information obtained for other similar opioids (Gentilini et al. 2002)
which are closely related to remifentanil, a linear model between eect-site concen-
trations of remifentanil and MAP is assumed with a negative gain equivalent to
-0.1762 mmHg=(ng=ml). The sign of the gain guarantees that the infusion rate will
decrease when MAP is low and increase when MAP is high.
6.3 Controllers Studied
Design of model predictive and decentralized PID control strategies for the reg-
ulation of hypnosis and analgesia are described briey in this section.
6.3.1 Model predictive controller (MPC)
The MPC scheme for simultaneous regulation of hypnosis and analgesia is shown
in Figure 6.3. The detailed description of the MPC scheme is provided in section
3.4.4. The patient model is used to predict the current values of the output variables
(BIS and MAP). The dierence between measured outputs from the patient and the
respective model outputs are called residuals, and serves as feedback signal to the
prediction block. The predictions are used in control calculations subject to suitable
constraints on the inputs up & ur and output variables BIS & MAP. That is, the
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control calculations are based on the current measurements and predictions of the
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Fig. 6.3. Schematic representation of the MPC scheme for simulta-
neous regulation of BIS and MAP










subject to absolute and rate constraints on the manipulated variables
umin  ui  umax (for i = k; k + 1; . . . , k +M   1)
ui 1  4umax  ui  ui 1 +4umax (for i = k; k + 1; . . . , k +M   1)
where, at each sampling instant i, 4ui = ui+1   ui is the vector of manipulated
variable deviations, ei = ri   yi is the vector of model predicted errors, ri is the
desired set-point, yi is the vector of predicted future values of BIS and MAP. The
length of these vectors depends on the prediction (output) horizon P . Also, S and
R are the diagonal weighting matrices for outputs (BIS and MAP) and variation
in inputs (propofol and remifentanil infusion rates, up and ur), respectively. These
weighting matrices can be used to tune the MPC controller to achieve the desired
tradeo between output performance and manipulated variable movement. The
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prediction horizon P is chosen on the basis of open-loop settling time whereas control
horizon M is chosen based on the tradeo between faster response (large value of
M) and robustness (small value of M). Generally, the chosen value for M will be
very small compared to P .
A linear MPC requires an internal linear time-invariant model (e.g., a linear step
response model) to estimate the future output values using the past and future values
of the inputs (Seborg et al. 2004). Here, the overall dynamic system for the patient
model is a combination of the propofol and remifentanil infusion systems, and the
PK & PD models as depicted in Figure 6.1. The propofol and remifentanil infusion
systems and the corresponding PK models are modeled as linear time invariant
systems arranged in series. The nonlinear PD interaction model which is linearized
at specic operating points (say BIS at 50 and MAP at 80) is then cascaded to this
system to get the overall linear representation in state-space form. The combined
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where kmp and kmr1 are the linearization constants with respect to BIS and kmr2 is
the linearization constant with respect to MAP. The above continuous state-space
model is converted to discrete time nite step response (FSR) model for designing
the MPC controller (Seborg et al. 2004).
6.3.2 Proportional-integral-derivative (PID) controller
Figure 6.4 shows the schematic representation of the two decentralized PID con-
trollers for the simultaneous regulation of hypnosis and analgesia. The detailed
description of the PID controller scheme is provided in section 5.3.1. Here also, the
PID parameters are obtained via optimization so as to get the best performance
















Fig. 6.4. Schematic representation of the PID controller scheme for
simultaneous regulation of BIS and MAP
148
Chapter 6 Simultaneous Regulation of Hypnosis and Analgesia Using MPC
6.4 Results and Discussion
This section provides the simulation results of the multi input-multi output
(MIMO) MPC and two single input-single output (SISO) PID controllers (decen-
tralized) for the control of BIS and MAP by simultaneous regulation of propofol
and remifentanil. Tuning of the MPC and decentralized PID controllers is rst
presented. Later, the performance of the two controllers will be evaluated and com-
pared in terms of ability to handle uncertainty in the model parameters, set-point
tracking, and rejection of disturbances, all in the presence of measurement noise.
Integral of the absolute error (IAE) and control eort are employed as the metrics
for performance evaluation.
The controller has to maintain BIS between 40 and 60 during the surgery (Ekman
et al. 2004). Initially, it is assumed that the patient is in a fully conscious state (BIS
 100) and average MAP is at 100 mm Hg. Then, the controller is turned on and the
set-point of BIS is changed from 100 to 50 and MAP from 100 to 80. This brings the
patient to the surgical operating range (40  BIS  60 & 70  MAP  110) that
must be maintained for the duration of the surgery. The set-point for MAP is kept
at a lower value to reduce the blood loss and to compensate the sudden increase
in blood pressure. The predicted C1p must be between 0.5 g=ml and 5 g=ml
and C1r between 0.5 ng=ml and 10 ng=ml (clinically acceptable ranges) (Absalom
et al. 2002); note that these are not measured and they are estimated using the
nominal patient model. The lower bound guarantees a minimum delivery of the
drug, whereas the upper bound prevents overdosing of the drug for an average
subject. It is important to maintain C1r within the limits because remifentanil is
hemodynamically stable and increasing its concentration in the plasma may not
decrease MAP unlike C1p which directly aects BIS response.
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The manipulated variables up and ur (propofol and remifentanil infusion rates)
are restricted between 0 and 20 mg=kg=hr (Sawaguchi et al. 2008) and from 0 to 1
g=kg=min (Struys et al. 2001), respectively. The upper bound is needed because
higher propofol and remifentanil infusions lead to faster increase of drug concentra-
tions in the subject's body and may lead to hypnotic crisis, cardiac arrhythmia, or
even cardiac arrest. The minimum bound on up and ur reects the impossibility of
administering negative concentrations of propofol and remifentanil. It is very impor-
tant to maintain the drug concentrations and infusion rates within the acceptable
limits, and the designed controller should not violate these constraints. The control
execution interval is set as 5 sec which is also the sampling time for BIS and the
same is assumed for MAP also.
6.4.1 Tuning of controllers
This section begins with the discussion on the design and tuning of MPC for
the nominal patient model (parameters mentioned in section 6.2). The tuning pa-
rameters in the MPC are: M, the input horizon; P, the prediction horizon; S1, the
weighting coecient for BIS; S2, the weighting coecient for MAP; R1, the weight-
ing coecient for propofol rate; and R2, the weighting coecient for remifentanil
rate (to penalize the large changes in up and ur). The prediction horizon P is chosen
as 30 sampling intervals and the control horizonM is chosen as 2 sampling intervals.
Simulations showed that further increase in P does not aect the performance of the
controller, and hence it is xed at that value. Also, very low value of M is chosen
(relative to P) because the closed-loop system should be robust and also expect
fast closed-loop response. Because the safe regulation of hypnosis and analgesia
levels are very crucial during the surgery, the constraints imposed on the inputs
will be hard constraints i.e., at any time controller should not violate these limits.
At the same time, smooth control action would be required to avoid sudden large
uctuations in control valve movement. Hence, to avoid problems associated with
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the constraints, the controller tuning weights should be chosen carefully. Table 6.2
shows the performance of the MPC with dierent weights on the measured output
variables and on the input rates. Here, IAE values are calculated for time, t = 0 { 50
min based on equation (3.26). Another measure of the controller performance, the
required control eort is computed by calculating the total variation (TV) of the
manipulated input, u given by equation (3.31). The TV of u(t) is the sum of all
up and down control moves. Thus, it is a good measure of the smoothness of the




R1 R2 IAEBIS IAEMAP TVP TVR
0 0 176 82 20.29 1.36
1 0 214 82 14.10 1.36
0 1 196 102 21.56 0.93
1 1 221 102 13.88 0.93
0.2 0.6 196 91 21.10 1.21
0.6 0.2 202 83 15.93 1.33
0.5 0.5 196 89 17.41 1.24
The performance of the MPC controller for dierent tuning weights on the output
variables and input variable rates are depicted in Figure 6.5. Plots (a) and (b),
respectively show the transient responses of BIS and MAP and plots (c) and (d),
respectively show the infusion rates of propofol and remifentanil. Equal preference
has been given for the control of BIS and MAP by keeping equal weights (S1 =
S2 = 1) on each of these variables. Next, tuning has been done by varying the
weights on input rates (R1 and R2). From all these plots, one can observe that, if
weights on input rates are low, performance is good (lower IAE) but control eort
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is more (higher TV). Also, if weights on input rates are high, performance is poor
(higher IAE) but control eort is less (lower TV). By compromising between these
contradicting situations, equal medium value on weights are chosen for each input
rate (i.e., R1 = R2 = 0.5).
Next, the tuning of the two decentralized PID controllers are discussed here.
Each PID controller infuses the respective drug (either propofol or remifentanil)
based on BIS and MAP levels. The two PID controllers are simultaneously tuned
for minimizing IAE and control eort (TV) with respect to BIS and also to MAP
for time, t = 0 { 50 min based on equations (3.26) and (3.31) by using direct
search optimization algorithm. The nal tuned settings for the two PID controllers
are given in Table 6.3. Also, plots (a) and (b) in Figure 6.6 show the transient
responses of BIS and MAP and plots (c) and (d), respectively show the infusion
rates of propofol and remifentanil. By considering the performance (minimum IAE)
of both the PID controllers, setting 3 is selected for the remaining performance
evaluations. Also, for the selected PID settings, IAE values are comparable with
the values of the selected MPC controller so that a fair comparison can be made
between MPC and decentralized PID.
152
Chapter 6 Simultaneous Regulation of Hypnosis and Analgesia Using MPC













Q1 = 1, Q2 = 1, R1 = 0, R2 = 0
Q1 = 1, Q2 = 1, R1 = 1, R2 = 0
Q1 = 1, Q2 = 1, R1 = 0, R2 = 1
Q1 = 1, Q2 = 1, R1 = 1, R2 = 1
Q1 = 1, Q2 = 1, R1 = 0.2, R2 = 0.6
Q1 = 1, Q2 = 1, R1 = 0.6, R2 = 0.2
Q1 = 1, Q2 = 1, R1 = 0.5, R2 = 0.5
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Fig. 6.5. Performance of the MPC controller for dierent weights (see Table 6.2)
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Fig. 6.6. Performance of the decentralized PID controller for dier-
ent tuning parameters (see Table 6.3)
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6.4 Results and Discussion
6.4.2 Performance of MPC and PID for step type set-point changes in
BIS and MAP during surgery
Set-point changes in BIS and blood pressure are often made depending on the
surgical procedure being performed (Doyle et al. 2007). Anesthesiologist can an-
ticipate the periods that would require more stimulation and also the periods in
which light sedation is required during the surgery. For example, if surgical stim-
ulation is severe at any time during the surgical process, the patient needs to be
more unconscious and hence the BIS value should be decreased to some lower value
(e.g., 40). Similarly, surgical stimulation increases the blood pressure, and hence it
should be compensated by decreasing the set-point for MAP. Afterwards, towards
the end of the surgery, the patient needs to be less unconscious and BIS set-point
may be increased, say from 40 to 70. Table 6.4 shows the set-point changes and
their time of introduction for BIS and MAP. Also, these two signals are generally
corrupted by measurement noise, which might come from the high impedance of
Table 6.4
Series of intraoperative set-point changes for BIS and MAP
Time (min) BIS Set-Point Change MAP Set-Point Change (mm Hg)
30 50 to 40 {
60 40 to 50 {
90 { 80 to 70
120 { 70 to 80
150 50 to 60 {
180 { 80 to 90
210 60 to 70 90 to 100
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the electrodes, corruption of the EEG and MAP with the electromyography (EMG)
signal etc. Hence, to simulate the realistic situations, 2% Gaussian noise is added
to BIS and MAP signals.
The performance of designed MPC controller is compared with the performance
of decentralized PID controllers designed separately for regulation of BIS and MAP.
The responses obtained with the two controllers are compared in Figures 6.7 and
6.8 for the set-point changes mentioned in Table 6.4, for the nominal PK-PD model
parameters described in section 6.2. Because of unavailability of plasma propofol
and remifentanil concentrations (C1p and C1r), they are predicted using the nominal
(and not the actual) patient model. To reduce the variation in the manipulated
variable (i.e., to reduce valve movements) because of noise in BIS and MAP, these
signals were passed through lters with a time constant of 1 min each. The IAE and
TV values are calculated for the maintenance period t = 30 { 280 min and are given
in Table 6.5. Hence, for the nominal patient, the IAE values for both controllers
are comparable although control eort with the PID controller is high for both the
drugs compared to MPC. This is because, although MPC is aggressive compared
to decentralized PID, noise in BIS and MAP signals caused the higher variation in
propofol and remifentanil infusions with decentralized PID compared to MPC.
Table 6.5
Performance of MPC and PID for nominal patient for the set-point
changes during the maintenance period
Controller IAEBIS IAEMAP TVP TVR
MPC 808 295 28.1 2.67
PID 815 307 34.5 6.20
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Fig. 6.7. Performance of MPC and PID controllers for set-point
changes during the maintenance period t = 30 { 280 min: BIS,
predicted propofol concentration in the plasma and propofol infusion
rate
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Fig. 6.8. Performance of MPC and PID controllers for set-point
changes during the maintenance period t = 30 { 280 min: MAP,
predicted remifentanil concentration in the plasma and remifentanil
infusion rate
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Next, tests are conducted to check if these two controllers (MPC and decentralized
PID) are able to meet performance specications despite signicant and reasonable
variation in the model parameters (inter-patient variability) based on PK-PD model
described in section 6.2. Here, assumption is that variability is in both the PK
(based on age and weight) and PD (based on patient's sensitivity to the drug) model
parameters. There is a variation of 25% in PK model parameters (Schttler & Ihmsen
2000) and a possible range of PD parameters for both the drugs (Schnider et al.
1999). Open-loop simulation studies showed that the variability in PD parameters
have more impact on BIS than the variability in PK parameters. Also, volumes
of the compartments (V1p, V2p, V3p, V1r, V2r and V3r) have negligible eect on the
BIS performance. Hence, the remaining PK parameters (k10p, k12p, k21p, k13p, k31p,
k10r, k12r, k21r, k13r and k31r) are assumed to vary over three levels (minimum,
average, maximum) and are given in Table 6.6. This gave, 310 = 59049 combinations
of patients and closed-loop simulations with MPC for the maintenance period are
carried out for these patients. Simulations showed that IAE values varied from 831
to 1049. Hence, from these 59049 combinations, 12 parameter sets which span the
entire IAE range were selected. With these 12 parameter sets, 7 PD parameters were
varied in 3 levels and this gave 1237 = 26244 combinations of patients. Closed-
loop simulations with MPC controller showed that IAE values varied in the range
662 to 1210. From the 26244 parameter combinations, 28 sets were selected to cover
the entire span of IAE. These 28 patient sets are arranged in the decreasing order
of their BIS sensitivity to propofol and remifentanil infusions (given in Table 6.7).
An insensitive patient requires relatively more drug dosage and also responds
slowly to the drug. For the insensitive patient, depletion rate constants of the central
compartment (k10p, k12p, k13p, k10r, k12r and k13r) are high (0.14875, 0.14, 0.052375,
0.63625, 0.4525 and 0.01625, respectively) and absorption rate constants (k21p, k31p,
k21r and k31r) are low (0.04125, 0.002475, 0.14625 and 0.0105, respectively). In the
PD parameters, higher EC50p and EC50r (3.7 and 14.56, respectively) indicate the
160
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Table 6.6
Variation in parameters in PK/PD models
Parameter Lower Limit  Mean  Upper Limit
k10p (min
 1) 0.08925  0.119  0.14875
k12p (min
 1) 0.084  0.112  0.140
k21p (min
 1) 0.04125  0.055  0.06875
k13p (min
 1) 0.031425  0.0419  0.052375
k31p (min
 1) 0.002475  0.0033  0.004125
ke0p (min
 1) 0.239  0.349  0.459
EC50p (g=ml) 1.6  2.65  3.7
p 2  2.561  3.122
k10r (min
 1) 0.38175  0.509  0.63625
k12r (min
 1) 0.2715  0.362  0.4525
k21r (min
 1) 0.14625  0.195  0.24375
k13r (min
 1) 0.00975  0.013  0.01625
k31r (min
 1) 0.0105  0.014  0.0175
ke0r (min
 1) 0.3612  0.516  0.6708
EC50r (ng=ml) 7.84  11.2  14.56
r 1.757  2.51  3.263
kr (mmHg=(ng=ml)) -0.12334  -0.1762  -0.22906
need for more drug to get the same hypnosis and analgesia levels, higher p and r
(3.122 and 3.263, respectively) represent higher nonlinearity, and lower ke0p and ke0r
(0.239 and 0.3612, respectively) indicate sluggishness in response. For the sensitive
patient k10p, k12p, k13p, k10r, k12r and k13r are low (0.08925, 0.084, 0.031425, 0.38175,
0.2715 and 0.00975, respectively) and k21p, k31p, k21r and k31r are high (0.06875,
161
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0.004125, 0.24375 and 0.0175, respectively). In the PD parameters, lower EC50p and
EC50r (1.6 and 7.84, respectively) indicate that less drug is required to get the same
hypnosis and analgesia levels, lower p and r (2 and 1.757, respectively) represent
lower nonlinearity, and higher ke0p and ke0r (0.459 and 0.6708, respectively) indicate
faster response. Inverse of ke0p and ke0r represent lag in the response with higher
values of these parameters representing faster response and lower values representing
slower response of the process.
Table 6.8 shows the performance comparison of MPC and decentralized PID con-
trollers for sensitive and insensitive patients together with their control eorts. For
both the controllers, high IAE values for the insensitive patient indicate the slug-
gish response (needs more drug) whereas low IAE values for the sensitive patient
indicate the faster response (needs less drug) when compared to the IAE values for
Table 6.8
Performance of MPC and PID for sensitive and insensitive patients
for the set-point changes during the maintenance period
Controller
Insensitive Patient Sensitive Patient
IAEBIS IAEMAP TVP TVR IAEBIS IAEMAP TVP TVR
MPC 1210 344 37.8 2.98 662 261 25.8 2.46
PID 1246 388 40.8 6.38 711 271 28.6 6.00
the nominal patient given in Table 6.5. Also, as mentioned earlier, C1p and C1r
are predicted using the nominal patient model. For the sensitive patient, nominal
patient model predicts lesser concentration than the actual concentration because it
infuses less drug based on the larger gain BIS response to propofol and remifentanil
infusions. Similarly, for the insensitive patient, higher C1p and C1r are predicted
with the nominal patient model than the actual concentration because more drug is
infused based on the smaller gain BIS and MAP responses to propofol and remifen-
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tanil infusions. Even though predicted concentrations are dierent from the actual
concentrations for these patients, the constraints imposed are not exceeded.
Figure 6.9 shows the performance comparison of MPC and PID controllers for
the maintenance period, t = 30 { 280 min for the 28 patients. Figures 6.9(a) and
(b) show the comparison of IAE values with respect to BIS and MAP, respectively
and Figures 6.9(c) and (d) show comparison of controller eort with respect to
propofol and remifentanil, respectively. Table 6.9 shows the average performance
and control eort of both controllers for the 28 patients together with corresponding
standard deviations. Here, IAEBIS values are high compared to IAEMAP because
changes in MAP aects the BIS response and not vice versa; possible reasons for
Table 6.9
Average performance of MPC and PID for the set-point changes
during the maintenance period, for 28 patients
Controller Mean IAEBIS (SD) Mean IAEMAP (SD) Mean TVP (SD) Mean TVR (SD)
MPC 905 (165) 299 (23) 30.1 (2.84) 2.76 (0.12)
PID 948 (169) 325 (26) 34.5 (3.05) 6.23 (0.09)
this are: (a) propofol aects BIS only whereas remifentanil aects both BIS and
MAP, and (b) nonlinear relation between eect concentration and BIS (see section
6.2.2). Hence, by considering average IAE and control eorts, controlling BIS is
critical compared to controlling MAP. Also, increase in remifentanil infusion adds
like an additive disturbance to BIS response - therefore, propofol infusion needs to be
changed to bring BIS to the specied set-point. From Table 6.9, it is clear that the
average performance of MPC controller is better compared to PID controller both
in terms of set-point tracking and control eort. Further, Figure 6.9 shows that
MPC performance is better than that of PID controller except for a few patients for
whom IAEBIS is comparable for both the controllers.
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Fig. 6.9. Performance of MPC and PID for all the 28 patients for
set-point changes during the maintenance period t = 30 { 280 min
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6.4.3 Performance of MPC and PID for disturbance rejection in BIS
and MAP during surgery
Surgical stimulation can cause arousal reex in the patient leading to distur-
bances in BIS and MAP during surgery. Strength of these disturbances is directly
proportional to the nature of surgical stimulus, and these disturbances increase
both BIS and MAP (Derighetti et al. 1997, Frei et al. 2000). Also, in typical op-
erating conditions, BIS and MAP signals are corrupted by noise as mentioned in
section 6.4.2. For better control performance, noise and disturbances in the BIS and
MAP signals must be handled appropriately (e.g., ltering noise). If not, it will be
harmful to the patient due to wrong drug dosage delivered to the patient. Here,
the simulations are carried out by adding 2% Gaussian noise to the BIS and MAP
signals. Noise in BIS and MAP signals cause uctuations in propofol and remifen-
tanil infusion rates leading to higher valve movement. Hence, lters are added to
feedback BIS and MAP signals to get smoother drug infusion proles. For the dis-
turbance, a typical stimulus prole (Struys et al. 2004) for BIS and MAP signals is
applied from t = 280 { 400 min to all the patients.
Figure 6.10 depicts the responses of MPC and PID controllers for disturbances in
the BIS and MAP signals for the nominal patient. Figures 6.10(a) and (b) shows the
regulation of BIS and MAP at set-point of 50 and 80, respectively for the nominal
patient. Both the controllers maintained the BIS and MAP within the operating
range in spite of noise in both signals. However, higher disturbance magnitudes
with higher frequency for longer duration of time causes the BIS and MAP signals
to cross the respective surgical operating range (40  BIS  60 & 70  MAP
 110) during the period of disturbance. From these gures, one can observe that
the disturbance in BIS (at t = 280 min) does not aect the MAP response but
disturbance in MAP (at t = 310 min) aects the BIS response because of the eect
of remifentanil infusion change to counteract the disturbance in MAP, on BIS. This
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is the same case with the disturbances in the remaining time period, t = 340 { 400
min. Also, when disturbance occurs, MAP settles very fast relative to BIS. This
is because propofol and remifentanil have to cross many barriers within the body
to aect BIS compared to remifentanil alone on MAP. Whenever BIS and MAP
increase due to disturbances, the controller will increase the corresponding plasma
drug concentrations, C1p and C1r (not shown) by increasing the infusion rates of
propofol and remifentanil (Figures 6.10(c) and (d)) to bring back BIS and MAP
to their original set-points. Even when BIS and MAP went out of their limits,
the controller maintained C1p and C1r within the constraints imposed and this is
very important for patient safety. Noise in BIS and MAP has very little eect on
predicted drug concentrations.
The performance of both controllers is checked for the remaining 27 patients and
the IAE and TV values are provided in Table 6.10 for the insensitive, nominal
and sensitive patients. Here also, response for the sensitive patient is faster (less
drug usage) and response for the insensitive patient is sluggish (high drug usage)
compared to response with the nominal patient. Figure 6.11 shows the performance
Table 6.10
Performance of MPC and PID controllers during disturbances for
sensitive, nominal and insensitive patients
Controller
MPC PID
IAEBIS IAEMAP TVP TVR IAEBIS IAEMAP TVP TVR
Insensitive Patient 847 788 39.7 9.96 1152 802 35.2 7.78
Nominal Patient 695 665 29.7 8.22 803 755 24.4 6.81
Sensitive Patient 617 641 24.2 7.42 726 733 21.0 6.25
comparison of MPC and PID controllers in the disturbance period, t = 280 { 440
min for the 28 patients. Table 6.11 compares the average performance and control
167
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Fig. 6.10. Performance of MPC and PID controllers for disturbance rejection
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Fig. 6.11. Performance of MPC and PID for all the 28 patients for
disturbances in BIS and MAP
Table 6.11
Average performance of MPC and PID controllers during distur-
bances for the 28 patients
Controller Mean IAEBIS (SD) Mean IAEMAP (SD) Mean TVP (SD) Mean TVR (SD)
MPC 716 (54) 668 (31) 32.4 (3.16) 8.66 (0.54)
PID 861 (83) 760 (15) 27.7 (3.91) 6.97 (0.43)
eort of both controllers together with their corresponding standard deviations.
From Figure 6.11 and Table 6.11, one can clearly conclude that the performance of
MPC is better than that of PID controller. The average control eort with MPC is
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higher compared to PID { this clearly shows the aggressive nature of MPC compared
to PID. This is not the case with set-point changes made during the maintenance
period discussed earlier. Here, larger disturbances cause higher valve movement
leading to higher control eort with MPC. These disturbance eects dominate the
eect of noise in BIS and MAP signals which mostly aect the performance and
control eort of decentralized PID compared to MPC.
6.5 Conclusions
Simultaneous automatic regulation of multiple drugs has more advantages when
compared to the automatic regulation of a single drug and manual administration of
other drugs. In this study, an advanced control strategy (model predictive control)
for simultaneous regulation of hypnosis and analgesia using BIS and MAP as respec-
tive controlled variables has been developed. The performance of the MPC controller
is compared with the performance of the decentralized PID control scheme. Both
the controllers were designed for the nominal patient model, and then tested for
their ecacy and robustness on 28 patient models covering sensitive to insensitive
patients and operating conditions via simulation. The MPC controller is capable of
improving hypnosis and analgesia regulation by 10 to 15% compared to decentral-
ized PID controller, and also displays better robustness in set-point tracking and
disturbance rejection when implemented on dierent patient proles.
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Chapter 7
CONCLUSIONS AND RECOMMENDATIONS
The previous chapters in this thesis described the application and simulation
results of several advanced feedback control techniques applied for regulating two
anesthetic components (hypnosis and analgesia) during surgery. General control
strategies such as PI, PID, PID-P and PID-PI as well as advanced model based
control strategies such as IMC, MEC (also in their cascade versions), RTDA and
MPC were considered in this work. The following concluding remarks are drawn
from the present study conducted on feedback control of hypnosis and analgesia.
7.1 Conclusions
Chapter 3 demonstrated the automatic control of hypnosis using bispectral index
(BIS) as the controlled variable and isourane infusion as the manipulated variable.
The main objective of this chapter was to design and evaluate the performance
of MPC and the RTDA control strategies. Further, the performance of these two
model based controllers was compared with the performance of SISO PI & PID and
also cascade PID-P & PID-PI controllers. The performance comparison of these six
controllers was conducted by considering parameter variations in the patient model
to account for patient-model mismatch, set-point changes and disturbances during
the surgery. For realistic assessment, measurement noise (white noise with zero mean
and SD of 3) was added to the BIS signal in the simulations. These performance
validations were done on a set of 16 patient proles that were constructed based on
dierent isourane sensitivities. MPC and RTDA controllers performed better and
were also found to more robust compared to PI/PID controllers. When compared to
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PI/PID, cascade controllers provided better and robust performance but not as good
as MPC or RTDA. Also, to cope with the possible loss of BIS signal during surgery,
estimation of a patient-specic EC50 value (based on BIS and endtidal concentration
measurements in the induction period) and its use for estimating BIS for subsequent
feedback was proposed, and its eectiveness was shown via simulation with all the
six controllers.
The automatic control of hypnosis using BIS as the controlled variable by ma-
nipulating isourane infusion is further studied in chapter 4. The performance of
the devised model predictive controller (MPC) was comprehensively compared with
the performances of cascade internal model control (CIMC) and cascade modeling
error compensation (CMEC) approaches available in the literature. The proposed
MPC used the approximate linear PK-PD model in the controller design which was
obtained by linearization of the nonlinear model around the operating point (BIS
equal to 50). A set of 28 patient proles (by varying PK-PD model parameters) was
constructed to represent patients with dierent drug sensitivities. MPC scheme pro-
vided better performance compared to other two control schemes while respecting
the imposed constraints on the manipulated and output variables. It is also more
robust to inter-patient variability and performed well in the presence of disturbances
and measurement noise in BIS signal.
The studies in chapters 3 and 4 were on closed-loop regulation of hypnosis with the
inhalational drug isourane. The study in chapter 5 evaluated the performances of
MPC, IMC and MEC controllers for closed-loop regulation of hypnosis using intra-
venous drug propofol with BIS as the controlled variable. Cascade control structures
used for closed-loop regulation of isourane in chapters 3 and 4 are impractical with
propofol because of unavailability of continuous plasma propofol concentration mea-
surement. Hence, instead of their cascade versions, SISO MEC and IMC strategies
were employed in this chapter. The performance of these model-based controllers
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were considered along with that of the conventional PID controller. A well-accepted
propofol PK-PD model taken from the literature and a set of 17 patient proles (ob-
tained by varying PK-PD model parameters) was constructed to represent patients
with dierent propofol sensitivities. Extensive simulations were conducted to test
the performance of the four controllers for robustness, set-point tracking, distur-
bance and noise rejection characteristics. Here also, model-based controllers (MPC,
IMC and MEC) showed robust performance, and were found to be better at handling
disturbances and measurement noise in comparison with the PID controller. Ex-
cessive manipulated variable movement was observed with MEC controller (because
of noise) when compared to MPC controller even though performances of both the
controllers appeared to be similar. With IMC controller, small manipulated move-
ment was observed but its performance turned out to be poorer compared to that
of the remaining two model-based controllers. Among the four controllers, MPC
performed better. Finally, the performance of MPC and PID controllers was com-
pared with that of the novel RTDA controller. The RTDA controller performance
was found to be better than the PID controller and even slightly better than the
MPC when tested on the same patient models. The RTDA controller appears to be
more robust compared to MPC and PID.
While studies in chapters 3 to 5 were limited to regulation of hypnosis by infusing
either isourane or propofol, the study in chapter 6 investigated the simultane-
ous closed-loop regulation of hypnosis and analgesia by infusing intravenous drugs
propofol and remifentanil. This chapter demonstrated the design and thorough eval-
uation of a MPC controller for optimal infusion of both propofol and remifentanil to
regulate patient's hypnotic and analgesic states (measured by BIS and MAP respec-
tively). Extensive simulations were conducted to test the robustness of the proposed
MPC controller, by considering parameter variations in the PK and PD models (28
patient models covering the entire spectrum of sensitive to insensitive patients) and
typical set-point changes and disturbances during surgical operations. Also, the per-
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formance of the MPC controller was compared with that of the decentralized PID
control scheme for all the above mentioned scenarios. Results show that the MPC
controller provides better performance when compared to decentralized PID con-
troller, and also displayed better robustness in set-point tracking and disturbance
rejection when implemented on dierent patient proles. When compared to results
in chapter 5, less propofol was infused for the same BIS set-point change (because of
synergistic interaction of propofol and remifentanil) and hence propofol overdosage
was limited. This is good for the patient's rehabilitation as less time will be spent
in postoperative care leading to a reduction in the cost of surgery.
All the above studies indicated that the model-based controllers work well, more
robust and suitable in surgical settings. Out of all the controllers studied, MPC
showed robust performance in all the scenarios tested and is therefore recommended
as a promising strategy for controlling hypnosis as well as simultaneous control of
hypnosis and analgesia. In general, comprehensive simulations and evaluations per-
formed in this study provide greater condence on closed-loop control of anesthesia
and its benets. Also, the patient proles developed and used in the present study
will be useful in future studies on anesthesia control.
7.2 Recommendations for Future Work
In this section several important topics on modeling and control of anesthesia are
outlined for further investigation.
7.2.1 Simultaneous control of hypnosis, analgesia and skeletal muscle
relaxation
During general anesthesia, drugs are administered to provide hypnosis, ensure
analgesia and skeletal muscle relaxation. As discussed in the previous chapters, hyp-
nosis is controlled by administration of hypnotic drugs (e.g., isourane, propofol),
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analgesia is maintained by administration of opioids (e.g., remifentanil, alfentanil)
and muscle relaxation is controlled using neuromuscular blocking agents (e.g., mi-
dazolam, mivacurium and rocuronium). Up to now, very few control strategies were
studied for simultaneous regulation of hypnosis and analgesia with limited combina-
tion of hypnotic and analgesic drugs (e.g., propofol and remifentanil). These control
strategies can be extended to other combinations of hypnotic and analgesic drugs
also (e.g., isourane and remifentanil, isourane and alfentanil, propofol and alfen-
tanil etc.). Although volatile hypnotic agents like isourane have slower onset and
require actuators which are dicult to handle than actuators for intravenous drugs
such as propofol, their concentrations in the central compartment can be measured
online. Also, opioids (e.g., remifentanil, alfentanil) can potentiate the hypotensive
eects of isourane, and hence further decrease in opioids infusion can be achieved
to get the same level of MAP. For some of the surgeries, skeletal muscle relaxation
should be maintained within acceptable limits. The administered neuro muscular
blocking agents to maintain skeletal muscle relaxation will also aect the properties
of both hypnotics and analgesics. Up to now, there is little or no work done on
the simultaneous regulation of hypnosis, analgesia and skeletal muscle relaxation.
Hence, it is desirable to develop and study a control strategy to regulate all these
three anesthesia components simultaneously. The available interaction models for
the drug combinations involving propofol, alfentanil and midazolam (e.g., Minto
et al. (2000)) can be used for such a study.
7.2.2 Fault-tolerant control
Occasionally, measurement artifacts deteriorate the controller's performance and
can be harmful to the patient. These artifacts could arise due to noise in the
measurement signals as well as due to disconnection of the sensors from the patient.
The designed controller should handle all these typical types of artifacts to assure
patient's safety. For this, a multivariable controller can be designed for simultaneous
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regulation of all anesthetic components and hemodynamic variables (e.g., cardiac
output (CO), blood pressure (BP) etc.). This controller should perform satisfactorily
even when any of the controlled output signals (e.g., BIS, MAP, CO and BP) have
artifacts. For example, when artifacts are present in the MAP signal, one should not
use MAP as the controlled variable but use the reliable measurements like CO or
BP as the controlled variable. To detect artifacts in any of the measured signals, an
observer based control algorithm (e.g., Noura et al. (2009)) can be developed based
on signal quality index (SQI). This algorithm will alert the controller on which signal
is reliable for use with the control algorithm to regulate the controlled outputs.
7.2.3 Nonlinear model-based control
The models developed for the drug eects and the eect of combination of drugs
are nonlinear. On the other hand, many of the developed control algorithms use
linearized models. Hence, the designed controller may not perform well. Nonlinear
controllers (e.g., Ricker & Lee (1995)) for anesthesia regulation can be developed to
further improve the patient's safety and rehabilitation during surgery.
7.2.4 Clinical validation
Although, this thesis has highlighted the superior performance of several model-
based controllers for anesthesia regulation using simulations, their clinical appli-
cability and performance need to be demonstrated. Hence, clinical tests must be
conducted before the developed control system can be used by the clinical sta in
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